Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


Articles published in Vaccine

Retrieve available abstracts of 790 articles:
HTML format
Text format



Single Articles


    May 2017
  1. HIRTH JM, Chang M, Resto VA
    Prevalence of oral human papillomavirus by vaccination status among young adults (18-30years old).
    Vaccine. 2017 May 16. pii: S0264-410X(17)30633.
    PubMed     Text format     Abstract available


  2. BUCKINGHAM L, Becher J, Voytek CD, Fiore D, et al
    Going social: Success in online recruitment of men who have sex with men for prevention HIV vaccine research.
    Vaccine. 2017 May 16. pii: S0264-410X(17)30587.
    PubMed     Text format     Abstract available


  3. AINSWORTH S, Ketter PM, Yu JJ, Grimm RC, et al
    Vaccination with a live attenuated Acinetobacter baumannii deficient in thioredoxin provides protection against systemic Acinetobacter infection.
    Vaccine. 2017 May 15. pii: S0264-410X(17)30625.
    PubMed     Text format     Abstract available


  4. LONE NA, Spackman E, Kapczynski D
    Immunologic evaluation of 10 different adjuvants for use in vaccines for chickens against highly pathogenic avian influenza virus.
    Vaccine. 2017 May 13. pii: S0264-410X(17)30608.
    PubMed     Text format     Abstract available


  5. KLEIN NP, Bartlett J, Fireman B, Aukes L, et al
    Waning protection following 5 doses of a 3-component diphtheria, tetanus, and acellular pertussis vaccine.
    Vaccine. 2017 May 12. pii: S0264-410X(17)30606.
    PubMed     Text format     Abstract available


  6. PATEL A, Erb SM, Strange L, Shukla RS, et al
    Combined semi-empirical screening and design of experiments (DOE) approach to identify candidate formulations of a lyophilized live attenuated tetravalent viral vaccine candidate.
    Vaccine. 2017 May 12. pii: S0264-410X(17)30602.
    PubMed     Text format     Abstract available


  7. WU HW, Fu ZQ, Lu K, Pond-Tor S, et al
    Vaccination with recombinant paramyosin in Montanide ISA206 protects against Schistosoma japonicum infection in water buffalo.
    Vaccine. 2017 May 11. pii: S0264-410X(17)30605.
    PubMed     Text format     Abstract available


  8. KOTIRUM S, Vutipongsatorn N, Kongpakwattana K, Hutubessy R, et al
    Global economic evaluations of rotavirus vaccines: A systematic review.
    Vaccine. 2017 May 11. pii: S0264-410X(17)30543.
    PubMed     Text format     Abstract available


  9. HOLMGREN J, Parashar UD, Plotkin S, Louis J, et al
    Correlates of protection for enteric vaccines.
    Vaccine. 2017 May 11. pii: S0264-410X(17)30603.
    PubMed     Text format     Abstract available


  10. DUMAS EK, Garman L, Cuthbertson H, Charlton S, et al
    Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated.
    Vaccine. 2017 May 11. pii: S0264-410X(17)30604.
    PubMed     Text format     Abstract available


  11. BERMAN M, Dube E, Quach C
    Exploring the acceptability of the available pneumococcal conjugate vaccines in Canadian health care professionals and immunization experts.
    Vaccine. 2017 May 10. pii: S0264-410X(17)30584.
    PubMed     Text format     Abstract available


  12. NAVARRO-ILLANA E, Lopez-Lacort M, Navarro-Illana P, Vilata JJ, et al
    Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain.
    Vaccine. 2017 May 9. pii: S0264-410X(17)30581.
    PubMed     Text format     Abstract available


  13. CAO W, Kim JH, Reber AJ, Hoelscher M, et al
    Nasal delivery of Protollin-adjuvanted H5N1 vaccine induces enhanced systemic as well as mucosal immunity in mice.
    Vaccine. 2017 May 9. pii: S0264-410X(17)30600.
    PubMed     Text format     Abstract available


  14. DE OLIVEIRA JS, Costa GB, Franco Luiz APM, Leite JA, et al
    Cross-sectional study involving healthcare professionals in a Vaccinia virus endemic area.
    Vaccine. 2017 May 8. pii: S0264-410X(17)30540.
    PubMed     Text format     Abstract available


  15. ARAFAT N, Eladl AH, Mahgoub H, El-Shafei RA, et al
    Effect of infectious bursal disease (IBD) vaccine on Salmonella Enteritidis infected chickens.
    Vaccine. 2017 May 8. pii: S0264-410X(17)30577.
    PubMed     Text format     Abstract available


  16. WON G, Kim B, Lee JH
    A novel approach for construction of an inactivated typhoid vaccine candidate that effectively augments both humoral and cellular immune responses.
    Vaccine. 2017 May 8. pii: S0264-410X(17)30585.
    PubMed     Text format     Abstract available


  17. BROKER M, Berti F, Schneider J, Vojtek I, et al
    Polysaccharide conjugate vaccine protein carriers as a "neglected valency" - Potential and limitations.
    Vaccine. 2017 May 6. pii: S0264-410X(17)30579.
    PubMed     Text format     Abstract available


  18. DENG Y, Chuai X, Chen P, Chen H, et al
    Recombinant vaccinia vector-based vaccine (Tiantan) boosting a novel HBV subunit vaccine induced more robust and lasting immunity in rhesus macaques.
    Vaccine. 2017 May 6. pii: S0264-410X(17)30551.
    PubMed     Text format     Abstract available


  19. CHADA KE, Forshee R, Golding H, Anderson S, et al
    A systematic review and meta-analysis of cross-reactivity of antibodies induced by oil-in-water emulsion adjuvanted influenza H5N1 virus monovalent vaccines.
    Vaccine. 2017 May 5. pii: S0264-410X(17)30507.
    PubMed     Text format     Abstract available


  20. FONSECA JA, McCaffery JN, Kashentseva E, Singh B, et al
    A prime-boost immunization regimen based on a simian adenovirus 36 vectored multi-stage malaria vaccine induces protective immunity in mice.
    Vaccine. 2017 May 5. pii: S0264-410X(17)30554.
    PubMed     Text format     Abstract available


  21. MANGEN MJ, Stibbe H, Urbanus A, Siedenburg EC, et al
    Targeted outreach hepatitis B vaccination program in high-risk adults: The fundamental challenge of the last mile.
    Vaccine. 2017 May 5. pii: S0264-410X(17)30560.
    PubMed     Text format     Abstract available


  22. IRO MA, Snape MD, Voysey M, Jawad S, et al
    Corrigendum to "Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial" [Vaccine 35 (
    Vaccine. 2017 May 5. pii: S0264-410X(17)30582.
    PubMed     Text format    


  23. PAN H, Li Z, Wang J, Song S, et al
    Bacterially expressed human papillomavirus type 6 and 11 bivalent vaccine: Characterization, antigenicity and immunogenicity.
    Vaccine. 2017 May 5. pii: S0264-410X(17)30556.
    PubMed     Text format     Abstract available


  24. XING J, Xu H, Wang Y, Tang X, et al
    Identification of immunogenic proteins and evaluation of four recombinant proteins as potential vaccine antigens from Vibrio anguillarum in flounder (Paralichthys olivaceus).
    Vaccine. 2017 May 5. pii: S0264-410X(17)30572.
    PubMed     Text format     Abstract available


  25. LI X, Huang J, Kawamura A, Funakoshi R, et al
    Co-localization of a CD1d-binding glycolipid with an adenovirus-based malaria vaccine for a potent adjuvant effect.
    Vaccine. 2017 May 5. pii: S0264-410X(17)30578.
    PubMed     Text format     Abstract available


  26. ZERBO O, Modaressi S, Chan B, Goddard K, et al
    No association between influenza vaccination during pregnancy and adverse birth outcomes.
    Vaccine. 2017 May 5. pii: S0264-410X(17)30575.
    PubMed     Text format     Abstract available


  27. SALEEM AF, Mach O, Yousafzai MT, Khan A, et al
    Needle adapters for intradermal administration of fractional dose of inactivated poliovirus vaccine: Evaluation of immunogenicity and programmatic feasibility in Pakistan.
    Vaccine. 2017 May 4. pii: S0264-410X(17)30576.
    PubMed     Text format     Abstract available


  28. HOSHI SL, Kondo M, Okubo I
    Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan.
    Vaccine. 2017 May 4. pii: S0264-410X(17)30537.
    PubMed     Text format     Abstract available


  29. IDOKO OT, Mboizi RB, Okoye M, Laudat F, et al
    Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine (PCV13) formulated with 2-phenoxyethanol in multidose vials given with routine vaccination in healthy infants: An open-label randomized controlled trial.
    Vaccine. 2017 May 4. pii: S0264-410X(17)30541.
    PubMed     Text format     Abstract available


  30. IZAC JR, Oliver LD Jr, Earnhart CG, Marconi RT, et al
    Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development.
    Vaccine. 2017 May 4. pii: S0264-410X(17)30580.
    PubMed     Text format     Abstract available


  31. PARK SH, Kim SA, Rubinelli PM, Roto SM, et al
    Microbial compositional changes in broiler chicken cecal contents from birds challenged with different Salmonella vaccine candidate strains.
    Vaccine. 2017 May 4. pii: S0264-410X(17)30574.
    PubMed     Text format     Abstract available


  32. HENDIN HE, Pillet S, Lara AN, Wu CY, et al
    Plant-made virus-like particle vaccines bearing the hemagglutinin of either seasonal (H1) or avian (H5) influenza have distinct patterns of interaction with human immune cells in vitro.
    Vaccine. 2017;35:2592-2599.
    PubMed     Text format     Abstract available


  33. ODUTOLA A, Ota MO, Antonio M, Ogundare EO, et al
    Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study.
    Vaccine. 2017;35:2531-2542.
    PubMed     Text format     Abstract available


  34. WONG CKH, Liao Q, Guo VYW, Xin Y, et al
    Cost-effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review.
    Vaccine. 2017 May 2. pii: S0264-410X(17)30542.
    PubMed     Text format     Abstract available


  35. BOGGIANO C, Eichelberg K, Ramachandra L, Shea J, et al
    "The Impact of Mycobacterium tuberculosis Immune Evasion on Protective Immunity: Implications for TB Vaccine Design" - Meeting report.
    Vaccine. 2017 May 2. pii: S0264-410X(17)30467.
    PubMed     Text format     Abstract available


  36. SAHIN Z, Akkoc S, Neeleman R, Haines J, et al
    Nile Red fluorescence spectrum decomposition enables rapid screening of large protein aggregates in complex biopharmaceutical formulations like influenza vaccines.
    Vaccine. 2017 May 2. pii: S0264-410X(17)30558.
    PubMed     Text format     Abstract available


    April 2017
  37. COHET C, Rosillon D, Willame C, Haguinet F, et al
    Challenges in conducting post-authorisation safety studies (PASS): A vaccine manufacturer's view.
    Vaccine. 2017 Apr 29. pii: S0264-410X(17)30550.
    PubMed     Text format     Abstract available


  38. ARRIOLA CS, Vasconez N, Thompson MG, Olsen SJ, et al
    Association of influenza vaccination during pregnancy with birth outcomes in Nicaragua.
    Vaccine. 2017 Apr 29. pii: S0264-410X(17)30536.
    PubMed     Text format     Abstract available


  39. DUNN AG, Surian D, Leask J, Dey A, et al
    Mapping information exposure on social media to explain differences in HPV vaccine coverage in the United States.
    Vaccine. 2017 Apr 28. pii: S0264-410X(17)30552.
    PubMed     Text format     Abstract available


  40. HU D, Bowder D, Wei W, Thompson J, et al
    Tryptophan 375 stabilizes the outer-domain core of gp120 for HIV vaccine immunogen design.
    Vaccine. 2017 Apr 28. pii: S0264-410X(17)30546.
    PubMed     Text format     Abstract available


  41. WICHGERS SCHREUR PJ, van Keulen L, Kant J, Kortekaas J, et al
    Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy.
    Vaccine. 2017 Apr 27. pii: S0264-410X(17)30498.
    PubMed     Text format     Abstract available


  42. BAXTER R, Eaton A, Hansen J, Aukes L, et al
    Corrigendum to "Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years" [Vaccine 35 (2017) 1254-1258].
    Vaccine. 2017 Apr 27. pii: S0264-410X(17)30553.
    PubMed     Text format    


  43. LU PJ, O'Halloran A, Kennedy ED, Williams WW, et al
    Awareness among adults of vaccine-preventable diseases and recommended vaccinations, United States, 2015.
    Vaccine. 2017 Apr 27. pii: S0264-410X(17)30503.
    PubMed     Text format     Abstract available


  44. DIAZ ORTEGA JL, Castaneda D, Arellano Quintanilla DM, Martinez D, et al
    Antibody persistence in children aged 6-7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection.
    Vaccine. 2017 Apr 27. pii: S0264-410X(17)30501.
    PubMed     Text format     Abstract available


  45. ZHANG Y, Wu P, Feng L, Yang P, et al
    Influenza vaccine effectiveness against influenza-associated hospitalization in 2015/16 season, Beijing, China.
    Vaccine. 2017 Apr 26. pii: S0264-410X(17)30436.
    PubMed     Text format     Abstract available


  46. SHANKAR MB, Staples JE, Meltzer MI, Fischer M, et al
    Cost effectiveness of a targeted age-based West Nile virus vaccination program.
    Vaccine. 2017 Apr 26. pii: S0264-410X(16)31149.
    PubMed     Text format     Abstract available


  47. JIANG P, Cai Y, Chen J, Ye X, et al
    Evaluation of tandem Chlamydia trachomatis MOMP multi-epitopes vaccine in BALB/c mice model.
    Vaccine. 2017 Apr 26. pii: S0264-410X(17)30509.
    PubMed     Text format     Abstract available


  48. PERRY J, Towers CV, Weitz B, Wolfe L, et al
    Patient reaction to Tdap vaccination in pregnancy.
    Vaccine. 2017 Apr 26. pii: S0264-410X(17)30521.
    PubMed     Text format     Abstract available


  49. KAPCZYNSKI DR, Pantin-Jackwood MJ, Spackman E, Chrzastek K, et al
    Homologous and heterologous antigenic matched vaccines containing different H5 hemagglutinins provide variable protection of chickens from the 2014 U.S. H5N8 and H5N2 clade 2.3.4.4 highly pathogenic avian influenza viruses.
    Vaccine. 2017 Apr 26. pii: S0264-410X(17)30520.
    PubMed     Text format     Abstract available


  50. DOMBKOWSKI KJ, Cowan AE, Reeves SL, Foley MR, et al
    The impacts of email reminder/recall on adolescent influenza vaccination.
    Vaccine. 2017 Apr 25. pii: S0264-410X(17)30511.
    PubMed     Text format     Abstract available


  51. LOPEZ-MEDINA E, Melgar M, Gaensbauer JT, Bandyopadhyay AS, et al
    Inactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin America.
    Vaccine. 2017 Apr 25. pii: S0264-410X(17)30519.
    PubMed     Text format     Abstract available


  52. MOBERLEY S, Licciardi PV, Balloch A, Andrews R, et al
    Repeat pneumococcal polysaccharide vaccine in Indigenous Australian adults is associated with decreased immune responsiveness.
    Vaccine. 2017 Apr 25. pii: S0264-410X(17)30518.
    PubMed     Text format     Abstract available


  53. D'ADDARIO M, Redmond S, Scott P, Egli-Gany D, et al
    Two-dose schedules for human papillomavirus vaccine: Systematic review and meta-analysis.
    Vaccine. 2017 Apr 25. pii: S0264-410X(17)30448.
    PubMed     Text format     Abstract available


  54. LEE BY, Wedlock PT, Haidari LA, Elder K, et al
    Economic impact of thermostable vaccines.
    Vaccine. 2017 Apr 25. pii: S0264-410X(17)30433.
    PubMed     Text format     Abstract available


  55. SANDHU SK, Hua W, MaCurdy TE, Franks RL, et al
    Near real-time surveillance for Guillain-Barre syndrome after influenza vaccination among the Medicare population, 2010/11 to 2013/14.
    Vaccine. 2017 Apr 24. pii: S0264-410X(17)30439.
    PubMed     Text format     Abstract available


  56. SIL A, Ravi MD, Patnaik BN, Dhingra MS, et al
    Effect of prophylactic or therapeutic administration of paracetamol on immune response to DTwP-HepB-Hib combination vaccine in Indian infants.
    Vaccine. 2017 Apr 24. pii: S0264-410X(17)30315.
    PubMed     Text format     Abstract available


  57. TSABAN G, Ben-Shimol S
    Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature.
    Vaccine. 2017 Apr 24. pii: S0264-410X(17)30510.
    PubMed     Text format     Abstract available


  58. KOHN M, Schaffner W
    Vaccinating adults with chronic disease: We can do better.
    Vaccine. 2017 Apr 24. pii: S0264-410X(17)30368.
    PubMed     Text format    


  59. VERANI JR, Baqui AH, Broome CV, Cherian T, et al
    Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls.
    Vaccine. 2017 Apr 22. pii: S0264-410X(17)30515.
    PubMed     Text format     Abstract available


  60. VERANI JR, Baqui AH, Broome CV, Cherian T, et al
    Case-control vaccine effectiveness studies: Data collection, analysis and reporting results.
    Vaccine. 2017 Apr 22. pii: S0264-410X(17)30513.
    PubMed     Text format     Abstract available


  61. MANNING NM, Bachanek-Bankowska K, Mertens PPC, Castillo-Olivares J, et al
    Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.
    Vaccine. 2017 Apr 21. pii: S0264-410X(17)30465.
    PubMed     Text format     Abstract available


  62. AFKHAMI S, LeClair DA, Haddadi S, Lai R, et al
    Spray dried human and chimpanzee adenoviral-vectored vaccines are thermally stable and immunogenic in vivo.
    Vaccine. 2017 Apr 21. pii: S0264-410X(17)30500.
    PubMed     Text format     Abstract available


  63. PEREZ-BREVA L, Abad-Torreblanca R, Martinez-Beneito MA, Puig-Barbera J, et al
    Seroprevalence of antibodies against serogroup C meningococci in the region of Valencia, Spain: Impact of meningococcal C conjugate vaccination.
    Vaccine. 2017 Apr 21. pii: S0264-410X(17)30486.
    PubMed     Text format     Abstract available


  64. ANAND A, Molodecky NA, Pallansch MA, Sutter RW, et al
    Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: A novel dose sparing immunization schedule.
    Vaccine. 2017 Apr 20. pii: S0264-410X(17)30314.
    PubMed     Text format     Abstract available


  65. SEREMBA E, Van Geertruyden JP, Ssenyonga R, Opio CK, et al
    Early childhood transmission of hepatitis B prior to the first hepatitis B vaccine dose is rare among babies born to HIV-infected and non-HIV infected mothers in Gulu, Uganda.
    Vaccine. 2017 Apr 20. pii: S0264-410X(17)30484.
    PubMed     Text format     Abstract available


  66. NAIK SP, Zade JK, Sabale RN, Pisal SS, et al
    Stability of heat stable, live attenuated Rotavirus vaccine (ROTASIIL(R)).
    Vaccine. 2017 Apr 20. pii: S0264-410X(17)30499.
    PubMed     Text format     Abstract available


  67. MOHD AZIZI FS, Kew Y, Moy FM
    Vaccine hesitancy among parents in a multi-ethnic country, Malaysia.
    Vaccine. 2017 Apr 20. pii: S0264-410X(17)30472.
    PubMed     Text format     Abstract available


  68. AZIMI T, Franzel L, Probst N
    Seizing market shaping opportunities for vaccine cold chain equipment.
    Vaccine. 2017;35:2260-2264.
    PubMed     Text format     Abstract available


  69. KARTOGLU U, Vesper J, Teras H, Reeves T, et al
    Experiential and authentic learning approaches in vaccine management.
    Vaccine. 2017;35:2243-2251.
    PubMed     Text format     Abstract available


  70. KAHN AL, Kristensen D, Rao R
    Extending supply chains and improving immunization coverage and equity through controlled temperature chain use of vaccines.
    Vaccine. 2017;35:2214-2216.
    PubMed     Text format    


  71. HUANG XX, Guillermet E, Le Gargasson JB, Alfa DA, et al
    Costing analysis and anthropological assessment of the vaccine supply chain system redesign in the Come District (Benin).
    Vaccine. 2017;35:2183-2188.
    PubMed     Text format     Abstract available


  72. AINA M, Igbokwe U, Jegede L, Fagge R, et al
    Preliminary results from direct-to-facility vaccine deliveries in Kano, Nigeria.
    Vaccine. 2017;35:2175-2182.
    PubMed     Text format     Abstract available


  73. SARLEY D, Mahmud M, Idris J, Osunkiyesi M, et al
    Transforming vaccines supply chains in Nigeria.
    Vaccine. 2017;35:2167-2174.
    PubMed     Text format     Abstract available


  74. ERIKSSON P, Gessner BD, Jaillard P, Morgan C, et al
    Vaccine vial monitor availability and use in low- and middle-income countries: A systematic review.
    Vaccine. 2017;35:2155-2161.
    PubMed     Text format     Abstract available


  75. HANSON CM, George AM, Sawadogo A, Schreiber B, et al
    Is freezing in the vaccine cold chain an ongoing issue? A literature review.
    Vaccine. 2017;35:2127-2133.
    PubMed     Text format     Abstract available


  76. LYDON P, Schreiber B, Gasca A, Dumolard L, et al
    Vaccine stockouts around the world: Are essential vaccines always available when needed?
    Vaccine. 2017;35:2121-2126.
    PubMed     Text format     Abstract available


  77. LLOYD J, Cheyne J
    The origins of the vaccine cold chain and a glimpse of the future.
    Vaccine. 2017;35:2115-2120.
    PubMed     Text format     Abstract available


  78. BROOKS A, Habimana D, Huckerby G
    Making the leap into the next generation: A commentary on how Gavi, the Vaccine Alliance is supporting countries' supply chain transformations in 2016-2020.
    Vaccine. 2017;35:2110-2114.
    PubMed     Text format    


  79. SUNASARA K, Cundy J, Srinivasan S, Evans B, et al
    Bivalent rLP2086 (Trumenba(R)): Development of a well-characterized vaccine through commercialization.
    Vaccine. 2017 Apr 19. pii: S0264-410X(17)30474.
    PubMed     Text format     Abstract available


  80. KIM N, Mountain TP
    Role of non-traditional locations for seasonal flu vaccination: Empirical evidence and evaluation.
    Vaccine. 2017 Apr 19. pii: S0264-410X(17)30487.
    PubMed     Text format     Abstract available


  81. TRAUSCH JJ, Shank-Retzlaff M, Verch T
    Replacing antibodies with modified DNA aptamers in vaccine potency assays.
    Vaccine. 2017 Apr 19. pii: S0264-410X(17)30454.
    PubMed     Text format     Abstract available


  82. PEREZ-CASAL J, Prysliak T, Maina T, Suleman M, et al
    Status of the development of a vaccine against Mycoplasma bovis.
    Vaccine. 2017 Apr 19. pii: S0264-410X(17)30447.
    PubMed     Text format     Abstract available


  83. NEVES FPG, Cardoso NT, Snyder RE, Marlow MA, et al
    Pneumococcal carriage among children after four years of routine 10-valent pneumococcal conjugate vaccine use in Brazil: The emergence of multidrug resistant serotype 6C.
    Vaccine. 2017 Apr 18. pii: S0264-410X(17)30483.
    PubMed     Text format     Abstract available


  84. CHATTOPADHYAY R, Pratt D
    Role of controlled human malaria infection (CHMI) in malaria vaccine development: A U.S. food & drug administration (FDA) perspective.
    Vaccine. 2017 Apr 18. pii: S0264-410X(17)30406.
    PubMed     Text format    


  85. WILKINSON K, Wei Y, Szwajcer A, Rabbani R, et al
    Efficacy and safety of high-dose influenza vaccine in elderly adults: A systematic review and meta-analysis.
    Vaccine. 2017 Apr 18. pii: S0264-410X(17)30444.
    PubMed     Text format     Abstract available


  86. BREAKWELL L, Anga J, Dadari I, Sadr-Azodi N, et al
    Evaluation of storing hepatitis B vaccine outside the cold chain in the Solomon Islands: Identifying opportunities and barriers to implementation.
    Vaccine. 2017 Apr 18. pii: S0264-410X(17)30473.
    PubMed     Text format     Abstract available


  87. NAKATSUKASA A, Kuruma K, Okamatsu M, Hiono T, et al
    Potency of whole virus particle and split virion vaccines using dissolving microneedle against challenges of H1N1 and H5N1 influenza viruses in mice.
    Vaccine. 2017 Apr 18. pii: S0264-410X(17)30469.
    PubMed     Text format     Abstract available



  88. Tetanus vaccines: WHO position paper, February 2017 - Recommendations.
    Vaccine. 2017 Apr 17. pii: S0264-410X(17)30228.
    PubMed     Text format     Abstract available


  89. LOZE PM, Nasciben LB, Sartori AMC, Itria A, et al
    Vaccines are different: A systematic review of budget impact analyses of vaccines.
    Vaccine. 2017 Apr 17. pii: S0264-410X(17)30440.
    PubMed     Text format     Abstract available


  90. SUH J, Kim B, Yang Y, Suh DC, et al
    Cost effectiveness of influenza vaccination in patients with acute coronary syndrome in Korea.
    Vaccine. 2017 Apr 17. pii: S0264-410X(17)30480.
    PubMed     Text format     Abstract available


  91. DAUNER A, Agrawal P, Salvatico J, Tapia T, et al
    The in vitro MIMIC(R) platform reflects age-associated changes in immunological responses after influenza vaccination.
    Vaccine. 2017 Apr 13. pii: S0264-410X(17)30451.
    PubMed     Text format     Abstract available


  92. MULLER T, Becker E, Stallmann S, Waldhuber A, et al
    Vaccination with the polymorphic membrane protein a reduces Chlamydia muridarum induced genital tract pathology.
    Vaccine. 2017 Apr 13. pii: S0264-410X(17)30481.
    PubMed     Text format     Abstract available


  93. SMITH TRF, Schultheis K, Morrow MP, Kraynyak KA, et al
    Development of an intradermal DNA vaccine delivery strategy to achieve single-dose immunity against respiratory syncytial virus.
    Vaccine. 2017 Apr 13. pii: S0264-410X(17)30468.
    PubMed     Text format     Abstract available


  94. VAN DOORN E, Darvishian M, Dijkstra F, Donker GA, et al
    Influenza vaccine effectiveness estimates in the Dutch population from 2003 to 2014: The test-negative design case-control study with different control groups.
    Vaccine. 2017 Apr 12. pii: S0264-410X(17)30476.
    PubMed     Text format     Abstract available


  95. GROOT N, Pileggi G, Sandoval CB, Grein I, et al
    Original article: Varicella vaccination elicits a humoral and cellular response in children with rheumatic diseases using immune suppressive treatment.
    Vaccine. 2017 Apr 12. pii: S0264-410X(17)30479.
    PubMed     Text format     Abstract available


  96. EILERS R, de Melker HE, Veldwijk J, Krabbe PFM, et al
    Vaccine preferences and acceptance of older adults.
    Vaccine. 2017 Apr 12. pii: S0264-410X(17)30478.
    PubMed     Text format     Abstract available


  97. GUO N, Zhang G, Zhu D, Wang J, et al
    The effects of convenience and quality on the demand for vaccination: Results from a discrete choice experiment.
    Vaccine. 2017 Apr 12. pii: S0264-410X(17)30466.
    PubMed     Text format     Abstract available


  98. HUIJTS SM, van Werkhoven CH, Bolkenbaas M, Grobbee DE, et al
    Post-hoc analysis of a randomized controlled trial: Diabetes mellitus modifies the efficacy of the 13-valent pneumococcal conjugate vaccine in elderly.
    Vaccine. 2017 Apr 12. pii: S0264-410X(17)30151.
    PubMed     Text format     Abstract available


  99. ZANGENAH S, Bjorkhem-Bergman L, Norlin AC, Hansen S, et al
    The Pneumocell-study: Vaccination of IgG1- and IgG2-deficient patients with Prevnar13.
    Vaccine. 2017 Apr 11. pii: S0264-410X(17)30449.
    PubMed     Text format     Abstract available


  100. BERLANDA SCORZA F
    Advancing new vaccines against pandemic influenza in low-resource countries.
    Vaccine. 2017 Apr 11. pii: S0264-410X(17)30446.
    PubMed     Text format     Abstract available


  101. BERESFORD NJ, Martino A, Feavers IM, Corbel MJ, et al
    Quality, immunogenicity and stability of meningococcal serogroup ACWY-CRM197, DT and TT glycoconjugate vaccines.
    Vaccine. 2017 Apr 10. pii: S0264-410X(17)30393.
    PubMed     Text format     Abstract available


  102. MCLEAN HQ, Caspard H, Griffin MR, Poehling KA, et al
    Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season.
    Vaccine. 2017 Apr 10. pii: S0264-410X(17)30437.
    PubMed     Text format     Abstract available


  103. SEANEHIA J, Treibich C, Holmberg C, Muller-Nordhorn J, et al
    Quantifying population preferences around vaccination against severe but rare diseases: A conjoint analysis among French university students, 2016.
    Vaccine. 2017 Apr 10. pii: S0264-410X(17)30438.
    PubMed     Text format     Abstract available


  104. FAVATO G, Easton T, Vecchiato R, Noikokyris E, et al
    Ecological validity of cost-effectiveness models of universal HPV vaccination: A systematic literature review.
    Vaccine. 2017 Apr 10. pii: S0264-410X(17)30445.
    PubMed     Text format     Abstract available


  105. WU Y, Zhu R, Xu L, Li Y, et al
    A novel combined vaccine based on monochimeric VLP co-displaying multiple conserved epitopes against enterovirus 71 and varicella-zoster virus.
    Vaccine. 2017 Apr 10. pii: S0264-410X(17)30392.
    PubMed     Text format     Abstract available


  106. JIANG HY, Wang SY, Deng M, Li YC, et al
    Immune response to hepatitis B vaccination among people with inflammatory bowel diseases: A systematic review and meta-analysis.
    Vaccine. 2017 Apr 9. pii: S0264-410X(17)30432.
    PubMed     Text format     Abstract available


  107. DHAR JP, Essenmacher L, Dhar R, Magee A, et al
    The safety and immunogenicity of Quadrivalent HPV (qHPV) vaccine in systemic lupus erythematosus.
    Vaccine. 2017 Apr 9. pii: S0264-410X(17)30452.
    PubMed     Text format     Abstract available


  108. KASTING ML, Lake P, Vadaparampil ST
    Physicians' current use and preferences for male HPV vaccine-related patient education materials.
    Vaccine. 2017 Apr 9. pii: S0264-410X(17)30450.
    PubMed     Text format     Abstract available


  109. RAY GT, Lewis N, Goddard K, Ross P, et al
    Asthma exacerbations among asthmatic children receiving live attenuated versus inactivated influenza vaccines.
    Vaccine. 2017 Apr 9. pii: S0264-410X(17)30434.
    PubMed     Text format     Abstract available


  110. KRAAN H, Soema P, Amorij JP, Kersten G, et al
    Intranasal and sublingual delivery of inactivated polio vaccine.
    Vaccine. 2017 Apr 8. pii: S0264-410X(17)30442.
    PubMed     Text format     Abstract available


  111. COOPER DL, Hernandez ND, Rollins L, Akintobi TH, et al
    HPV vaccine awareness and the association of trust in cancer information from physicians among males.
    Vaccine. 2017 Apr 7. pii: S0264-410X(17)30435.
    PubMed     Text format     Abstract available


  112. GUPTA A, Ahmed KA, Ayalew LE, Popowich S, et al
    Immunogenicity and protective efficacy of virus-like particles and recombinant fiber proteins in broiler-breeder vaccination against fowl adenovirus (FAdV)-8b.
    Vaccine. 2017 Apr 7. pii: S0264-410X(17)30409.
    PubMed     Text format     Abstract available


  113. FISHBOURNE E, Ludi AB, Wilsden G, Hamblin P, et al
    Efficacy of a high potency O1 Manisa foot-and-mouth disease vaccine in cattle against heterologous challenge with a field virus from the O/ME-SA/Ind-2001 lineage collected in North Africa.
    Vaccine. 2017 Apr 7. pii: S0264-410X(17)30250.
    PubMed     Text format     Abstract available


  114. KIRKWOOD CD, Ma LF, Carey ME, Steele AD, et al
    The rotavirus vaccine development pipeline.
    Vaccine. 2017 Apr 7. pii: S0264-410X(17)30410.
    PubMed     Text format     Abstract available


  115. MELNYCHUK L, Ajamian L, Jean-Pierre P, Liang J, et al
    Development of a DNA vaccine expressing a secreted HIV-1 gp41 ectodomain that includes the membrane-proximal external region.
    Vaccine. 2017 Apr 6. pii: S0264-410X(17)30355.
    PubMed     Text format     Abstract available


  116. HOFSTETTER AM, Robinson JD, Lepere K, Cunningham M, et al
    Clinician-parent discussions about influenza vaccination of children and their association with vaccine acceptance.
    Vaccine. 2017 Apr 6. pii: S0264-410X(17)30411.
    PubMed     Text format     Abstract available


  117. AIREY J, Albano FR, Sawlwin DC, Jones AG, et al
    Immunogenicity and safety of a quadrivalent inactivated influenza virus vaccine compared with a comparator quadrivalent inactivated influenza vaccine in a pediatric population: A phase 3, randomized noninferiority study.
    Vaccine. 2017 Apr 5. pii: S0264-410X(17)30334.
    PubMed     Text format     Abstract available


  118. AFONSO MM, Pinchbeck GL, Smith SL, Daly JM, et al
    A multi-national European cross-sectional study of feline calicivirus epidemiology, diversity and vaccine cross-reactivity.
    Vaccine. 2017 Apr 4. pii: S0264-410X(17)30336.
    PubMed     Text format     Abstract available



  119. Malaria vaccine: WHO position paper, January 2016 - Recommendations.
    Vaccine. 2017 Apr 3. pii: S0264-410X(16)30982.
    PubMed     Text format     Abstract available


  120. PEIFFER-SMADJA N, Ouedraogo R, D'Ortenzio E, Cisse PN, et al
    Vaccination and blood sampling acceptability during Ramadan fasting month: A cross-sectional study in Conakry, Guinea.
    Vaccine. 2017 Apr 3. pii: S0264-410X(17)30395.
    PubMed     Text format     Abstract available


  121. LEUNG VK, Carolan LA, Worth LJ, Harper SA, et al
    Influenza vaccination responses: Evaluating impact of repeat vaccination among health care workers.
    Vaccine. 2017 Apr 3. pii: S0264-410X(17)30390.
    PubMed     Text format     Abstract available


    March 2017
  122. ROBERTS LM, Wehrly TD, Crane DD, Bosio CM, et al
    Expansion and retention of pulmonary CD4+ T cells after prime boost vaccination correlates with improved longevity and strength of immunity against tularemia.
    Vaccine. 2017 Mar 31. pii: S0264-410X(17)30391.
    PubMed     Text format     Abstract available


  123. BARRETT AD
    Yellow fever live attenuated vaccine: A very successful live attenuated vaccine but still we have problems controlling the disease.
    Vaccine. 2017 Mar 30. pii: S0264-410X(17)30338.
    PubMed     Text format     Abstract available


  124. TANG X, Guo J, Cheng L, Sun C, et al
    Single N277A substitution in C2 of simian immunodeficiency virus envelope influences vaccine-elicited CD4i neutralizing and anti-V2 antibody responses.
    Vaccine. 2017 Mar 30. pii: S0264-410X(17)30389.
    PubMed     Text format     Abstract available


  125. KIMIZUKA Y, Callahan JJ, Huang Z, Morse K, et al
    Semiconductor diode laser device adjuvanting intradermal vaccine.
    Vaccine. 2017 Mar 29. pii: S0264-410X(17)30342.
    PubMed     Text format     Abstract available


  126. ARSENAULT C, Johri M, Nandi A, Mendoza Rodriguez JM, et al
    Country-level predictors of vaccination coverage and inequalities in Gavi-supported countries.
    Vaccine. 2017 Mar 29. pii: S0264-410X(17)30335.
    PubMed     Text format     Abstract available


  127. TONTINI M, Romano MR, Proietti D, Balducci E, et al
    Corrigendum to "Preclinical studies on new proteins as carrier for glycoconjugate vaccines" [Vaccine 34 (2016) 4235-4242].
    Vaccine. 2017 Mar 29. pii: S0264-410X(17)30317.
    PubMed     Text format    


  128. WARD C, Byrne L, White JM, Amirthalingam G, et al
    Sociodemographic predictors of variation in coverage of the national shingles vaccination programme in England, 2014/15.
    Vaccine. 2017 Mar 28. pii: S0264-410X(17)30358.
    PubMed     Text format     Abstract available


  129. DUNCAN JR, Witkop CT, Webber BJ, Costello AA, et al
    Varicella seroepidemiology in United States air force recruits: A retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection.
    Vaccine. 2017 Mar 27. pii: S0264-410X(17)30371.
    PubMed     Text format     Abstract available


  130. LEURIDAN E
    Pertussis vaccination in pregnancy: State of the art.
    Vaccine. 2017 Mar 27. pii: S0264-410X(17)30388.
    PubMed     Text format     Abstract available


  131. IMBURGIA TM, Hendrix KS, Donahue KL, Sturm LA, et al
    Predictors of influenza vaccination in the U.S. among children 9-13years of age.
    Vaccine. 2017 Mar 27. pii: S0264-410X(17)30387.
    PubMed     Text format     Abstract available


  132. LI X, Yang L, Zhao P, Yao Y, et al
    Adjuvanticity of a CTLA-4 3' UTR complementary oligonucleotide for emulsion formulated recombinant subunit and inactivated vaccines.
    Vaccine. 2017 Mar 27. pii: S0264-410X(17)30359.
    PubMed     Text format     Abstract available


  133. SURAGH TA, Miller ER, Hibbs BF, Winiecki SK, et al
    Cognitive testing to evaluate revisions to the Vaccine Adverse Event Reporting System (VAERS) reporting form.
    Vaccine. 2017 Mar 25. pii: S0264-410X(17)30372.
    PubMed     Text format     Abstract available


  134. LOBAINA Y, Michel ML
    Chronic hepatitis B: Immunological profile and current therapeutic vaccines in clinical trials.
    Vaccine. 2017 Mar 25. pii: S0264-410X(17)30366.
    PubMed     Text format     Abstract available


  135. OFSTEAD CL, Amelang MR, Wetzler HP, Tan L, et al
    Moving the needle on nursing staff influenza vaccination in long-term care: Results of an evidence-based intervention.
    Vaccine. 2017 Mar 25. pii: S0264-410X(17)30357.
    PubMed     Text format     Abstract available


  136. CHARLTON HUME HK, Lua LH
    Platform technologies for modern vaccine manufacturing.
    Vaccine. 2017 Mar 24. pii: S0264-410X(17)30365.
    PubMed     Text format     Abstract available


  137. TRICARICO S, McNeil HC, Head MG, Cleary DW, et al
    Informing pneumococcal conjugate vaccine policy in middle-income countries: The case of Malaysia.
    Vaccine. 2017 Mar 24. pii: S0264-410X(17)30370.
    PubMed     Text format    


  138. MACDOUGALL DM, Langley JM, Li L, Ye L, et al
    Knowledge, attitudes, beliefs, and behaviors of university students, faculty, and staff during a meningococcal serogroup B outbreak vaccination program.
    Vaccine. 2017 Mar 24. pii: S0264-410X(17)30176.
    PubMed     Text format     Abstract available


  139. HELLFRITZSCH M, Thomsen RW, Baggesen LM, Larsen FB, et al
    Lifestyle, socioeconomic characteristics, and medical history of elderly persons who receive seasonal influenza vaccination in a tax-supported healthcare system.
    Vaccine. 2017 Mar 23. pii: S0264-410X(17)30356.
    PubMed     Text format     Abstract available


  140. GALDO NOVO S, Malirat V, Maradei ED, Espinoza AM, et al
    Antigenic and immunogenic spectrum of foot-and-mouth disease vaccine strain O1 Campos against representative viruses of topotypes that circulated in Asia over the past decade.
    Vaccine. 2017 Mar 23. pii: S0264-410X(17)30332.
    PubMed     Text format     Abstract available


  141. XU L, Zhao J, Liu M, Kurath G, et al
    A effective DNA vaccine against diverse genotype J infectious hematopoietic necrosis virus strains prevalent in China.
    Vaccine. 2017 Mar 23. pii: S0264-410X(17)30363.
    PubMed     Text format     Abstract available


  142. JAIN A, van Hoek AJ, Boccia D, Thomas SL, et al
    Lower vaccine uptake amongst older individuals living alone: A systematic review and meta-analysis of social determinants of vaccine uptake.
    Vaccine. 2017 Mar 23. pii: S0264-410X(17)30319.
    PubMed     Text format     Abstract available


  143. SHI J, Feng Y, Gao L, Feng D, et al
    Immunogenicity and safety of a high-dose hepatitis B vaccine among patients receiving methadone maintenance treatment: A randomized, double-blinded, parallel-controlled trial.
    Vaccine. 2017 Mar 23. pii: S0264-410X(17)30340.
    PubMed     Text format     Abstract available


  144. TIAN D, Cao D, Lynn Heffron C, Yugo DM, et al
    Enhancing heterologous protection in pigs vaccinated with chimeric porcine reproductive and respiratory syndrome virus containing the full-length sequences of shuffled structural genes of multiple heterologous strains.
    Vaccine. 2017 Mar 23. pii: S0264-410X(17)30362.
    PubMed     Text format     Abstract available


  145. FELL DB, Bhutta ZA, Hutcheon JA, Karron RA, et al
    Report of the WHO technical consultation on the effect of maternal influenza and influenza vaccination on the developing fetus: Montreal, Canada, September 30-October 1, 2015.
    Vaccine. 2017 Mar 23. pii: S0264-410X(17)30373.
    PubMed     Text format     Abstract available


  146. LUO K, Zavala F, Gordy J, Zhang H, et al
    Extended protection capabilities of an immature dendritic-cell targeting malaria sporozoite vaccine.
    Vaccine. 2017 Mar 22. pii: S0264-410X(17)30369.
    PubMed     Text format     Abstract available


  147. YANG Y, Zhao Q, Li Z, Sun L, et al
    Stabilization study of inactivated foot and mouth disease virus vaccine by size-exclusion HPLC and differential scanning calorimetry.
    Vaccine. 2017 Mar 22. pii: S0264-410X(17)30343.
    PubMed     Text format     Abstract available


  148. CHITLARU T, Israeli M, Rotem S, Elia U, et al
    A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
    Vaccine. 2017 Mar 22. pii: S0264-410X(17)30339.
    PubMed     Text format     Abstract available


  149. WELAGA P, Oduro A, Debpuur C, Aaby P, et al
    Fewer out-of-sequence vaccinations and reduction of child mortality in Northern Ghana.
    Vaccine. 2017 Mar 21. pii: S0264-410X(17)30310.
    PubMed     Text format     Abstract available


  150. KOEPKE R, Schauer SL, Davis JP
    Measuring maternal Tdap and influenza vaccination rates: Comparison of two population-based methods.
    Vaccine. 2017 Mar 21. pii: S0264-410X(17)30330.
    PubMed     Text format     Abstract available


  151. WEYER CT, Grewar JD, Burger P, Joone C, et al
    Dynamics of African horse sickness virus nucleic acid and antibody in horses following immunization with a commercial polyvalent live attenuated vaccine.
    Vaccine. 2017 Mar 21. pii: S0264-410X(17)30311.
    PubMed     Text format     Abstract available


  152. NEELS P, Southern J, Abramson J, Duclos P, et al
    Off-label use of vaccines.
    Vaccine. 2017 Mar 21. pii: S0264-410X(17)30269.
    PubMed     Text format     Abstract available


  153. TITBALL RW, Burtnick MN, Bancroft GJ, Brett P, et al
    Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials?
    Vaccine. 2017 Mar 20. pii: S0264-410X(17)30328.
    PubMed     Text format     Abstract available


  154. IWATA S, Okada K, Kawana K
    Consensus statement from 17 relevant Japanese academic societies on the promotion of the human papillomavirus vaccine.
    Vaccine. 2017 Mar 18. pii: S0264-410X(17)30321.
    PubMed     Text format    


  155. KANG GJ, Culp RK, Abbas KM
    Facilitators and barriers of parental attitudes and beliefs toward school-located influenza vaccination in the United States: Systematic review.
    Vaccine. 2017 Mar 17. pii: S0264-410X(17)30320.
    PubMed     Text format     Abstract available


  156. XU B, Zhu D, Bi Y, Wang Y, et al
    Minimal association of alleles of human leukocyte antigen class II gene and long-term antibody response to hepatitis B vaccine vaccinated during infancy.
    Vaccine. 2017 Mar 17. pii: S0264-410X(17)30327.
    PubMed     Text format     Abstract available


  157. DAVTYAN H, Chen WW, Zagorski K, Davis J, et al
    MultiTEP platform-based DNA epitope vaccine targeting N-terminus of tau induces strong immune responses and reduces tau pathology in THY-Tau22 mice.
    Vaccine. 2017 Mar 17. pii: S0264-410X(17)30326.
    PubMed     Text format     Abstract available


  158. SCHODEL F, Moreland NJ, Wittes JT, Mulholland K, et al
    Clinical development strategy for a candidate group A streptococcal vaccine.
    Vaccine. 2017 Mar 16. pii: S0264-410X(17)30273.
    PubMed     Text format     Abstract available


  159. ANDRADE AL, Minamisava R, Tomich LM, Lemos AP, et al
    Impact of meningococcal C conjugate vaccination four years after introduction of routine childhood immunization in Brazil.
    Vaccine. 2017 Mar 15. pii: S0264-410X(17)30316.
    PubMed     Text format     Abstract available


  160. P SAFADI MA, Martinon-Torres F, Weckx LY, Moreira ED Junior, et al
    Immunogenicity and safety of concomitant administration of meningococcal serogroup B (4CMenB) and serogroup C (MenC-CRM) vaccines in infants: A phase 3b, randomized controlled trial.
    Vaccine. 2017 Mar 15. pii: S0264-410X(17)30295.
    PubMed     Text format     Abstract available


  161. NISSEN TN, Birk NM, Smits G, Jeppesen DL, et al
    Bacille Calmette-Guerin (BCG) vaccination at birth and antibody responses to childhood vaccines. A randomised clinical trial.
    Vaccine. 2017 Mar 15. pii: S0264-410X(17)30251.
    PubMed     Text format     Abstract available


  162. GIERSING BK, Karron RA, Vekemans J, Kaslow DC, et al
    Meeting report: WHO consultation on Respiratory Syncytial Virus (RSV) vaccine development, Geneva, 25-26 April 2016.
    Vaccine. 2017 Mar 14. pii: S0264-410X(17)30293.
    PubMed     Text format     Abstract available


  163. LANSBURY LE, Smith S, Beyer W, Karamehic E, et al
    Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: A systematic review and meta-analysis.
    Vaccine. 2017 Mar 14. pii: S0264-410X(17)30272.
    PubMed     Text format     Abstract available


  164. CHI H, Zheng X, Wang X, Wang C, et al
    DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice.
    Vaccine. 2017 Mar 14. pii: S0264-410X(17)30288.
    PubMed     Text format     Abstract available


  165. TREANOR JT, Albano FR, Sawlwin DC, Graves Jones A, et al
    Immunogenicity and safety of a quadrivalent inactivated influenza vaccine compared with two trivalent inactivated influenza vaccines containing alternate B strains in adults: A phase 3, randomized noninferiority study.
    Vaccine. 2017 Mar 13. pii: S0264-410X(17)30291.
    PubMed     Text format     Abstract available


  166. MADAN A, Ferguson M, Rheault P, Seiden D, et al
    Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in adults 65years of age and older: A phase II, observer-blind, randomized, controlled trial.
    Vaccine. 2017 Mar 13. pii: S0264-410X(17)30270.
    PubMed     Text format     Abstract available


  167. VENTURAS C, Umeh K
    Health professional feedback on HPV vaccination roll-out in a developing country.
    Vaccine. 2017 Mar 10. pii: S0264-410X(17)30265.
    PubMed     Text format     Abstract available


  168. MOSNIER A, Daviaud I, Caini S, Berche H, et al
    Does seasonal vaccination affect the clinical presentation of influenza among the elderly? A cross-sectional analysis in the outpatient setting in France, 2003-2014.
    Vaccine. 2017 Mar 10. pii: S0264-410X(17)30292.
    PubMed     Text format     Abstract available


  169. FORD T, Wenden C, Mbekeani A, Dally L, et al
    Cryopreservation-related loss of antigen-specific IFNgamma producing CD4+ T-cells can skew immunogenicity data in vaccine trials: Lessons from a malaria vaccine trial substudy.
    Vaccine. 2017 Mar 9. pii: S0264-410X(17)30241.
    PubMed     Text format     Abstract available


  170. KURZ X, Bauchau V, Mahy P, Glismann S, et al
    The ADVANCE Code of Conduct for collaborative vaccine studies.
    Vaccine. 2017 Mar 9. pii: S0264-410X(17)30242.
    PubMed     Text format     Abstract available


  171. DALEY MF, Glanz JM, Newcomer SR, Jackson ML, et al
    Assessing misclassification of vaccination status: Implications for studies of the safety of the childhood immunization schedule.
    Vaccine. 2017 Mar 9. pii: S0264-410X(17)30271.
    PubMed     Text format     Abstract available


  172. UI H, Yamayoshi S, Uraki R, Kiso M, et al
    Evaluation of seasonal influenza vaccines for H1N1pdm09 and type B viruses based on a replication-incompetent PB2-KO virus.
    Vaccine. 2017 Mar 9. pii: S0264-410X(17)30244.
    PubMed     Text format     Abstract available


  173. LEVIN Y, Kochba E, Mani S
    Cutaneous vaccination: Briefings of the third skin vaccination summit, September 2-4, 2015, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
    Vaccine. 2017 Mar 8. pii: S0264-410X(17)30268.
    PubMed     Text format    


  174. SEIB K, Pollard AJ, de Wals P, Andrews RM, et al
    Policy making for vaccine use as a driver of vaccine innovation and development in the developed world.
    Vaccine. 2017;35:1380-1389.
    PubMed     Text format     Abstract available


  175. OVSYANNIKOVA IG, Larrabee BR, Schaid DJ, Poland GA, et al
    Immunoglobulin GM and KM genes and measles vaccine-induced humoral immunity.
    Vaccine. 2017 Mar 6. pii: S0264-410X(17)30249.
    PubMed     Text format     Abstract available


  176. LIU CC, Wu SC, Wu SR, Lin HY, et al
    Enhancing enterovirus A71 vaccine production yield by microcarrier profusion bioreactor culture.
    Vaccine. 2017 Mar 6. pii: S0264-410X(17)30245.
    PubMed     Text format     Abstract available


  177. ALLEMANN A, Frey PM, Brugger SD, Hilty M, et al
    Pneumococcal carriage and serotype variation before and after introduction of pneumococcal conjugate vaccines in patients with acute otitis media in Switzerland.
    Vaccine. 2017 Mar 6. pii: S0264-410X(17)30174.
    PubMed     Text format     Abstract available


  178. PROBST P, Grigg JB, Wang M, Munoz E, et al
    A small-molecule IRF3 agonist functions as an influenza vaccine adjuvant by modulating the antiviral immune response.
    Vaccine. 2017 Mar 6. pii: S0264-410X(17)30118.
    PubMed     Text format     Abstract available


  179. GERSHWIN LJ, Behrens NE, McEligot HA, Carvallo-Chaigneau FR, et al
    A recombinant subunit vaccine for bovine RSV and Histophilus somni protects calves against dual pathogen challenge.
    Vaccine. 2017 Mar 5. pii: S0264-410X(17)30125.
    PubMed     Text format     Abstract available


  180. SETH L, Bingham Ferlez KM, Kaba SA, Musser DM, et al
    Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum Circumsporozoite Protein delivered in three Army Liposome Formulation adjuvants.
    Vaccine. 2017 Mar 5. pii: S0264-410X(17)30243.
    PubMed     Text format     Abstract available


  181. PORTER CK, Sorrell T, Mitra I, Riddle MS, et al
    Vaccination of active component US military personnel against Salmonella Typhi.
    Vaccine. 2017 Mar 3. pii: S0264-410X(17)30263.
    PubMed     Text format     Abstract available


  182. PARRINO J, McNeil SA, Lawrence SJ, Kimby E, et al
    Safety and immunogenicity of inactivated varicella-zoster virus vaccine in adults with hematologic malignancies receiving treatment with anti-CD20 monoclonal antibodies.
    Vaccine. 2017 Mar 3. pii: S0264-410X(16)30990.
    PubMed     Text format     Abstract available


  183. BEYERLEIN A, Strobl AN, Winkler C, Carpus M, et al
    Vaccinations in early life are not associated with development of islet autoimmunity in type 1 diabetes high-risk children: Results from prospective cohort data.
    Vaccine. 2017 Mar 3. pii: S0264-410X(17)30262.
    PubMed     Text format     Abstract available


  184. KUCK LR, Saye S, Loob S, Roth-Eichhorn S, et al
    VaxArray assessment of influenza split vaccine potency and stability.
    Vaccine. 2017 Mar 2. pii: S0264-410X(17)30222.
    PubMed     Text format     Abstract available


  185. HOTEZ PJ
    Developing and financing neglected disease vaccines in our new era of "blue marble health" and the anthropocene epoch.
    Vaccine. 2017 Mar 2. pii: S0264-410X(17)30165.
    PubMed     Text format     Abstract available


  186. GIERSING BK, Vekemans J, Nava S, Kaslow DC, et al
    Report from the World Health Organization's third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8-10th June 2016.
    Vaccine. 2017 Mar 2. pii: S0264-410X(16)31205.
    PubMed     Text format     Abstract available


  187. MYERS TR, McNeil MM, Ng CS, Li R, et al
    Adverse events following quadrivalent meningococcal CRM-conjugate vaccine (Menveo(R)) reported to the Vaccine Adverse Event Reporting system (VAERS), 2010-2015.
    Vaccine. 2017 Mar 2. pii: S0264-410X(17)30224.
    PubMed     Text format     Abstract available


  188. WYSOCKI J, Center KJ, Brzostek J, Majda-Stanislawska E, et al
    A randomized study of fever prophylaxis and the immunogenicity of routine pediatric vaccinations.
    Vaccine. 2017 Mar 2. pii: S0264-410X(17)30229.
    PubMed     Text format     Abstract available


  189. WORLD HEALTH ORGANIZATION
    Dengue vaccine: WHO position paper, July 2016 - recommendations.
    Vaccine. 2017;35:1200-1201.
    PubMed     Text format     Abstract available


  190. FUCHS LI, Fort MC, Cano D, Bonetti CM, et al
    Clearance of Tritrichomonas foetus in experimentally infected heifers protected with vaccines based on killed-T. foetus with different adjuvants.
    Vaccine. 2017;35:1341-1346.
    PubMed     Text format     Abstract available


  191. NARWANEY KJ, Breslin K, Ross CA, Shoup JA, et al
    Vaccine adverse events in a safety net healthcare system and a managed care organization.
    Vaccine. 2017;35:1335-1340.
    PubMed     Text format     Abstract available


    February 2017
  192. JACKSON LA, Frey SE, El Sahly HM, Mulligan MJ, et al
    Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial.
    Vaccine. 2017 Feb 27. pii: S0264-410X(17)30226.
    PubMed     Text format     Abstract available


  193. ANDREWS N, Stowe J, Miller E
    No increased risk of Guillain-Barre syndrome after human papilloma virus vaccine: A self-controlled case-series study in England.
    Vaccine. 2017 Feb 25. pii: S0264-410X(17)30156.
    PubMed     Text format     Abstract available


  194. MORTON JB, Morrill HJ, LaPlante KL, Caffrey AR, et al
    Risk stacking of pneumococcal vaccination indications increases mortality in unvaccinated adults with Streptococcus pneumoniae infections.
    Vaccine. 2017 Feb 25. pii: S0264-410X(17)30220.
    PubMed     Text format     Abstract available


  195. MANDOMANDO I, Weldegebriel G, de Deus N, Mwenda JM, et al
    Feasibility of using regional sentinel surveillance to monitor the rotavirus vaccine impact, effectiveness and intussusception incidence in the African Region.
    Vaccine. 2017 Feb 24. pii: S0264-410X(17)30152.
    PubMed     Text format     Abstract available


  196. CHANG X, Yu W, Ji S, Shen L, et al
    Conjugation of PEG-hexadecane markedly increases the immunogenicity of pneumococcal polysaccharide conjugate vaccine.
    Vaccine. 2017 Feb 24. pii: S0264-410X(17)30221.
    PubMed     Text format     Abstract available


  197. SMITH LE, Webster RK, Weinman J, Amlot R, et al
    Psychological factors associated with uptake of the childhood influenza vaccine and perception of post-vaccination side-effects: A cross-sectional survey in England.
    Vaccine. 2017 Feb 24. pii: S0264-410X(17)30225.
    PubMed     Text format     Abstract available


  198. LEVIN MJ, Huang S, Moscicki AB, Song LY, et al
    Four-year persistence of type-specific immunity after quadrivalent human papillomavirus vaccination in HIV-infected children: Effect of a fourth dose of vaccine.
    Vaccine. 2017 Feb 23. pii: S0264-410X(17)30215.
    PubMed     Text format     Abstract available


  199. XU H, Li X, Cui Z
    Toward understanding the mechanism underlying the strong adjuvant activity of aluminum salt nanoparticles. Ruwona TB, Xu H, Li X, Taylor AN, Shi Y, Cui Z. Vaccine 2016;34:3059-67.
    Vaccine. 2017;35:1102-1103.
    PubMed     Text format    


  200. MOLD M, Shardlow E, Exley C
    Toward understanding the mechanisms underlying the strong adjuvant activity of aluminium salt nanoparticles. Ruwona TB, Xu H, Li X, Taylor AN, Shi Y, Cui Z. Vaccine 2016;34:3059-67.
    Vaccine. 2017;35:1101.
    PubMed     Text format    


  201. PAGLIUSI S, Ting CC, Lobos F
    Vaccines: Shaping global health.
    Vaccine. 2017 Feb 22. pii: S0264-410X(17)30198.
    PubMed     Text format     Abstract available


  202. MADHI SA, Dangor Z
    Prospects for preventing infant invasive GBS disease through maternal vaccination.
    Vaccine. 2017 Feb 22. pii: S0264-410X(17)30219.
    PubMed     Text format     Abstract available


  203. LI Y, Meng F, Cui S, Fu J, et al
    Cooperative effects of immune enhancer TPPPS and different adjuvants on antibody responses induced by recombinant ALV-J gp85 subunit vaccines in SPF chickens.
    Vaccine. 2017 Feb 22. pii: S0264-410X(17)30216.
    PubMed     Text format     Abstract available


  204. KOIVISTO K, Puhakka L, Lappalainen M, Blomqvist S, et al
    Immunity against vaccine-preventable diseases in Finnish pediatric healthcare workers in 2015.
    Vaccine. 2017 Feb 20. pii: S0264-410X(17)30210.
    PubMed     Text format     Abstract available


  205. KLEIN NP, Lewis E, McDonald J, Fireman B, et al
    Risk factors and familial clustering for fever 7-10days after the first dose of measles vaccines.
    Vaccine. 2017 Feb 20. pii: S0264-410X(17)30194.
    PubMed     Text format     Abstract available


  206. BATRA SA, Shanthalingam S, Donofrio G, Haldorson GJ, et al
    Immunization of bighorn sheep against Mannheimia haemolytica with a bovine herpesvirus 1-vectored vaccine.
    Vaccine. 2017 Feb 19. pii: S0264-410X(17)30170.
    PubMed     Text format     Abstract available


  207. VAN AALST S, Ludwig IS, van Kooten PJ, van der Zee R, et al
    Dynamics of APC recruitment at the site of injection following injection of vaccine adjuvants.
    Vaccine. 2017 Feb 17. pii: S0264-410X(17)30168.
    PubMed     Text format     Abstract available


  208. MODOLO DG, Araldi RP, Mazzuchelli-de-Souza J, Pereira A, et al
    Integrated analysis of recombinant BPV-1 L1 protein for the production of a bovine papillomavirus VLP vaccine.
    Vaccine. 2017 Feb 17. pii: S0264-410X(17)30171.
    PubMed     Text format     Abstract available


  209. KRISS JL, Frew PM, Cortes M, Malik FA, et al
    Evaluation of two vaccine education interventions to improve pertussis vaccination among pregnant African American women: A randomized controlled trial.
    Vaccine. 2017 Feb 16. pii: S0264-410X(17)30086.
    PubMed     Text format     Abstract available


  210. LAVAN RP, King AI, Sutton DJ, Tunceli K, et al
    Rationale and support for a One Health program for canine vaccination as the most cost-effective means of controlling zoonotic rabies in endemic settings.
    Vaccine. 2017 Feb 16. pii: S0264-410X(17)30195.
    PubMed     Text format     Abstract available


  211. PRADA JM, Metcalf CJ, Takahashi S, Lessler J, et al
    Demographics, epidemiology and the impact of vaccination campaigns in a measles-free world - Can elimination be maintained?
    Vaccine. 2017 Feb 16. pii: S0264-410X(17)30172.
    PubMed     Text format     Abstract available


  212. DE SILVA R, Dasanayake WM, Wickramasinhe GD, Karunatilake C, et al
    Sensitization to bovine serum albumin as a possible cause of allergic reactions to vaccines.
    Vaccine. 2017 Feb 16. pii: S0264-410X(17)30173.
    PubMed     Text format     Abstract available


  213. MASLOW JN
    Vaccine development for emerging virulent infectious diseases.
    Vaccine. 2017 Feb 16. pii: S0264-410X(17)30196.
    PubMed     Text format     Abstract available


  214. NORRBY M, Vesikari T, Lindqvist L, Maeurer M, et al
    Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials.
    Vaccine. 2017 Feb 16. pii: S0264-410X(17)30120.
    PubMed     Text format     Abstract available


  215. CHEUNG K, Ho SM, Lam W
    Factors affecting the willingness of nursing students to receive annual seasonal influenza vaccination: A large-scale cross-sectional study.
    Vaccine. 2017 Feb 14. pii: S0264-410X(17)30164.
    PubMed     Text format     Abstract available


  216. WEILHAMMER D, Dunkle AD, Blanchette CD, Fischer NO, et al
    Enhancement of antigen-specific CD4+ and CD8+ T cell responses using a self-assembled biologic nanolipoprotein particle vaccine.
    Vaccine. 2017 Feb 14. pii: S0264-410X(17)30167.
    PubMed     Text format     Abstract available


  217. TRINH L, Macartney K, McIntyre P, Chiu C, et al
    Investigating adverse events following immunisation with pneumococcal polysaccharide vaccine using electronic General Practice data.
    Vaccine. 2017 Feb 12. pii: S0264-410X(17)30143.
    PubMed     Text format     Abstract available


  218. KHAN AI, Ali M, Chowdhury F, Saha A, et al
    Safety of the oral cholera vaccine in pregnancy: Retrospective findings from a subgroup following mass vaccination campaign in Dhaka, Bangladesh.
    Vaccine. 2017 Feb 11. pii: S0264-410X(17)30160.
    PubMed     Text format     Abstract available


  219. MEIJER WJ, Wensing AM, Bos AA, Kuiphuis JC, et al
    Influenza vaccination in healthcare workers; comparison of side effects and preferred route of administration of intradermal versus intramuscular administration.
    Vaccine. 2017 Feb 10. pii: S0264-410X(17)30145.
    PubMed     Text format     Abstract available


  220. ESQUERRE M, Momot M, Goubier A, Gonindard C, et al
    GTL001 and bivalent CyaA-based therapeutic vaccine strategies against human papillomavirus and other tumor-associated antigens induce effector and memory T-cell responses that inhibit tumor growth.
    Vaccine. 2017 Feb 10. pii: S0264-410X(17)30154.
    PubMed     Text format     Abstract available


  221. TAHA MK, Hawkins JC, Liberator P, Deghmane AE, et al
    Bactericidal activity of sera from adolescents vaccinated with bivalent rLP2086 against meningococcal serogroup B outbreak strains from France.
    Vaccine. 2017 Feb 10. pii: S0264-410X(17)30146.
    PubMed     Text format     Abstract available


  222. MCHUGH L, Andrews RM, Lambert SB, Viney KA, et al
    Birth outcomes for Australian mother-infant pairs who received an influenza vaccine during pregnancy, 2012-2014: The FluMum study.
    Vaccine. 2017 Feb 9. pii: S0264-410X(17)30155.
    PubMed     Text format     Abstract available


  223. POLLET J, Versteeg L, Rezende W, Strych U, et al
    A simple fluorescence-based assay for quantification of the Toll-Like Receptor agonist E6020 in vaccine formulations.
    Vaccine. 2017 Feb 9. pii: S0264-410X(17)30157.
    PubMed     Text format     Abstract available


  224. YANG FL, Lou TC, Kuo SC, Wu WL, et al
    A medically relevant capsular polysaccharide in Acinetobacter baumannii is a potential vaccine candidate.
    Vaccine. 2017 Feb 9. pii: S0264-410X(17)30126.
    PubMed     Text format     Abstract available


  225. CHAPPUIS F, Farinelli T, Deckx H, Sarnecki M, et al
    Immunogenicity and estimation of antibody persistence following vaccination with an inactivated virosomal hepatitis A vaccine in adults: A 20-year follow-up study.
    Vaccine. 2017 Feb 9. pii: S0264-410X(17)30080.
    PubMed     Text format     Abstract available


  226. LARROUY-MAUMUS G, Layre E, Clark S, Prandi J, et al
    Protective efficacy of a lipid antigen vaccine in a guinea pig model of tuberculosis.
    Vaccine. 2017 Feb 9. pii: S0264-410X(17)30159.
    PubMed     Text format     Abstract available


  227. JARRAHIAN C, Rein-Weston A, Saxon G, Creelman B, et al
    Vial usage, device dead space, vaccine wastage, and dose accuracy of intradermal delivery devices for inactivated poliovirus vaccine (IPV).
    Vaccine. 2017 Feb 8. pii: S0264-410X(17)30050.
    PubMed     Text format     Abstract available


  228. LENNY BJ, Sonnberg S, Danner AF, Friedman K, et al
    Evaluation of multivalent H2 influenza pandemic vaccines in mice.
    Vaccine. 2017 Feb 8. pii: S0264-410X(17)30061.
    PubMed     Text format     Abstract available


  229. SCHAID DJ, Haralambieva IH, Larrabee BR, Ovsyannikova IG, et al
    Heritability of vaccine-induced measles neutralizing antibody titers.
    Vaccine. 2017 Feb 8. pii: S0264-410X(17)30158.
    PubMed     Text format     Abstract available


  230. MADAN A, Ferguson M, Sheldon E, Segall N, et al
    Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in healthy adults: A phase I/II, observer-blind, randomized, controlled trial.
    Vaccine. 2017 Feb 7. pii: S0264-410X(17)30119.
    PubMed     Text format     Abstract available


  231. ZHENG X, Yang X, Li X, Qiu GH, et al
    Omp16-based vaccine encapsulated by alginate-chitosan microspheres provides significant protection against Haemophilus parasuis in mice.
    Vaccine. 2017 Feb 7. pii: S0264-410X(17)30147.
    PubMed     Text format     Abstract available


  232. BALASUBRAMANIAN P, Kumar R, Williams C, Itri V, et al
    Differential induction of anti-V3 crown antibodies with cradle- and ladle-binding modes in response to HIV-1 envelope vaccination.
    Vaccine. 2017 Feb 6. pii: S0264-410X(17)30089.
    PubMed     Text format     Abstract available


  233. PEREZ AC, Murphy TF
    Do we need a vaccine against Moraxella catarrhalis in chronic lung disease? What are the options and opportunities?
    Vaccine. 2017 Feb 6. pii: S0264-410X(16)31300.
    PubMed     Text format     Abstract available


  234. MCCLENATHAN BM, Stewart DA, Spooner CE, Pathmasiri WW, et al
    Metabolites as biomarkers of adverse reactions following vaccination: A pilot study using nuclear magnetic resonance metabolomics.
    Vaccine. 2017 Feb 3. pii: S0264-410X(17)30122.
    PubMed     Text format     Abstract available


  235. WUMKES ML, van der Velden AM, de Bruin E, Meerveld-Eggink A, et al
    Microarray profile of the humoral immune response to influenza vaccination in breast cancer patients treated with chemotherapy.
    Vaccine. 2017 Feb 3. pii: S0264-410X(17)30088.
    PubMed     Text format     Abstract available


  236. YUK SS, Erdene-Ochir TO, Kwon JH, Noh JY, et al
    Efficacy of clade 2.3.2 H5 commercial vaccines in protecting chickens from clade 2.3.4.4 H5N8 highly pathogenic avian influenza infection.
    Vaccine. 2017 Feb 3. pii: S0264-410X(17)30082.
    PubMed     Text format     Abstract available


  237. BERENSON AB, Croisant S
    Early sexual debut warrants HPV vaccination at an earlier age.
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30123.
    PubMed     Text format    


  238. BAXTER R, Eaton A, Hansen J, Aukes L, et al
    Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years.
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30128.
    PubMed     Text format     Abstract available


  239. SANCHEZ-RAMOS EL, Monarrez-Espino J, Noyola DE
    Impact of vaccination on influenza mortality in children <5years old in Mexico.
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30087.
    PubMed     Text format     Abstract available


  240. BAKER JA, Lewis EL, Byland LM, Bonakdar M, et al
    Mucosal vaccination promotes clearance of Streptococcus agalactiae vaginal colonization.
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30078.
    PubMed     Text format     Abstract available


  241. HEATON A, Krudwig K, Lorenson T, Burgess C, et al
    Doses per vaccine vial container: An understated and underestimated driver of performance that needs more evidence.
    Vaccine. 2017 Feb 2. pii: S0264-410X(16)31137.
    PubMed     Text format     Abstract available


  242. CROCE E, Hatz C, Jonker EF, Visser LG, et al
    Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - A systematic review of randomized trials, observational studies and cas
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30113.
    PubMed     Text format     Abstract available


  243. BARMAN S, Krylov PS, Turner JC, Franks J, et al
    Manipulation of neuraminidase packaging signals and hemagglutinin residues improves the growth of A/Anhui/1/2013 (H7N9) influenza vaccine virus yield in eggs.
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30127.
    PubMed     Text format     Abstract available


  244. LIU G, Yin J, Barkema HW, Chen L, et al
    Development of a single-dose recombinant CAMP factor entrapping poly(lactide-co-glycolide) microspheres-based vaccine against Streptococcus agalactiae.
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30102.
    PubMed     Text format     Abstract available


  245. HAMBIDGE SJ, Ross C, Shoup JA, Wain K, et al
    Integration of data from a safety net health care system into the Vaccine Safety Datalink.
    Vaccine. 2017 Feb 1. pii: S0264-410X(17)30076.
    PubMed     Text format     Abstract available


  246. PERO SC, Sun YJ, Shukla GS, Carman CL, et al
    Vaccine draining lymph nodes are a source of antigen-specific B cells.
    Vaccine. 2017 Feb 1. pii: S0264-410X(17)30085.
    PubMed     Text format     Abstract available


  247. CAMPOS IB, Herd M, Moffitt KL, Lu YJ, et al
    IL-17A and complement contribute to killing of pneumococci following immunization with a pneumococcal whole cell vaccine.
    Vaccine. 2017 Feb 1. pii: S0264-410X(17)30079.
    PubMed     Text format     Abstract available


  248. LIU Y, Wang J, Liu S, Du J, et al
    Introduction of inactivated poliovirus vaccine leading into the polio eradication endgame strategic plan; Hangzhou, China, 2010-2014.
    Vaccine. 2017 Feb 1. pii: S0264-410X(17)30083.
    PubMed     Text format     Abstract available


  249. CONTRERAS M, de la Fuente J
    Control of infestations by Ixodes ricinus tick larvae in rabbits vaccinated with aquaporin recombinant antigens.
    Vaccine. 2017 Feb 1. pii: S0264-410X(17)30117.
    PubMed     Text format     Abstract available


  250. BERENSON AB, Hirth JM, Fuchs EL
    US medical students' willingness to offer the HPV vaccine by vaccination status.
    Vaccine. 2017 Feb 1. pii: S0264-410X(17)30077.
    PubMed     Text format     Abstract available


    January 2017
  251. XING Y, Schmitt HJ, Arguedas A, Yang J, et al
    Tick-borne encephalitis in China: A review of epidemiology and vaccines.
    Vaccine. 2017 Jan 30. pii: S0264-410X(17)30032.
    PubMed     Text format     Abstract available


  252. BEGIER E, Seiden DJ, Patton M, Zito E, et al
    SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies.
    Vaccine. 2017 Jan 28. pii: S0264-410X(17)30043.
    PubMed     Text format     Abstract available


  253. SUTCLIFFE K, Kilgore PE, DeHoff K, Evans R, et al
    Survey of vaccination knowledge and acceptance among adults admitted to an urban emergency department.
    Vaccine. 2017 Jan 28. pii: S0264-410X(17)30031.
    PubMed     Text format     Abstract available


  254. BENN CS, Jacobsen LH, Fisker AB, Rodrigues A, et al
    Campaigns with oral polio vaccine may lower mortality and create unexpected results.
    Vaccine. 2017 Jan 27. pii: S0264-410X(16)31035.
    PubMed     Text format     Abstract available


  255. ZHOU J, Li S, Wang X, Zou M, et al
    Bartha-k61 vaccine protects growing pigs against challenge with an emerging variant pseudorabies virus.
    Vaccine. 2017 Jan 25. pii: S0264-410X(17)30005.
    PubMed     Text format     Abstract available


  256. HUANG Y, Zhang L, Janes H, Frahm N, et al
    Predictors of durable immune responses six months after the last vaccination in preventive HIV vaccine trials.
    Vaccine. 2017 Jan 25. pii: S0264-410X(16)30879.
    PubMed     Text format     Abstract available


  257. ALAN H, Ian B, Nancy C, Ruben O D, et al
    Improving the selection and development of influenza vaccine viruses - Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015.
    Vaccine. 2017 Jan 25. pii: S0264-410X(17)30037.
    PubMed     Text format     Abstract available


  258. HOONAKKER ME, Verhagen LM, van der Maas L, Sloots A, et al
    Reporter cell lines for detection of pertussis toxin in acellular pertussis vaccines as a functional animal-free alternative to the in vivo histamine sensitization test.
    Vaccine. 2017 Jan 24. pii: S0264-410X(17)30016.
    PubMed     Text format     Abstract available


  259. WIJAYA L, Tham CY, Chan YF, Wong AW, et al
    An accelerated rabies vaccine schedule based on toll-like receptor 3 (TLR3) agonist PIKA adjuvant augments rabies virus specific antibody and T cell response in healthy adult volunteers.
    Vaccine. 2017 Jan 21. pii: S0264-410X(16)31256.
    PubMed     Text format     Abstract available


  260. SMALL PA JR, Cronin BJ
    The Advisory Committee on Immunization Practices' controversial recommendation against the use of live attenuated influenza vaccine is based on a biased study design that ignores secondary protection.
    Vaccine. 2017 Jan 21. pii: S0264-410X(17)30041.
    PubMed     Text format    


  261. JONES RM, Burke M, Dubose D, Chichester JA, et al
    Stability and pre-formulation development of a plant-produced anthrax vaccine candidate.
    Vaccine. 2017 Jan 20. pii: S0264-410X(16)31206.
    PubMed     Text format     Abstract available


  262. SCHEIBLHOFER S, Strobl A, Hoepflinger V, Thalhamer T, et al
    Skin vaccination via fractional infrared laser ablation - Optimization of laser-parameters and adjuvantation.
    Vaccine. 2017 Jan 20. pii: S0264-410X(17)30058.
    PubMed     Text format     Abstract available


  263. ABARA WE, Collier MG, Teshale EH
    Impact of universal infant hepatitis B vaccination in the US-affiliated Pacific Islands, 1985-2015.
    Vaccine. 2017 Jan 20. pii: S0264-410X(17)30039.
    PubMed     Text format     Abstract available


  264. XIAO Y, Daniell H
    Long-term evaluation of mucosal and systemic immunity and protection conferred by different polio booster vaccines.
    Vaccine. 2017 Jan 19. pii: S0264-410X(16)31295.
    PubMed     Text format     Abstract available


  265. POSTON TB, Gottlieb SL, Darville T
    Status of vaccine research and development of vaccines for Chlamydia trachomatis infection.
    Vaccine. 2017 Jan 19. pii: S0264-410X(17)30042.
    PubMed     Text format     Abstract available


  266. WALZ PH, Givens MD, Rodning SP, Riddell KP, et al
    Evaluation of reproductive protection against bovine viral diarrhea virus and bovine herpesvirus-1 afforded by annual revaccination with modified-live viral or combination modified-live/killed viral vaccines after primary vaccination with modified-liv
    Vaccine. 2017 Jan 19. pii: S0264-410X(17)30009.
    PubMed     Text format     Abstract available


  267. MORIYAMA M, Chino S, Ichinohe T
    Consecutive inoculations of influenza virus vaccine and poly(I:C) protects mice against homologous and heterologous virus challenge.
    Vaccine. 2017 Jan 19. pii: S0264-410X(17)30046.
    PubMed     Text format     Abstract available


  268. DAVID SC, Lau J, Singleton EV, Babb R, et al
    The effect of gamma-irradiation conditions on the immunogenicity of whole-inactivated Influenza A virus vaccine.
    Vaccine. 2017 Jan 18. pii: S0264-410X(16)31269.
    PubMed     Text format     Abstract available


  269. NAKAYAMA M, Itoh Y, Shichinohe S, Nakabayashi R, et al
    Potential risk of repeated nasal vaccination that induces allergic reaction with mucosal IgE and airway eosinophilic infiltration in cynomolgus macaques infected with H5N1 highly pathogenic avian influenza virus.
    Vaccine. 2017 Jan 18. pii: S0264-410X(17)30013.
    PubMed     Text format     Abstract available


  270. SUNDARAM N, Chen C, Yoong J, Luvsan ME, et al
    Cost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia.
    Vaccine. 2017 Jan 18. pii: S0264-410X(17)30010.
    PubMed     Text format     Abstract available


  271. WEINBERG M, Dietz S, Potter R, Swanson R, et al
    Vaccine shot-limiting: Estimating the prevalence, indicators, and impact on vaccination status - Michigan, 2012.
    Vaccine. 2017 Jan 17. pii: S0264-410X(17)30019.
    PubMed     Text format     Abstract available


  272. ACKERSON B, Hechter R, Sidell M, Sy LS, et al
    Human papillomavirus vaccine series completion in boys before and after recommendation for routine immunization.
    Vaccine. 2017 Jan 13. pii: S0264-410X(17)30011.
    PubMed     Text format     Abstract available


  273. YANG L, Nan H, Liang J, Chan YH, et al
    Influenza vaccination in older people with diabetes and their household contacts.
    Vaccine. 2017 Jan 13. pii: S0264-410X(17)30007.
    PubMed     Text format     Abstract available


  274. QUINN SC, Jamison A, Freimuth VS, An J, et al
    Exploring racial influences on flu vaccine attitudes and behavior: Results of a national survey of White and African American adults.
    Vaccine. 2017 Jan 13. pii: S0264-410X(16)31271.
    PubMed     Text format     Abstract available


  275. KURUKULASURIYA S, Ahmed KA, Ojkic D, Gunawardana T, et al
    Modified live infectious bursal disease virus (IBDV) vaccine delays infection of neonatal broiler chickens with variant IBDV compared to turkey herpesvirus (HVT)-IBDV vectored vaccine.
    Vaccine. 2017 Jan 12. pii: S0264-410X(17)30008.
    PubMed     Text format     Abstract available


  276. ABHYANKAR MM, Noor Z, Tomai MA, Elvecrog J, et al
    Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolytica.
    Vaccine. 2017 Jan 12. pii: S0264-410X(16)31290.
    PubMed     Text format     Abstract available


  277. LUO J, Zhang B, Wu Y, Tian Q, et al
    Expression of interleukin-6 by a recombinant rabies virus enhances its immunogenicity as a potential vaccine.
    Vaccine. 2017 Jan 12. pii: S0264-410X(17)30006.
    PubMed     Text format     Abstract available


  278. HOEST C, Seidman JC, Lee G, Platts-Mills JA, et al
    Vaccine coverage and adherence to EPI schedules in eight resource poor settings in the MAL-ED cohort study.
    Vaccine. 2017;35:443-451.
    PubMed     Text format     Abstract available


  279. DE BENEDETTO G, Alfini R, Cescutti P, Caboni M, et al
    Characterization of O-antigen delivered by Generalized Modules for Membrane Antigens (GMMA) vaccine candidates against nontyphoidal Salmonella.
    Vaccine. 2017;35:419-426.
    PubMed     Text format     Abstract available


  280. CHIU C
    Novel immunological insights in accelerating RSV vaccine development.
    Vaccine. 2017;35:459-460.
    PubMed     Text format    


  281. GARGANO LM, Hajjeh R, Cookson ST
    Pneumonia prevention: Cost-effectiveness analyses of two vaccines among refugee children aged under two years, Haemophilus influenzae type b-containing and pneumococcal conjugate vaccines, during a humanitarian emergency, Yida camp, South Sudan.
    Vaccine. 2017;35:435-442.
    PubMed     Text format     Abstract available


  282. TREANOR JJ, Chu L, Essink B, Muse D, et al
    Stable emulsion (SE) alone is an effective adjuvant for a recombinant, baculovirus-expressed H5 influenza vaccine in healthy adults: A Phase 2 trial.
    Vaccine. 2017 Jan 11. pii: S0264-410X(16)31286.
    PubMed     Text format     Abstract available


  283. ZHANG W, Hirve S, Kieny MP
    Seasonal vaccines - Critical path to pandemic influenza response.
    Vaccine. 2017 Jan 10. pii: S0264-410X(16)31289.
    PubMed     Text format    


  284. CARO-AGUILAR I, Indrawati L, Kaufhold RM, Gaunt C, et al
    Immunogenicity differences of a 15-valent pneumococcal polysaccharide conjugate vaccine (PCV15) based on vaccine dose, route of immunization and mouse strain.
    Vaccine. 2017 Jan 10. pii: S0264-410X(16)31288.
    PubMed     Text format     Abstract available


  285. SARFRAZ M, Suleman M, Tikoo SK, Wheler C, et al
    Immune responses to in ovo vaccine formulations containing inactivated fowl adenovirus 8b with poly[di(sodium carboxylatoethylphenoxy)]phosphazene (PCEP) and avian beta defensin as adjuvants in chickens.
    Vaccine. 2017 Jan 10. pii: S0264-410X(16)31230.
    PubMed     Text format     Abstract available


  286. DAGAN R, Juergens C, Trammel J, Patterson S, et al
    PCV13-vaccinated children still carrying PCV13 additional serotypes show similar carriage density to a control group of PCV7-vaccinated children.
    Vaccine. 2017 Jan 10. pii: S0264-410X(16)31277.
    PubMed     Text format     Abstract available


  287. KAPETANOVIC MC, Nagel J, Nordstrom I, Saxne T, et al
    Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine.
    Vaccine. 2017 Jan 9. pii: S0264-410X(17)30002.
    PubMed     Text format     Abstract available


  288. MORGEAUX S, Poirier B, Ragan CI, Wilkinson D, et al
    Replacement of in vivo human rabies vaccine potency testing by in vitro glycoprotein quantification using ELISA - Results of an international collaborative study.
    Vaccine. 2017 Jan 9. pii: S0264-410X(16)31264.
    PubMed     Text format     Abstract available


  289. CORNICK JE, Tastan Bishop O, Yalcin F, Kiran AM, et al
    The global distribution and diversity of protein vaccine candidate antigens in the highly virulent Streptococcus pnuemoniae serotype 1.
    Vaccine. 2017 Jan 9. pii: S0264-410X(16)31262.
    PubMed     Text format     Abstract available


  290. GOWTAGE S, Williams GA, Henderson R, Aylett P, et al
    Testing of a palatable bait and compatible vaccine carrier for the oral vaccination of European badgers (Meles meles) against tuberculosis.
    Vaccine. 2017 Jan 9. pii: S0264-410X(16)31198.
    PubMed     Text format     Abstract available


  291. WANG Y, Chen T, Lu LL, Wang M, et al
    Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults.
    Vaccine. 2017 Jan 6. pii: S0264-410X(16)31296.
    PubMed     Text format     Abstract available


  292. KUMAR S, Sunagar R, Pham G, Gosselin EJ, et al
    Ex vivo antigen-pulsed PBMCs generate potent and long lasting immunity to infection when administered as a vaccine.
    Vaccine. 2017 Jan 6. pii: S0264-410X(16)31260.
    PubMed     Text format     Abstract available


  293. CHEGE GK, Burgers WA, Muller TL, Gray CM, et al
    DNA-MVA-protein vaccination of rhesus macaques induces HIV-specific immunity in mucosal-associated lymph nodes and functional antibodies.
    Vaccine. 2017 Jan 6. pii: S0264-410X(16)31294.
    PubMed     Text format     Abstract available


  294. PAINTER JE, Plaster AN, Tjersland DH, Jacobsen KH, et al
    Zika virus knowledge, attitudes, and vaccine interest among university students.
    Vaccine. 2017 Jan 6. pii: S0264-410X(16)31275.
    PubMed     Text format     Abstract available


  295. ARSENAULT C, Harper S, Nandi A, Mendoza Rodriguez JM, et al
    Monitoring equity in vaccination coverage: A systematic analysis of demographic and health surveys from 45 Gavi-supported countries.
    Vaccine. 2017 Jan 6. pii: S0264-410X(16)31266.
    PubMed     Text format     Abstract available


  296. HEDBERG AL, Pauksens K, Enblad P, Soderberg J, et al
    Pneumococcal polysaccharide vaccination administered early after neurotrauma or neurosurgery.
    Vaccine. 2017 Jan 6. pii: S0264-410X(16)31299.
    PubMed     Text format     Abstract available


  297. KARLSEN M, Tingbo T, Solbakk IT, Furevik A, et al
    Response to request for Corrigendum to "Efficacy and safety of an inactivated vaccine against Salmonid alphavirus (family Togaviridae)". [Vaccine 30(38) (2012) 5688-5694].
    Vaccine. 2017;35:204.
    PubMed     Text format    


  298. GRISEZ L, Frost P
    Efficacy and safety of an inactivated vaccine against Salmonid alphavirus (family Togaviridae) [Vaccine 30 (2012) 5688-5694].
    Vaccine. 2017;35:203.
    PubMed     Text format    


  299. MILLIGAN P, Flach C, Theisen M
    Efficacy of the GMZ2 malaria vaccine in African children.
    Vaccine. 2017;35:202.
    PubMed     Text format    


  300. EJIGU DA
    When should a time at risk start in efficacy malaria vaccine trials?
    Vaccine. 2017;35:201.
    PubMed     Text format    


  301. NEROME K, Matsuda S, Maegawa K, Sugita S, et al
    Quantitative analysis of the yield of avian H7 influenza virus haemagglutinin protein produced in silkworm pupae with the use of the codon-optimized DNA: A possible oral vaccine.
    Vaccine. 2017 Jan 5. pii: S0264-410X(16)31291.
    PubMed     Text format     Abstract available


  302. LOWELL GH, Ziv S, Bruzil S, Babecoff R, et al
    Back to the future: Immunization with M-001 prior to trivalent influenza vaccine in 2011/12 enhanced protective immune responses against 2014/15 epidemic strain.
    Vaccine. 2017 Jan 5. pii: S0264-410X(16)31297.
    PubMed     Text format     Abstract available


  303. GESSNER BD, Knobel DL, Conan A, Finn A, et al
    Could the RTS,S/AS01 meningitis safety signal really be a protective effect of rabies vaccine?
    Vaccine. 2017 Jan 5. pii: S0264-410X(17)30001.
    PubMed     Text format     Abstract available


  304. CESPEDES PF, Rey-Jurado E, Espinoza JA, Rivera CA, et al
    A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice.
    Vaccine. 2017 Jan 5. pii: S0264-410X(16)31273.
    PubMed     Text format     Abstract available


  305. SASAKI E, Kuramitsu M, Momose H, Kobiyama K, et al
    A novel vaccinological evaluation of intranasal vaccine and adjuvant safety for preclinical tests.
    Vaccine. 2017 Jan 4. pii: S0264-410X(16)31261.
    PubMed     Text format     Abstract available


  306. FU LY, Zimet GD, Latkin CA, Joseph JG, et al
    Associations of trust and healthcare provider advice with HPV vaccine acceptance among African American parents.
    Vaccine. 2017 Jan 4. pii: S0264-410X(16)31270.
    PubMed     Text format     Abstract available


  307. YUDIN MH, Mistry N, De Souza LR, Besel K, et al
    Text messages for influenza vaccination among pregnant women: A randomized controlled trial.
    Vaccine. 2017 Jan 3. pii: S0264-410X(16)31195.
    PubMed     Text format     Abstract available


  308. YU Q, Spatz S, Li Y, Yang J, et al
    Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
    Vaccine. 2017 Jan 2. pii: S0264-410X(16)31263.
    PubMed     Text format     Abstract available


  309. THARMAPHORNPILAS P, Jiamsiri S, Boonchaiya S, Rochanathimoke O, et al
    Evaluating the first introduction of rotavirus vaccine in Thailand: Moving from evidence to policy.
    Vaccine. 2017 Jan 2. pii: S0264-410X(16)31268.
    PubMed     Text format     Abstract available


    December 2016
  310. DAI Z, Huang J, Lei X, Yan Y, et al
    Efficacy of an autophagy-targeted DNA vaccine against avian leukosis virus subgroup J.
    Vaccine. 2016 Dec 31. pii: S0264-410X(16)31259.
    PubMed     Text format     Abstract available


  311. ZITT E, Hafner-Giessauf H, Wimmer B, Herr A, et al
    Response to active hepatitis B vaccination and mortality in incident dialysis patients.
    Vaccine. 2016 Dec 31. pii: S0264-410X(16)31257.
    PubMed     Text format     Abstract available


  312. SAITO N, Komori K, Suzuki M, Morimoto K, et al
    Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: A test-negative case-control study in Japan.
    Vaccine. 2016 Dec 30. pii: S0264-410X(16)31071.
    PubMed     Text format     Abstract available


  313. SHIBLI R, Shemer R, Lerner-Geva L, Rishpon S, et al
    Knowledge and recommendation regarding routine childhood vaccinations among pediatric healthcare providers in Israel.
    Vaccine. 2016 Dec 30. pii: S0264-410X(16)31199.
    PubMed     Text format     Abstract available


  314. SAKAI A, Noguchi E, Fukushima T, Tagawa M, et al
    Identification of amino acids in antigen-binding site of class II HLA proteins independently associated with hepatitis B vaccine response.
    Vaccine. 2016 Dec 30. pii: S0264-410X(16)30764.
    PubMed     Text format     Abstract available


  315. BOLTON DL, Song K, Tomaras GD, Rao S, et al
    Unique cellular and humoral immunogenicity profiles generated by aerosol, intranasal, or parenteral vaccination in rhesus macaques.
    Vaccine. 2016 Dec 29. pii: S0264-410X(16)31203.
    PubMed     Text format     Abstract available


  316. MILLMAN AJ, Reynolds S, Duffy J, Chen J, et al
    Hospitalizations within 14days of vaccination among pediatric recipients of the live attenuated influenza vaccine, United States 2010-2012.
    Vaccine. 2016 Dec 29. pii: S0264-410X(16)31258.
    PubMed     Text format     Abstract available


  317. PAINTER JE, DiClemente RJ, von Fricken ME
    Interest in an Ebola vaccine among a U.S. national sample during the height of the 2014-2016 Ebola outbreak in West Africa.
    Vaccine. 2016 Dec 28. pii: S0264-410X(16)31204.
    PubMed     Text format     Abstract available


  318. WIERZBA TF, Bourgis A
    Defining cases of severe pediatric diarrhea for an efficacy trial of an enterotoxigenic Escherichia coli (ETEC) vaccine: Report on an international workshop, Washington DC, March 2016.
    Vaccine. 2016 Dec 26. pii: S0264-410X(16)31200.
    PubMed     Text format     Abstract available


  319. CHEN W, Messonnier M, Zhou F
    Corrigendum to "Trends in childhood vaccine purchase costs in the US public sector: 1996-2014" [Vaccine 34 (2016) 4706-4711].
    Vaccine. 2016 Dec 26. pii: S0264-410X(16)31217.
    PubMed     Text format    


  320. LINDGREN LM, Tingskov PN, Justesen AH, Nedergaard BS, et al
    First-in-human safety and immunogenicity investigations of three adjuvanted reduced dose inactivated poliovirus vaccines (IPV-Al SSI) compared to full dose IPV Vaccine SSI when given as a booster vaccination to adolescents with a history of IPV vaccin
    Vaccine. 2016 Dec 24. pii: S0264-410X(16)31234.
    PubMed     Text format     Abstract available


  321. LEE TY, Kim CU, Bae EH, Seo SH, et al
    Outer membrane vesicles harboring modified lipid A moiety augment the efficacy of an influenza vaccine exhibiting reduced endotoxicity in a mouse model.
    Vaccine. 2016 Dec 23. pii: S0264-410X(16)31232.
    PubMed     Text format     Abstract available


  322. DOMNICH A, Arata L, Amicizia D, Puig-Barbera J, et al
    Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis.
    Vaccine. 2016 Dec 23. pii: S0264-410X(16)31218.
    PubMed     Text format     Abstract available


  323. CAMACHO A, Eggo RM, Goeyvaerts N, Vandebosch A, et al
    Real-time dynamic modelling for the design of a cluster-randomized phase 3 Ebola vaccine trial in Sierra Leone.
    Vaccine. 2016 Dec 23. pii: S0264-410X(16)31226.
    PubMed     Text format     Abstract available


  324. TIMMIS JK, Rigat F, Rappuoli R
    Core values for vaccine evaluation.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31082.
    PubMed     Text format     Abstract available


  325. PHELPS CE, Madhavan G, Gellin B
    Planning and priority setting for vaccine development and immunization.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31057.
    PubMed     Text format     Abstract available


  326. MATTHIESSEN L, Lang H, Klimathianaki M, Hanrahan F, et al
    European strategy for vaccine development against infectious diseases.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)30952.
    PubMed     Text format     Abstract available


  327. SAUL A, O'Brien KL
    Prioritizing vaccines for developing world diseases.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31062.
    PubMed     Text format     Abstract available


  328. SOUTHERN J, Waight PA, Andrews N, Miller E, et al
    Extensive swelling of the limb and systemic symptoms after a fourth dose of acellular pertussis containing vaccines in England in children aged 3-6years.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31224.
    PubMed     Text format     Abstract available


  329. ALMOND J, Medaglini D
    The role of the vaccines industry in Mission Grand Convergence.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31058.
    PubMed     Text format     Abstract available


  330. KASLOW DC, Kalil J, Bloom D, Breghi G, et al
    The role of vaccines and vaccine decision-making to achieve the goals of the Grand Convergence in public health.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31080.
    PubMed     Text format     Abstract available


  331. RAPPUOLI R
    Introduction to the vaccine supplement.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31099.
    PubMed     Text format    


  332. BLOOM DE, Brenzel L, Cadarette D, Sullivan J, et al
    Moving beyond traditional valuation of vaccination: Needs and opportunities.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31181.
    PubMed     Text format     Abstract available


  333. KNOBLER S, Bok K, Gellin B
    Informing vaccine decision-making: A strategic multi-attribute ranking tool for vaccines-SMART Vaccines 2.0.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31060.
    PubMed     Text format     Abstract available


  334. KOBAYASHI M, Schrag SJ, Alderson MR, Madhi SA, et al
    WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27-28 April 2016.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31236.
    PubMed     Text format     Abstract available


  335. LEE BY, Mueller LE, Tilchin CG
    A systems approach to vaccine decision making.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31081.
    PubMed     Text format     Abstract available


  336. POWELL AM, Luo Z, Martin L, Wan Z, et al
    The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31233.
    PubMed     Text format     Abstract available


  337. RUNGE S, Olbert M, Herden C, Malberg S, et al
    Viral vector vaccines protect cockatiels from inflammatory lesions after heterologous parrot bornavirus 2 challenge infection.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31229.
    PubMed     Text format     Abstract available


  338. STANFIELD BA, Pahar B, Chouljenko VN, Veazey R, et al
    Vaccination of rhesus macaques with the live-attenuated HSV-1 vaccine VC2 stimulates the proliferation of mucosal T cells and germinal center responses resulting in sustained production of highly neutralizing antibodies.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31225.
    PubMed     Text format     Abstract available


  339. RISSMANN M, Ulrich R, Schroder C, Hammerschmidt B, et al
    Vaccination of alpacas against Rift Valley fever virus: Safety, immunogenicity and pathogenicity of MP-12 vaccine.
    Vaccine. 2016 Dec 21. pii: S0264-410X(16)31197.
    PubMed     Text format     Abstract available


  340. SCHAEDLER E, Remy-Ziller C, Hortelano J, Kehrer N, et al
    Sequential administration of a MVA-based MUC1 cancer vaccine and the TLR9 ligand Litenimod (Li28) improves local immune defense against tumors.
    Vaccine. 2016 Dec 21. pii: S0264-410X(16)31227.
    PubMed     Text format     Abstract available


  341. REYES M, Ramirez C, Nancucheo I, Villegas R, et al
    A novel "in-feed" delivery platform applied for oral DNA vaccination against IPNV enables high protection in Atlantic salmon (Salmon salar).
    Vaccine. 2016 Dec 21. pii: S0264-410X(16)31220.
    PubMed     Text format     Abstract available


  342. PEHRSON C, Heno KK, Adams Y, Resende M, et al
    Comparison of functional assays used in the clinical development of a placental malaria vaccine.
    Vaccine. 2016 Dec 21. pii: S0264-410X(16)31235.
    PubMed     Text format     Abstract available


  343. THOMAS SL, Walker JL, Fenty J, Atkins KE, et al
    Impact of the national rotavirus vaccination programme on acute gastroenteritis in England and associated costs averted.
    Vaccine. 2016 Dec 19. pii: S0264-410X(16)31119.
    PubMed     Text format     Abstract available


  344. FUENTES S, Arenas D, Moore MM, Golding H, et al
    Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines.
    Vaccine. 2016 Dec 15. pii: S0264-410X(16)31105.
    PubMed     Text format     Abstract available


  345. VESIKARI T, Borrow R, Da Costa X, Richard P, et al
    Concomitant administration of a fully liquid, ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal serogroup C conjugate vaccine in infants.
    Vaccine. 2016 Dec 8. pii: S0264-410X(16)31115.
    PubMed     Text format     Abstract available


  346. STOWE J, Andrews N, Ladhani S, Miller E, et al
    The risk of intussusception following monovalent rotavirus vaccination in England: A self-controlled case-series evaluation Ref. No: JVAC-D-16-01124.
    Vaccine. 2016;34:6115.
    PubMed     Text format    


  347. DRYSDALE SB, Pollard AJ
    Intussusception risk after rotavirus vaccination in England.
    Vaccine. 2016;34:6114.
    PubMed     Text format    


  348. CUTTS FT, Claquin P, Danovaro-Holliday MC, Rhoda DA, et al
    Reply to comments on Monitoring vaccination coverage: Defining the role of surveys.
    Vaccine. 2016;34:6112-6113.
    PubMed     Text format    


  349. POND R, Mounier-Jack S
    Comments on "Monitoring vaccination coverage: Defining the role of surveys".
    Vaccine. 2016;34:6111.
    PubMed     Text format    


  350. MARUGGI G, Chiarot E, Giovani C, Buccato S, et al
    Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens.
    Vaccine. 2016 Dec 7. pii: S0264-410X(16)31101.
    PubMed     Text format     Abstract available


  351. YOUNG B, Zhao X, Cook AR, Parry CM, et al
    Do antibody responses to the influenza vaccine persist year-round in the elderly? A systematic review and meta-analysis.
    Vaccine. 2016 Dec 7. pii: S0264-410X(16)31044.
    PubMed     Text format     Abstract available


  352. CHRISTENSEN H, Trotter CL
    Modelling the cost-effectiveness of catch-up 'MenB' (Bexsero) vaccination in England.
    Vaccine. 2016 Dec 3. pii: S0264-410X(16)31147.
    PubMed     Text format     Abstract available


  353. OPRIESSNIG T, Xiao CT, Halbur PG, Gerber PF, et al
    A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naive pigs under experimental conditions.
    Vaccine. 2016 Dec 2. pii: S0264-410X(16)31157.
    PubMed     Text format     Abstract available


  354. PILKINTON MA, Nicholas KJ, Warren CM, Smith RM, et al
    Greater activation of peripheral T follicular helper cells following high dose influenza vaccine in older adults forecasts seroconversion.
    Vaccine. 2016 Dec 2. pii: S0264-410X(16)31121.
    PubMed     Text format     Abstract available


  355. SONG JY, Cheong HJ, Hyun HJ, Seo YB, et al
    Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine and an MF59-adjuvanted influenza vaccine after concomitant vaccination in 60-year-old adults.
    Vaccine. 2016 Dec 2. pii: S0264-410X(16)31109.
    PubMed     Text format     Abstract available


  356. CHONG Y, Ikematsu H
    Effect of seasonal vaccination on the selection of influenza A/H3N2 epidemic variants.
    Vaccine. 2016 Dec 2. pii: S0264-410X(16)31156.
    PubMed     Text format     Abstract available


  357. HULO S, Nuvoli A, Sobaszek A, Salembier-Trichard A, et al
    Knowledge and attitudes towards influenza vaccination of health care workers in emergency services.
    Vaccine. 2016 Dec 2. pii: S0264-410X(16)31158.
    PubMed     Text format     Abstract available


  358. POORE EA, Slifka DK, Raue HP, Thomas A, et al
    Pre-clinical development of a hydrogen peroxide-inactivated West Nile virus vaccine.
    Vaccine. 2016 Dec 2. pii: S0264-410X(16)31151.
    PubMed     Text format     Abstract available


  359. XU Q, Pryharski K, Pichichero ME
    Trivalent pneumococcal protein vaccine protects against experimental acute otitis media caused by Streptococcus pneumoniae in an infant murine model.
    Vaccine. 2016 Dec 2. pii: S0264-410X(16)31108.
    PubMed     Text format     Abstract available


  360. LUQUERO FJ, Ballard A, Sack DA
    Ensuring access to oral cholera vaccine to those who need them most.
    Vaccine. 2016 Dec 1. pii: S0264-410X(16)31145.
    PubMed     Text format    


  361. FAIRBROTHER JM, Nadeau E, Belanger L, Tremblay CL, et al
    Immunogenicity and protective efficacy of a single-dose live non-pathogenic Escherichia coli oral vaccine against F4-positive enterotoxigenic Escherichia coli challenge in pigs.
    Vaccine. 2016 Dec 1. pii: S0264-410X(16)31106.
    PubMed     Text format     Abstract available


  362. AKHTAR M, Qadri F, Bhuiyan TR, Akter S, et al
    Kinetics of antibody-secreting cell and fecal IgA responses after oral cholera vaccination in different age groups in a cholera endemic country.
    Vaccine. 2016 Dec 1. pii: S0264-410X(16)31117.
    PubMed     Text format     Abstract available


  363. REYES JF, Wood JG, Beutels P, Macartney K, et al
    Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia.
    Vaccine. 2016 Dec 1. pii: S0264-410X(16)31118.
    PubMed     Text format     Abstract available


  364. VANNICE KS, Giersing BK, Kaslow DC, Griffiths E, et al
    Meeting Report: WHO consultation on considerations for regulatory expectations of Zika virus vaccines for use during an emergency.
    Vaccine. 2016 Dec 1. pii: S0264-410X(16)30969.
    PubMed     Text format     Abstract available


  365. VAN RIJN PA, Daus FJ, Maris-Veldhuis MA, Feenstra F, et al
    Bluetongue Disabled Infectious Single Animal (DISA) vaccine: Studies on the optimal route and dose in sheep.
    Vaccine. 2016 Dec 1. pii: S0264-410X(16)31153.
    PubMed     Text format     Abstract available


  366. FRENCK RW JR, Buddy Creech C, Sheldon EA, Seiden DJ, et al
    Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study.
    Vaccine. 2016 Dec 1. pii: S0264-410X(16)31041.
    PubMed     Text format     Abstract available


    November 2016
  367. IRO MA, Snape MD, Voysey M, Jawad S, et al
    Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial.
    Vaccine. 2016 Nov 30. pii: S0264-410X(16)31040.
    PubMed     Text format     Abstract available


  368. DE VRIES RD, Nieuwkoop NJ, Pronk M, de Bruin E, et al
    Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection.
    Vaccine. 2016 Nov 30. pii: S0264-410X(16)31154.
    PubMed     Text format     Abstract available


  369. CHENG J, Wen S, Wang S, Hao P, et al
    gp85 protein vaccine adjuvanted with silica nanoparticles against ALV-J in chickens.
    Vaccine. 2016 Nov 29. pii: S0264-410X(16)31148.
    PubMed     Text format     Abstract available


  370. READ RC, Dull P, Bai X, Nolan K, et al
    A phase III observer-blind randomized, controlled study to evaluate the immune response and the correlation with nasopharyngeal carriage after immunization of university students with a quadrivalent meningococcal ACWY glycoconjugate or serogroup B men
    Vaccine. 2016 Nov 29. pii: S0264-410X(16)31142.
    PubMed     Text format     Abstract available


  371. DATTA D, Bansal GP, Gerloff DL, Ellefsen B, et al
    Immunogenicity and malaria transmission reducing potency of Pfs48/45 and Pfs25 encoded by DNA vaccines administered by intramuscular electroporation.
    Vaccine. 2016 Nov 29. pii: S0264-410X(16)31143.
    PubMed     Text format     Abstract available


  372. LIU X, Zhang H, Jiao C, Liu Q, et al
    Flagellin enhances the immunoprotection of formalin-inactivated Edwardsiella tarda vaccine in turbot.
    Vaccine. 2016 Nov 28. pii: S0264-410X(16)31078.
    PubMed     Text format     Abstract available


  373. CHOTPITAYASUNONDH T, Pruekprasert P, Puthanakit T, Pancharoen C, et al
    Post-licensure, phase IV, safety study of a live attenuated Japanese encephalitis recombinant vaccine in children in Thailand.
    Vaccine. 2016 Nov 28. pii: S0264-410X(16)31133.
    PubMed     Text format     Abstract available


  374. PAN-NGUM W, Kinyanjui T, Kiti M, Taylor S, et al
    Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach.
    Vaccine. 2016 Nov 28. pii: S0264-410X(16)31023.
    PubMed     Text format     Abstract available


  375. JIAMING L, Yanfeng Y, Yao D, Yawei H, et al
    The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection.
    Vaccine. 2016 Nov 26. pii: S0264-410X(16)31135.
    PubMed     Text format     Abstract available


  376. SCHUCK-PAIM C, Taylor RJ, Simonsen L, Lustig R, et al
    Challenges to estimating vaccine impact using hospitalization data.
    Vaccine. 2016 Nov 26. pii: S0264-410X(16)31077.
    PubMed     Text format     Abstract available


  377. KHO MM, Zuijderwijk JM, van der Eijk AA, de Kuiper R, et al
    Humoral and cellular response after varicella vaccination in VZV IgG seronegative kidney transplant candidates.
    Vaccine. 2016 Nov 26. pii: S0264-410X(16)31104.
    PubMed     Text format     Abstract available


  378. ALANKO BLOME M, Bjorkman P, Flamholc L, Jacobsson H, et al
    Vaccination against hepatitis B virus among people who inject drugs - A 20year experience from a Swedish needle exchange program.
    Vaccine. 2016 Nov 25. pii: S0264-410X(16)31102.
    PubMed     Text format     Abstract available


  379. WORLD HEALTH ORGANIZATION
    Polio vaccines: WHO position paper, March 2016-recommendations.
    Vaccine. 2016 Nov 25. pii: S0264-410X(16)31064.
    PubMed     Text format     Abstract available


  380. WANEESORN J, Wibowo N, Bingham J, Middelberg AP, et al
    Structural-based designed modular capsomere comprising HA1 for low-cost poultry influenza vaccination.
    Vaccine. 2016 Nov 25. pii: S0264-410X(16)31120.
    PubMed     Text format     Abstract available


  381. LU Y, Liang XF, Wang FZ, Yan L, et al
    Hepatitis B vaccine alone may be enough for preventing hepatitis B virus transmission in neonates of HBsAg (+)/HBeAg (-) mothers.
    Vaccine. 2016 Nov 25. pii: S0264-410X(16)31123.
    PubMed     Text format     Abstract available


  382. SCHULTHEIS K, Schaefer H, Yung BS, Oh J, et al
    Characterization of guinea pig T cell responses elicited after EP-assisted delivery of DNA vaccines to the skin.
    Vaccine. 2016 Nov 25. pii: S0264-410X(16)31114.
    PubMed     Text format     Abstract available


  383. GALACTIONOVA K, Tediosi F, Camponovo F, Smith TA, et al
    Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa.
    Vaccine. 2016 Nov 24. pii: S0264-410X(16)31103.
    PubMed     Text format     Abstract available


  384. JIMENEZ-GARCIA R, Lopez-de-Andres A, Hernandez-Barrera V, Gomez-Campelo P, et al
    Influenza vaccination in people with type 2 diabetes, coverage, predictors of uptake, and perceptions. Result of the MADIABETES cohort a 7years follow up study.
    Vaccine. 2016 Nov 24. pii: S0264-410X(16)31100.
    PubMed     Text format     Abstract available


  385. BYBERG S, Thysen SM, Rodrigues A, Martins C, et al
    A general measles vaccination campaign in urban Guinea-Bissau: Comparing child mortality among participants and non-participants.
    Vaccine. 2016 Nov 24. pii: S0264-410X(16)31111.
    PubMed     Text format     Abstract available


  386. DALE JB, Smeesters PR, Courtney HS, Penfound TA, et al
    Structure-based design of broadly protective group a streptococcal M protein-based vaccines.
    Vaccine. 2016 Nov 24. pii: S0264-410X(16)31136.
    PubMed     Text format     Abstract available


  387. RUTTEN LJ, St Sauver JL, Beebe TJ, Wilson PM, et al
    Clinician knowledge, clinician barriers, and perceived parental barriers regarding human papillomavirus vaccination: Association with initiation and completion rates.
    Vaccine. 2016 Nov 23. pii: S0264-410X(16)31043.
    PubMed     Text format     Abstract available


  388. HARDT K, Bonanni P, King S, Santos JI, et al
    Vaccine strategies: Optimising outcomes.
    Vaccine. 2016 Nov 22. pii: S0264-410X(16)31030.
    PubMed     Text format     Abstract available


  389. PREISS S, Garcon N, Cunningham AL, Strugnell R, et al
    Vaccine provision: Delivering sustained & widespread use.
    Vaccine. 2016 Nov 21. pii: S0264-410X(16)31031.
    PubMed     Text format     Abstract available


  390. HAIDARI LA, Brown ST, Wedlock P, Lee BY, et al
    Map of different vaccine supply chain efficiency measures.
    Vaccine. 2016 Nov 21. pii: S0264-410X(16)31072.
    PubMed     Text format    


  391. SHEN Z, Bowen RA, Ge P, Yu J, et al
    Evaluation of a candidate live attenuated influenza vaccine prepared in Changchun BCHT (China) for safety and efficacy in ferrets.
    Vaccine. 2016;34:5953-5958.
    PubMed     Text format     Abstract available


  392. KRASZEWSKA-G OMBA B, Matkowska-Kocjan A, Mi Kiewicz K, Szyma Ska-Toczek Z, et al
    Mumps, measles and rubella vaccination in children with PFAPA syndrome.
    Vaccine. 2016;34:5903-5906.
    PubMed     Text format     Abstract available


  393. KULKARNI SP, Thanapati S, Arankalle VA, Tripathy AS, et al
    Specific memory B cell response and participation of CD4+ central and effector memory T cells in mice immunized with liposome encapsulated recombinant NE protein based Hepatitis E vaccine candidate.
    Vaccine. 2016;34:5895-5902.
    PubMed     Text format     Abstract available


  394. LEON A, David AL, Madeline B, Guianvarc'h L, et al
    The EB66(R) cell line as a valuable cell substrate for MVA-based vaccines production.
    Vaccine. 2016;34:5878-5885.
    PubMed     Text format     Abstract available


  395. FONTANELLA E, Ma Z, Zhang Y, de Castro AM, et al
    An interferon inducing porcine reproductive and respiratory syndrome virus vaccine candidate elicits protection against challenge with the heterologous virulent type 2 strain VR-2385 in pigs.
    Vaccine. 2016 Nov 18. pii: S0264-410X(16)31067.
    PubMed     Text format     Abstract available


  396. MUKHOPADHYA I, Murdoch H, Berry S, Hunt A, et al
    Changing molecular epidemiology of rotavirus infection after introduction of monovalent rotavirus vaccination in Scotland.
    Vaccine. 2016 Nov 18. pii: S0264-410X(16)31075.
    PubMed     Text format     Abstract available


  397. ZIMMERMAN RK, Moehling KK, Lin CJ, Zhang S, et al
    Improving adolescent HPV vaccination in a randomized controlled cluster trial using the 4 Pillars practice Transformation Program.
    Vaccine. 2016 Nov 18. pii: S0264-410X(16)31065.
    PubMed     Text format     Abstract available


  398. SCHWARTZ LM, Halloran ME, Rowhani-Rahbar A, Neuzil KM, et al
    Rotavirus vaccine effectiveness in low-income settings: An evaluation of the test-negative design.
    Vaccine. 2016 Nov 18. pii: S0264-410X(16)31028.
    PubMed     Text format     Abstract available


  399. DOHERTY M, Schmidt-Ott R, Santos JI, Stanberry LR, et al
    Vaccination of special populations: Protecting the vulnerable.
    Vaccine. 2016 Nov 18. pii: S0264-410X(16)31061.
    PubMed     Text format     Abstract available


  400. RADKE S, Petousis-Harris H, Watson D, Gentles D, et al
    Age-specific effectiveness following each dose of acellular pertussis vaccine among infants and children in New Zealand.
    Vaccine. 2016 Nov 18. pii: S0264-410X(16)31029.
    PubMed     Text format     Abstract available


  401. ZHENG D, Chen S, Qu D, Chen J, et al
    Influenza H7N9 LAH-HBc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses.
    Vaccine. 2016 Nov 17. pii: S0264-410X(16)31073.
    PubMed     Text format     Abstract available


  402. MEARNS H, Geldenhuys HD, Kagina BM, Musvosvi M, et al
    H1:IC31 vaccination is safe and induces long-lived TNF-alpha+IL-2+CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trial.
    Vaccine. 2016 Nov 17. pii: S0264-410X(16)31070.
    PubMed     Text format     Abstract available


  403. STERN PL
    The changing face of vaccines and vaccination.
    Vaccine. 2016 Nov 17. pii: S0264-410X(16)31056.
    PubMed     Text format    


  404. JANJANAM VD, Mukherjee N, Lockett GA, Rezwan FI, et al
    Tetanus vaccination is associated with differential DNA-methylation: Reduces the risk of asthma in adolescence.
    Vaccine. 2016 Nov 17. pii: S0264-410X(16)31016.
    PubMed     Text format     Abstract available


  405. SETH A, Kong IG, Lee SH, Yang JY, et al
    Modular virus-like particles for sublingual vaccination against group A streptococcus.
    Vaccine. 2016 Nov 17. pii: S0264-410X(16)31039.
    PubMed     Text format     Abstract available


  406. ALLEMAN MM, Wannemuehler KA, Hao L, Perelygina L, et al
    Estimating the burden of rubella virus infection and congenital rubella syndrome through a rubella immunity assessment among pregnant women in the Democratic Republic of the Congo: Potential impact on vaccination policy.
    Vaccine. 2016 Nov 17. pii: S0264-410X(16)30994.
    PubMed     Text format     Abstract available


  407. LIN X, Yang J, Lu H, Zhou Y, et al
    Minimization of hepatitis B infection among children in Jiangsu, China, 12years after integration of hepatitis B vaccine into the expanded program on immunization.
    Vaccine. 2016 Nov 17. pii: S0264-410X(16)31069.
    PubMed     Text format     Abstract available


  408. CREECH CB, Frenck RW Jr, Sheldon EA, Seiden DJ, et al
    Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial.
    Vaccine. 2016 Nov 17. pii: S0264-410X(16)31079.
    PubMed     Text format     Abstract available


  409. PEREIRA-MANFRO WF, Alvino RM, Cruz AC, Silva GP, et al
    Association of serum bactericidal antibody and opsonic antibody levels after Neisseria meningitidis serogroup C conjugate vaccine in Brazilian children and adolescents infected or not infected with HIV.
    Vaccine. 2016 Nov 12. pii: S0264-410X(16)31042.
    PubMed     Text format     Abstract available


  410. ADHIKARI RP, Thompson CD, Aman MJ, Lee JC, et al
    Protective efficacy of a novel alpha hemolysin subunit vaccine (AT62) against Staphylococcus aureus skin and soft tissue infections.
    Vaccine. 2016 Nov 12. pii: S0264-410X(16)30897.
    PubMed     Text format     Abstract available


  411. DEMPSEY AF, Lockhart S, Campagna EJ, Pyrzanowski J, et al
    Providers' time spent and tools used when discussing the HPV vaccine with parents of adolescents.
    Vaccine. 2016 Nov 10. pii: S0264-410X(16)31037.
    PubMed     Text format     Abstract available


  412. KANG J, Song YM
    Factors associated with vaccination status among Korean submariners who are eligible for free non-mandatory influenza vaccination.
    Vaccine. 2016 Nov 10. pii: S0264-410X(16)31027.
    PubMed     Text format     Abstract available


  413. SORUP S, Benn CS, Poulsen A, Krause TG, et al
    Simultaneous vaccination with MMR and DTaP-IPV-Hib and rate of hospital admissions with any infections: A nationwide register based cohort study.
    Vaccine. 2016 Nov 10. pii: S0264-410X(16)31033.
    PubMed     Text format     Abstract available


  414. BECKER BF, Larson HJ, Bonhoeffer J, van Mulligen EM, et al
    Evaluation of a multinational, multilingual vaccine debate on Twitter.
    Vaccine. 2016 Nov 10. pii: S0264-410X(16)31038.
    PubMed     Text format     Abstract available


  415. ZHAO D, Gai Tobe R, Cui M, He J, et al
    Cost-effectiveness of a 23-valent pneumococcal polysaccharide vaccine immunization programme for the elderly in Shanghai, China.
    Vaccine. 2016 Nov 9. pii: S0264-410X(16)31025.
    PubMed     Text format     Abstract available


  416. FONTENOT HB, Fantasia HC, Vetters R, Zimet GD, et al
    Increasing HPV vaccination and eliminating barriers: Recommendations from young men who have sex with men.
    Vaccine. 2016 Nov 9. pii: S0264-410X(16)31026.
    PubMed     Text format     Abstract available


  417. OLIGBU G, Hsia Y, Folgori L, Collins S, et al
    Pneumococcal conjugate vaccine failure in children: A systematic review of the literature.
    Vaccine. 2016 Nov 9. pii: S0264-410X(16)30985.
    PubMed     Text format     Abstract available


  418. WALKER L, Newall A, Heywood AE
    Knowledge, attitudes and practices of Australian medical students towards influenza vaccination.
    Vaccine. 2016 Nov 8. pii: S0264-410X(16)31024.
    PubMed     Text format     Abstract available


  419. KRISTENSEN DD, Bartholomew K, Villadiego S, Lorenson K, et al
    What vaccine product attributes do immunization program stakeholders value? Results from interviews in six low- and middle-income countries.
    Vaccine. 2016 Nov 8. pii: S0264-410X(16)30992.
    PubMed     Text format     Abstract available


  420. HABER P, Arana J, Pilishvili T, Lewis P, et al
    Post-licensure surveillance of 13-valent pneumococcal conjugate vaccine (PCV13) in adults aged 19years old in the United States, Vaccine Adverse Event Reporting System (VAERS), June 1, 2012-December 31, 2015.
    Vaccine. 2016 Nov 8. pii: S0264-410X(16)30987.
    PubMed     Text format     Abstract available


  421. DI PASQUALE A, Bonanni P, Garcon N, Stanberry LR, et al
    Vaccine safety evaluation: Practical aspects in assessing benefits and risks.
    Vaccine. 2016 Nov 8. pii: S0264-410X(16)30974.
    PubMed     Text format     Abstract available


  422. WIESE AD, Griffin MR, Zhu Y, Mitchel EF Jr, et al
    Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era.
    Vaccine. 2016 Nov 7. pii: S0264-410X(16)30997.
    PubMed     Text format     Abstract available


  423. SHARMA M, Dixit A
    Immune response characterization and vaccine potential of a recombinant chimera comprising B-cell epitope of Aeromonas hydrophila outer membrane protein C and LTB.
    Vaccine. 2016 Nov 7. pii: S0264-410X(16)31012.
    PubMed     Text format     Abstract available


  424. DAI G, Rady HF, Huang W, Shellito JE, et al
    Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B.
    Vaccine. 2016 Nov 4. pii: S0264-410X(16)31013.
    PubMed     Text format     Abstract available


  425. HUANG CH, Chao DY, Wu CC, Hsu SY, et al
    Influenza vaccination and the endurance against air pollution among elderly with acute coronary syndrome.
    Vaccine. 2016 Nov 4. pii: S0264-410X(16)30989.
    PubMed     Text format     Abstract available


  426. VAN RAVENHORST MB, Marinovic AB, van der Klis FR, van Rooijen DM, et al
    Long-term persistence of protective antibodies in Dutch adolescents following a meningococcal serogroup C tetanus booster vaccination.
    Vaccine. 2016 Nov 4. pii: S0264-410X(16)30984.
    PubMed     Text format     Abstract available


  427. ZIKMUND-FISHER BJ, Wittenberg E, Lieu TA
    Parental weighting of seizure risks vs. fever risks in vaccination tradeoff decisions.
    Vaccine. 2016 Nov 3. pii: S0264-410X(16)30949.
    PubMed     Text format     Abstract available


  428. POWELL GA, Zinszer K, Verma A, Bahk C, et al
    Media content about vaccines in the United States and Canada, 2012-2014: An analysis using data from the Vaccine Sentimeter.
    Vaccine. 2016 Nov 3. pii: S0264-410X(16)31015.
    PubMed     Text format     Abstract available


  429. YU C, Li X, Liu J, Diao W, et al
    Replacing the decoy epitope of PCV2b capsid protein with a protective epitope enhances efficacy of PCV2b vaccine.
    Vaccine. 2016 Nov 3. pii: S0264-410X(16)30979.
    PubMed     Text format     Abstract available


  430. RHODES SJ, Zelmer A, Knight GM, Prabowo SA, et al
    The TB vaccine H56+IC31 dose-response curve is peaked not saturating: Data generation for new mathematical modelling methods to inform vaccine dose decisions.
    Vaccine. 2016 Nov 2. pii: S0264-410X(16)30995.
    PubMed     Text format     Abstract available


  431. PIELER MM, Frentzel S, Bruder D, Wolff MW, et al
    A cell culture-derived whole virus influenza A vaccine based on magnetic sulfated cellulose particles confers protection in mice against lethal influenza A virus infection.
    Vaccine. 2016 Nov 2. pii: S0264-410X(16)30976.
    PubMed     Text format     Abstract available


  432. LUTTJEBOER J, Setiawan D, Cao Q, Cahh Daemen T, et al
    Threshold cost-effectiveness analysis for a therapeutic vaccine against HPV-16/18-positive cervical intraepithelial neoplasia in the Netherlands.
    Vaccine. 2016 Nov 2. pii: S0264-410X(16)30935.
    PubMed     Text format     Abstract available


    October 2016
  433. PRINGLE K, Cardemil CV, Pabst LJ, Parashar UD, et al
    Uptake of rotavirus vaccine among US infants at Immunization Information System Sentinel Sites.
    Vaccine. 2016 Oct 31. pii: S0264-410X(16)30903.
    PubMed     Text format     Abstract available


  434. MAURER KA, Chen HF, Wagner AL, Hegde ST, et al
    Cost-effectiveness analysis of pneumococcal vaccination for infants in China.
    Vaccine. 2016 Oct 31. pii: S0264-410X(16)30986.
    PubMed     Text format     Abstract available


  435. PATERSON P, Meurice F, Stanberry LR, Glismann S, et al
    Vaccine hesitancy and healthcare providers.
    Vaccine. 2016 Oct 31. pii: S0264-410X(16)30977.
    PubMed     Text format     Abstract available


  436. ENDO IC, Ziegelmann PK, Patel A
    The economic promise of developing and implementing dengue vaccines: Evidence from a systematic review.
    Vaccine. 2016 Oct 31. pii: S0264-410X(16)30972.
    PubMed     Text format     Abstract available


  437. RAMEZANPOUR B, Haan I, Osterhaus A, Claassen E, et al
    Vector-based genetically modified vaccines: Exploiting Jenner's legacy.
    Vaccine. 2016 Oct 28. pii: S0264-410X(16)30510.
    PubMed     Text format     Abstract available


  438. PACE D, Khatami A, Attard-Montalto S, Voysey M, et al
    Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy.
    Vaccine. 2016 Oct 28. pii: S0264-410X(16)30973.
    PubMed     Text format     Abstract available


  439. LIU H, Frijlink HW, Huckriede A, van Doorn E, et al
    Influenza Vaccine Research funded by the European Commission FP7-Health-2013-Innovation-1 project.
    Vaccine. 2016 Oct 25. pii: S0264-410X(16)30975.
    PubMed     Text format     Abstract available


  440. JONES CE, Munoz FM, Kochhar S, Vergnano S, et al
    Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy.
    Vaccine. 2016 Oct 25. pii: S0264-410X(16)30570.
    PubMed     Text format     Abstract available


  441. ZHANG X, Wei M, Sun G, Wang X, et al
    Real-time stability of a hepatitis E vaccine (Hecolin(R)) demonstrated with potency assays and multifaceted physicochemical methods.
    Vaccine. 2016 Oct 25. pii: S0264-410X(16)30980.
    PubMed     Text format     Abstract available


  442. FREW PM, Chung Y, Fisher AK, Schamel J, et al
    Parental experiences with vaccine information statements: Implications for timing, delivery, and parent-provider immunization communication.
    Vaccine. 2016 Oct 24. pii: S0264-410X(16)30944.
    PubMed     Text format     Abstract available


  443. BRICKLEY EB, Coulibaly M, Gabriel EE, Healy SA, et al
    Utilizing direct skin feeding assays for development of vaccines that interrupt malaria transmission: A systematic review of methods and case study.
    Vaccine. 2016 Oct 24. pii: S0264-410X(16)30945.
    PubMed     Text format     Abstract available


  444. LOPEZ-LACORT M, Collado S, Diez-Gandia A, Diez-Domingo J, et al
    Rotavirus, vaccine failure or diagnostic error?
    Vaccine. 2016 Oct 24. pii: S0264-410X(16)30953.
    PubMed     Text format     Abstract available


  445. MANENTI A, Tete SM, Mohn KG, Jul-Larsen A, et al
    Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination.
    Vaccine. 2016 Oct 24. pii: S0264-410X(16)30940.
    PubMed     Text format     Abstract available


  446. TASHANI M, Alfelali M, Barasheed O, Alqahtani AS, et al
    Effect of Tdap when administered before, with or after the 13-valent pneumococcal conjugate vaccine (coadministered with the quadrivalent meningococcal conjugate vaccine) in adults: A randomised controlled trial.
    Vaccine. 2016 Oct 22. pii: S0264-410X(16)30936.
    PubMed     Text format     Abstract available


  447. DOHERTY M, Buchy P, Standaert B, Giaquinto C, et al
    Vaccine impact: Benefits for human health.
    Vaccine. 2016 Oct 20. pii: S0264-410X(16)30943.
    PubMed     Text format     Abstract available


  448. DVALISHVILI M, Mesxishvili D, Butsashvili M, Kamkamidze G, et al
    Knowledge, attitudes, and practices of healthcare providers in the country of Georgia regarding influenza vaccinations for pregnant women.
    Vaccine. 2016 Oct 20. pii: S0264-410X(16)30954.
    PubMed     Text format     Abstract available


  449. WIJESINGHE PR, Abeysinghe MR, Yoksan S, Yao Y, et al
    Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine.
    Vaccine. 2016 Oct 20. pii: S0264-410X(16)30946.
    PubMed     Text format     Abstract available


  450. VAN STRATEN M, Bardenstein S, Keningswald G, Banai M, et al
    Brucella abortus S19 vaccine protects dairy cattle against natural infection with Brucella melitensis.
    Vaccine. 2016 Oct 19. pii: S0264-410X(16)30909.
    PubMed     Text format     Abstract available


  451. CLENDINEN C, Zhang Y, Warburton RN, Light DW, et al
    Manufacturing costs of HPV vaccines for developing countries.
    Vaccine. 2016 Oct 19. pii: S0264-410X(16)30856.
    PubMed     Text format     Abstract available


  452. YANG L, Liu Y, Li S, Zhao H, et al
    A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.
    Vaccine. 2016 Oct 19. pii: S0264-410X(16)30934.
    PubMed     Text format     Abstract available


  453. CUNNINGHAM AL, Garcon N, Leo O, Friedland LR, et al
    Vaccine development: From concept to early clinical testing.
    Vaccine. 2016 Oct 18. pii: S0264-410X(16)30917.
    PubMed     Text format     Abstract available


  454. ISENOR JE, Edwards NT, Alia TA, Slayter KL, et al
    Impact of pharmacists as immunizers on vaccination rates: A systematic review and meta-analysis.
    Vaccine. 2016 Oct 17. pii: S0264-410X(16)30792.
    PubMed     Text format     Abstract available


  455. HERTZ T, Logan MG, Rolland M, Magaret CA, et al
    A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial.
    Vaccine. 2016 Oct 15. pii: S0264-410X(16)30880.
    PubMed     Text format     Abstract available


  456. OLOWOOKERE SA, Abioye-Kuteyi EA, Adekanle O
    Willingness to participate in Ebola viral disease vaccine trials and receive vaccination by health workers in a tertiary hospital in Ile-Ife, Southwest Nigeria.
    Vaccine. 2016 Oct 14. pii: S0264-410X(16)30900.
    PubMed     Text format     Abstract available


  457. ARNABOLDI PM, Sambir M, D'Arco C, Peters LA, et al
    Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.
    Vaccine. 2016 Oct 13. pii: S0264-410X(16)30901.
    PubMed     Text format     Abstract available


  458. SCHMID P, MacDonald NE, Habersaat K, Butler R, et al
    Commentary to: How to respond to vocal vaccine deniers in public.
    Vaccine. 2016 Oct 13. pii: S0264-410X(16)30914.
    PubMed     Text format    


  459. YANG J, Atkins KE, Feng L, Pang M, et al
    Seasonal influenza vaccination in China: Landscape of diverse regional reimbursement policy, and budget impact analysis.
    Vaccine. 2016 Oct 13. pii: S0264-410X(16)30911.
    PubMed     Text format     Abstract available


  460. SURENDRAN N, Nicolosi T, Pichichero M
    Infants with low vaccine antibody responses have altered innate cytokine response.
    Vaccine. 2016 Oct 13. pii: S0264-410X(16)30875.
    PubMed     Text format     Abstract available


  461. SHENG Z, Gao N, Cui X, Fan D, et al
    Electroporation enhances protective immune response of a DNA vaccine against Japanese encephalitis in mice and pigs.
    Vaccine. 2016 Oct 12. pii: S0264-410X(16)30892.
    PubMed     Text format     Abstract available


  462. DANIEL C, Titecat M, Poiret S, Cayet D, et al
    Characterization of the protective immune response to Yersinia pseudotuberculosis infection in mice vaccinated with an LcrV-secreting strain of Lactococcus lactis.
    Vaccine. 2016 Oct 11. pii: S0264-410X(16)30896.
    PubMed     Text format     Abstract available


  463. DAILY A, Kennedy ED, Fierro LA, Reed JH, et al
    Evaluation of scanning 2D barcoded vaccines to improve data accuracy of vaccines administered.
    Vaccine. 2016 Oct 11. pii: S0264-410X(16)30878.
    PubMed     Text format     Abstract available


  464. JORRITSMA SH, Gowans EJ, Grubor-Bauk B, Wijesundara DK, et al
    Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines.
    Vaccine. 2016 Oct 11. pii: S0264-410X(16)30898.
    PubMed     Text format     Abstract available


  465. EVENSON D, Gerber PF, Xiao CT, Halbur PG, et al
    A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.
    Vaccine. 2016 Oct 11. pii: S0264-410X(16)30874.
    PubMed     Text format     Abstract available


  466. KARKI S, Dyda A, Newall A, Heywood A, et al
    Comparison of influenza vaccination coverage between immigrant and Australian-born adults.
    Vaccine. 2016 Oct 11. pii: S0264-410X(16)30910.
    PubMed     Text format     Abstract available


  467. SITARAS I, Rousou X, Peeters B, de Jong MC, et al
    Mutations in the haemagglutinin protein and their effect in transmission of highly pathogenic avian influenza (HPAI) H5N1 virus in sub-optimally vaccinated chickens.
    Vaccine. 2016 Oct 8. pii: S0264-410X(16)30894.
    PubMed     Text format     Abstract available


  468. LANKESTER FJ, Wouters PA, Czupryna A, Palmer GH, et al
    Thermotolerance of an inactivated rabies vaccine for dogs.
    Vaccine. 2016 Oct 8. pii: S0264-410X(16)30913.
    PubMed     Text format     Abstract available


  469. DUVAL L, Wolff FC, McKee M, Roberts B, et al
    The Roma vaccination gap: Evidence from twelve countries in Central and South-East Europe.
    Vaccine. 2016 Oct 7. pii: S0264-410X(16)30899.
    PubMed     Text format     Abstract available


  470. VAN KLEEF E, Deeny SR, Jit M, Cookson B, et al
    The projected effectiveness of Clostridium difficile vaccination as part of an integrated infection control strategy.
    Vaccine. 2016 Oct 7. pii: S0264-410X(16)30871.
    PubMed     Text format     Abstract available


  471. ALCOLEA PJ, Alonso A, Larraga V
    Rationale for selection of developmentally regulated genes as vaccine candidates against Leishmania infantum infection.
    Vaccine. 2016 Oct 5. pii: S0264-410X(16)30788.
    PubMed     Text format    


  472. MCPHERSON MC, Cheng HH, Delany ME
    Marek's disease herpesvirus vaccines integrate into chicken host chromosomes yet lack a virus-host phenotype associated with oncogenic transformation.
    Vaccine. 2016 Oct 5. pii: S0264-410X(16)30876.
    PubMed     Text format     Abstract available


  473. BAI X, Wang Y, Xu X, Sun Z, et al
    Commercial vaccines provide limited protection to NADC30-like PRRSV infection.
    Vaccine. 2016 Oct 3. pii: S0264-410X(16)30873.
    PubMed     Text format     Abstract available


    September 2016
  474. SPEARMAN P, Mulligan M, Anderson EJ, Shane AL, et al
    A phase 1, randomized, controlled dose-escalation study of EP-1300 polyepitope DNA vaccine against Plasmodium falciparum malaria administered via electroporation.
    Vaccine. 2016 Sep 30. pii: S0264-410X(16)30855.
    PubMed     Text format     Abstract available


  475. GUPTA N, Vedi S, Kunimoto DY, Agrawal B, et al
    Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacy.
    Vaccine. 2016 Sep 29. pii: S0264-410X(16)30771.
    PubMed     Text format     Abstract available


  476. NELSON KN, Wallace AS, Sodha SV, Daniels D, et al
    Assessing strategies for increasing urban routine immunization coverage of childhood vaccines in low and middle-income countries: A systematic review of peer-reviewed literature.
    Vaccine. 2016 Sep 28. pii: S0264-410X(16)30851.
    PubMed     Text format     Abstract available


  477. NTEGE EH, Arisue N, Ito D, Hasegawa T, et al
    Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.
    Vaccine. 2016 Sep 28. pii: S0264-410X(16)30841.
    PubMed     Text format     Abstract available


  478. BRANDILEONE MC, Zanella RC, Almeida SC, Brandao AP, et al
    Effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae among children in Sao Paulo, Brazil.
    Vaccine. 2016 Sep 28. pii: S0264-410X(16)30840.
    PubMed     Text format     Abstract available


  479. GIRARD MP, Le-Grand R, Picot V, Longuet C, et al
    Report of the Cent Gardes HIV Vaccines Conference, Part 2: The cellular immune response. Fondation Merieux Conference Center, Veyrier-du-Lac, France, 25-27 October 2015.
    Vaccine. 2016 Sep 27. pii: S0264-410X(16)30847.
    PubMed     Text format    


  480. MELERO JA, Mas V, McLellan JS
    Structural, antigenic and immunogenic features of respiratory syncytial virus glycoproteins relevant for vaccine development.
    Vaccine. 2016 Sep 27. pii: S0264-410X(16)30870.
    PubMed     Text format     Abstract available


  481. RAINA MACINTYRE C, Menzies R, Kpozehouen E, Chapman M, et al
    Equity in disease prevention: Vaccines for the older adults - Proceedings of a workshop, Melbourne, Australia 20 June 2014.
    Vaccine. 2016 Sep 26. pii: S0264-410X(16)30852.
    PubMed     Text format     Abstract available


  482. FITZGERALD TJ, Kang Y, Bridges CB, Talbert T, et al
    Integrating pharmacies into public health program planning for pandemic influenza vaccine response.
    Vaccine. 2016 Sep 26. pii: S0264-410X(16)30833.
    PubMed     Text format     Abstract available


  483. CHOKEPHAIBULKIT K, Sirivichayakul C, Thisyakorn U, Pancharoen C, et al
    Long-term follow-up of Japanese encephalitis chimeric virus vaccine: Immune responses in children.
    Vaccine. 2016 Sep 26. pii: S0264-410X(16)30831.
    PubMed     Text format     Abstract available


  484. FAASSE K, Chatman CJ, Martin LR
    A comparison of language use in pro- and anti-vaccination comments in response to a high profile Facebook post.
    Vaccine. 2016 Sep 24. pii: S0264-410X(16)30842.
    PubMed     Text format     Abstract available


  485. WU Y, Wood J, Khandaker G, Waddington C, et al
    Informing rubella vaccination strategies in East Java, Indonesia through transmission modelling.
    Vaccine. 2016 Sep 23. pii: S0264-410X(16)30823.
    PubMed     Text format     Abstract available


  486. FRIEDRICH BM, Beasley DW, Rudra JS
    Supramolecular peptide hydrogel adjuvanted subunit vaccine elicits protective antibody responses against West Nile virus.
    Vaccine. 2016 Sep 23. pii: S0264-410X(16)30858.
    PubMed     Text format     Abstract available


  487. LIN X, Fiebelkorn AP, Pabst LJ
    Trends in compliance with two-dose influenza vaccine recommendations in children aged 6 months through 8 years, 2010-2015.
    Vaccine. 2016 Sep 23. pii: S0264-410X(16)30850.
    PubMed     Text format     Abstract available


  488. WILLIS E, Parkhouse K, Krammer F, Hensley SE, et al
    Canine H3N8 influenza vaccines partially protect mice against the canine H3N2 strain currently circulating in the United States.
    Vaccine. 2016 Sep 23. pii: S0264-410X(16)30830.
    PubMed     Text format     Abstract available


  489. HOLECHEK SA, McAfee MS, Nieves LM, Guzman VP, et al
    Retinaldehyde dehydrogenase 2 as a molecular adjuvant for enhancement of mucosal immunity during DNA vaccination.
    Vaccine. 2016 Sep 23. pii: S0264-410X(16)30826.
    PubMed     Text format     Abstract available


  490. FRANZO G, Tucciarone CM, Blanco A, Nofrarias M, et al
    Effect of different vaccination strategies on IBV QX population dynamics and clinical outbreaks.
    Vaccine. 2016 Sep 23. pii: S0264-410X(16)30827.
    PubMed     Text format     Abstract available


  491. LEVIN Y, Kochba E, Shukarev G, Rusch S, et al
    A phase 1, open-label, randomized study to compare the immunogenicity and safety of different administration routes and doses of virosomal influenza vaccine in elderly.
    Vaccine. 2016 Sep 22. pii: S0264-410X(16)30804.
    PubMed     Text format     Abstract available


  492. GRANT BD, Smith CA, Castle PE, Scheurer ME, et al
    A paper-based immunoassay to determine HPV vaccination status at the point-of-care.
    Vaccine. 2016 Sep 22. pii: S0264-410X(16)30834.
    PubMed     Text format     Abstract available


  493. WONG VW, Fong DY, Lok KY, Wong JY, et al
    Brief education to promote maternal influenza vaccine uptake: A randomized controlled trial.
    Vaccine. 2016 Sep 22. pii: S0264-410X(16)30832.
    PubMed     Text format     Abstract available


  494. TAN L, Zhang Y, Liu F, Yuan Y, et al
    Infectious bronchitis virus poly-epitope-based vaccine protects chickens from acute infection.
    Vaccine. 2016 Sep 21. pii: S0264-410X(16)30835.
    PubMed     Text format     Abstract available


  495. SCHAUT RG, Grinnage-Pulley TL, Esch KJ, Toepp AJ, et al
    Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant.
    Vaccine. 2016 Sep 21. pii: S0264-410X(16)30829.
    PubMed     Text format     Abstract available


  496. SLAUNWHITE JM, Smith SM, Halperin BA, Langley JM, et al
    The role of healthcare provider attitudes in increasing willingness to accept seasonal influenza vaccine policy changes.
    Vaccine. 2016 Sep 21. pii: S0264-410X(16)30790.
    PubMed     Text format     Abstract available


  497. STADING BR, Osorio JE, Velasco-Villa A, Smotherman M, et al
    Infectivity of attenuated poxvirus vaccine vectors and immunogenicity of a raccoonpox vectored rabies vaccine in the Brazilian Free-tailed bat (Tadarida brasiliensis).
    Vaccine. 2016 Sep 17. pii: S0264-410X(16)30796.
    PubMed     Text format     Abstract available


  498. NANNEI C, Goldin S, Torelli G, Fatima H, et al
    Stakeholders' perceptions of 10years of the Global Action Plan for Influenza Vaccines (GAP) - Results from a survey.
    Vaccine. 2016 Sep 16. pii: S0264-410X(16)30712.
    PubMed     Text format     Abstract available


  499. STEIN DF, O'Connor D, Blohmke CJ, Sadarangani M, et al
    Gene expression profiles are different in venous and capillary blood: Implications for vaccine studies.
    Vaccine. 2016 Sep 15. pii: S0264-410X(16)30803.
    PubMed     Text format     Abstract available


  500. ROBERTSON CA, Greenberg DP, Hedrick J, Pichichero M, et al
    Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
    Vaccine. 2016 Sep 15. pii: S0264-410X(16)30799.
    PubMed     Text format     Abstract available


  501. BRUCKNER S, Agnandji ST, Elias J, Berberich S, et al
    A single-dose antihelminthic treatment does not influence immunogenicity of a meningococcal and a cholera vaccine in Gabonese school children.
    Vaccine. 2016 Sep 15. pii: S0264-410X(16)30624.
    PubMed     Text format     Abstract available


  502. FLECHTNER JB, Long D, Larson S, Clemens V, et al
    Immune responses elicited by the GEN-003 candidate HSV-2 therapeutic vaccine in a randomized controlled dose-ranging phase 1/2a trial.
    Vaccine. 2016 Sep 15. pii: S0264-410X(16)30795.
    PubMed     Text format     Abstract available


  503. YANG X, Clapp B, Thornburg T, Hoffman C, et al
    Vaccination with a DeltanorD DeltaznuA Brucella abortus mutant confers potent protection against virulent challenge.
    Vaccine. 2016 Sep 14. pii: S0264-410X(16)30800.
    PubMed     Text format     Abstract available


  504. MUNIER CM, van Bockel D, Bailey M, Ip S, et al
    The primary immune response to Vaccinia virus vaccination includes cells with a distinct cytotoxic effector CD4 T-cell phenotype.
    Vaccine. 2016 Sep 14. pii: S0264-410X(16)30805.
    PubMed     Text format     Abstract available


  505. GATERA M, Uwimana J, Manzi E, Ngabo F, et al
    Use of administrative records to assess pneumococcal conjugate vaccine impact on pediatric meningitis and pneumonia hospitalizations in Rwanda.
    Vaccine. 2016 Sep 14. pii: S0264-410X(16)30791.
    PubMed     Text format     Abstract available


  506. JANEWONGWIROT P, Puthanakit T, Anugulruengkitt S, Jantarabenjakul W, et al
    Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children.
    Vaccine. 2016 Sep 12. pii: S0264-410X(16)30801.
    PubMed     Text format     Abstract available


  507. SMITH SG, Zelmer A, Blitz R, Fletcher HA, et al
    Polyfunctional CD4 T-cells correlate with in vitro mycobacterial growth inhibition following Mycobacterium bovis BCG-vaccination of infants.
    Vaccine. 2016 Sep 9. pii: S0264-410X(16)30797.
    PubMed     Text format     Abstract available


  508. HURTGEN BJ, Castro-Lopez N, Jimenez-Alzate MD, Cole GT, et al
    Preclinical identification of vaccine induced protective correlates in human leukocyte antigen expressing transgenic mice infected with Coccidioides posadasii.
    Vaccine. 2016 Sep 9. pii: S0264-410X(16)30785.
    PubMed     Text format     Abstract available


  509. LI R, Fang KX, Young M Jr, Zhou X, et al
    Long-term antibody persistence study (3 years after last dose) of the 7-valent pneumococcal conjugate vaccine in young children in China.
    Vaccine. 2016 Sep 8. pii: S0264-410X(16)30766.
    PubMed     Text format     Abstract available


  510. SULLIVAN SG, Cowling BJ, Greenland S
    Frailty and influenza vaccine effectiveness.
    Vaccine. 2016;34:4645-6.
    PubMed     Text format    


  511. NANNEI C, Chadwick C, Fatima H, Goldin S, et al
    Considerations for sustainable influenza vaccine production in developing countries.
    Vaccine. 2016 Sep 7. pii: S0264-410X(16)30743.
    PubMed     Text format     Abstract available


  512. COWAN AE, Clark SJ, Gordon JL, Bok K, et al
    Vaccine purchasing groups in the United States: An overview of their policies and practices.
    Vaccine. 2016 Sep 7. pii: S0264-410X(16)30787.
    PubMed     Text format     Abstract available


  513. TANG VA, Renner TM, Varette O, Le Boeuf F, et al
    Single-particle characterization of oncolytic vaccinia virus by flow virometry.
    Vaccine. 2016 Sep 7. pii: S0264-410X(16)30770.
    PubMed     Text format     Abstract available


  514. DHAND NK, Eppleston J, Whittington RJ, Windsor PA, et al
    Changes in prevalence of ovine paratuberculosis following vaccination with Gudair(R): Results of a longitudinal study conducted over a decade.
    Vaccine. 2016 Sep 7. pii: S0264-410X(16)30760.
    PubMed     Text format     Abstract available


  515. HOWLADER DR, Sinha R, Nag D, Majumder N, et al
    Zebrafish as a novel model for non-typhoidal Salmonella pathogenesis, transmission and vaccine efficacy.
    Vaccine. 2016 Sep 7. pii: S0264-410X(16)30773.
    PubMed     Text format     Abstract available


  516. CASPARD H, Coelingh KL, Mallory RM, Ambrose CS, et al
    Association of vaccine handling conditions with effectiveness of live attenuated influenza vaccine against H1N1pdm09 viruses in the United States.
    Vaccine. 2016 Sep 6. pii: S0264-410X(16)30786.
    PubMed     Text format     Abstract available


  517. DOWNEY-SLINKER ED, Ridpath JF, Sawyer JE, Skow LC, et al
    Antibody titers to vaccination are not predictive of level of protection against a BVDV type 1b challenge in Bos indicus - Bos taurus steers.
    Vaccine. 2016 Sep 3. pii: S0264-410X(16)30794.
    PubMed     Text format     Abstract available


  518. COUDEVILLE L, Baurin N, L'Azou M, Guy B, et al
    Potential impact of dengue vaccination: Insights from two large-scale phase III trials with a tetravalent dengue vaccine.
    Vaccine. 2016 Sep 3. pii: S0264-410X(16)30735.
    PubMed     Text format     Abstract available


  519. TABYNOV K, Orynbayev M, Renukaradhya GJ, Sansyzbay A, et al
    Simultaneous subcutaneous and conjunctival administration of the influenza viral vector based Brucella abortus vaccine to pregnant heifers provides better protection against B. abortus 544 infection than the commercial B. abortus S19 vaccine.
    Vaccine. 2016 Sep 2. pii: S0264-410X(16)30768.
    PubMed     Text format     Abstract available


  520. SARAWAR S, Hatta Y, Watanabe S, Dias P, et al
    M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice.
    Vaccine. 2016 Sep 2. pii: S0264-410X(16)30757.
    PubMed     Text format     Abstract available


  521. RUDENKO L, Yeolekar L, Kiseleva I, Isakova-Sivak I, et al
    Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories.
    Vaccine. 2016 Sep 1. pii: S0264-410X(16)30675.
    PubMed     Text format     Abstract available


  522. PLATTEEL AC, Marit de Groot A, Keller C, Andersen P, et al
    Strategies to enhance immunogenicity of cDNA vaccine encoded antigens by modulation of antigen processing.
    Vaccine. 2016 Sep 1. pii: S0264-410X(16)30711.
    PubMed     Text format     Abstract available


    August 2016
  523. PRIDGEON JW, Klesius PH
    Retraction notice to "Development of live attenuated Streptococcus agalactiae as potential vaccines by selecting for resistance to sparfloxacin" [Vaccine 31 (2013) 2705-2712].
    Vaccine. 2016;34:4642.
    PubMed     Text format    


  524. HENDRICKSON JE, Tormey CA
    Human papilloma virus vaccination and dysautonomia: Considerations for autoantibody evaluation and HLA typing.
    Vaccine. 2016;34:4468.
    PubMed     Text format    


  525. BRYANT K, Frenck RW Jr
    Response to Letter to the Editor regarding: Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 18-49 years of age, naive to 23-valent pneumococcal polysaccharide vaccine.
    Vaccine. 2016;34:4467.
    PubMed     Text format    


  526. FEDSON DS
    PCV13 vaccination for older adults: Another view.
    Vaccine. 2016;34:4466.
    PubMed     Text format    


  527. PHAN TL, Ho VT, Vu MH, Nguyen TN, et al
    Clinical testing of an inactivated influenza A/H5N1 vaccine candidate in a double-blinded, placebo-controlled, randomized trial in healthy adults in Vietnam.
    Vaccine. 2016 Aug 31. pii: S0264-410X(16)30742.
    PubMed     Text format     Abstract available


  528. CHITRADEVI ST, Kaur G, Sivaramakrishna U, Singh D, et al
    Development of recombinant vaccine candidate molecule against Shigella infection.
    Vaccine. 2016 Aug 31. pii: S0264-410X(16)30706.
    PubMed     Text format     Abstract available


  529. VOIGT EA, Ovsyannikova IG, Haralambieva IH, Kennedy RB, et al
    Genetically defined race, but not sex, is associated with higher humoral and cellular immune responses to measles vaccination.
    Vaccine. 2016 Aug 30. pii: S0264-410X(16)30756.
    PubMed     Text format     Abstract available


  530. YOSHIKAWA T, Ando Y, Nakagawa T, Gomi Y, et al
    Safety profile of the varicella vaccine (Oka vaccine strain) based on reported cases from 2005 to 2015 in Japan.
    Vaccine. 2016 Aug 30. pii: S0264-410X(16)30729.
    PubMed     Text format     Abstract available


  531. PROVEAUX T, Lambach P, Ortiz JR, Hombach J, et al
    Review of prescribing information for influenza vaccines for pregnant and lactating women.
    Vaccine. 2016 Aug 29. pii: S0264-410X(16)30714.
    PubMed     Text format     Abstract available


  532. ASTRAY-MOCHALES J, Lopez de Andres A, Hernandez-Barrera V, Rodriguez-Rieiro C, et al
    Influenza vaccination coverages among high risk subjects and health care workers in Spain. Results of two consecutive National Health Surveys (2011-2014).
    Vaccine. 2016 Aug 29. pii: S0264-410X(16)30761.
    PubMed     Text format     Abstract available


  533. DENMAN DC, Baldwin AS, Marks EG, Lee SC, et al
    Modification and validation of the Treatment Self Regulation Questionnaire to assess parental motivation for HPV vaccination of adolescents.
    Vaccine. 2016 Aug 29. pii: S0264-410X(16)30709.
    PubMed     Text format     Abstract available


  534. YEUNG KH, Tate JE, Chan CC, Chan MC, et al
    Rotavirus vaccine effectiveness in Hong Kong children.
    Vaccine. 2016 Aug 29. pii: S0264-410X(16)30732.
    PubMed     Text format     Abstract available


  535. COHEN R, Varon E, Bechet S, Bonacorsi S, et al
    Comparative impact of pneumococcal conjugate vaccines on pneumococcal meningitis according to underlying conditions.
    Vaccine. 2016 Aug 29. pii: S0264-410X(16)30765.
    PubMed     Text format     Abstract available


  536. ISSA MN, Ashhab Y
    Identification of Brucella melitensis Rev.1 vaccine-strain genetic markers: Towards understanding the molecular mechanism behind virulence attenuation.
    Vaccine. 2016 Aug 29. pii: S0264-410X(16)30755.
    PubMed     Text format     Abstract available


  537. MCBRIDE WJ, Abhayaratna WP, Barr I, Booy R, et al
    Efficacy of a trivalent influenza vaccine against seasonal strains and against 2009 pandemic H1N1: A randomized, placebo-controlled trial.
    Vaccine. 2016 Aug 29. pii: S0264-410X(16)30710.
    PubMed     Text format     Abstract available


  538. CRUM-CIANFLONE NF, Won S, Lee R, Lalani T, et al
    Vitamin D levels and influenza vaccine immunogenicity among HIV-infected and HIV-uninfected adults.
    Vaccine. 2016 Aug 28. pii: S0264-410X(16)30432.
    PubMed     Text format     Abstract available


  539. FIELDING JE, Levy A, Chilver MB, Deng YM, et al
    Effectiveness of seasonal influenza vaccine in Australia, 2015: An epidemiological, antigenic and phylogenetic assessment.
    Vaccine. 2016 Aug 28. pii: S0264-410X(16)30763.
    PubMed     Text format     Abstract available


  540. JIA Q, Bowen R, Lee BY, Dillon BJ, et al
    Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
    Vaccine. 2016 Aug 28. pii: S0264-410X(16)30713.
    PubMed     Text format     Abstract available


  541. GADROEN K, Straus SM, Pacurariu A, Weibel D, et al
    Patterns of spontaneous reports on narcolepsy following administration of pandemic influenza vaccine; a case series of individual case safety reports in Eudravigilance.
    Vaccine. 2016 Aug 27. pii: S0264-410X(16)30758.
    PubMed     Text format     Abstract available


  542. VUTA V, Picard-Meyer E, Robardet E, Barboi G, et al
    Vaccine-induced rabies case in a cow (Bos taurus): Molecular characterisation of vaccine strain in brain tissue.
    Vaccine. 2016 Aug 27. pii: S0264-410X(16)30670.
    PubMed     Text format     Abstract available


  543. ELNEKAVE E, Dekker A, Eble P, van Hemert-Kluitenberg F, et al
    The serological response against foot and mouth disease virus elicited by repeated vaccination of dairy cattle.
    Vaccine. 2016 Aug 26. pii: S0264-410X(16)30741.
    PubMed     Text format     Abstract available


  544. LEE BY, Haidari LA, Prosser W, Connor DL, et al
    Re-designing the Mozambique vaccine supply chain to improve access to vaccines.
    Vaccine. 2016 Aug 26. pii: S0264-410X(16)30708.
    PubMed     Text format     Abstract available


  545. PITTET LF, Posfay-Barbe KM, Chehade H, Rudin C, et al
    Optimizing seroprotection against pneumococcus in children with nephrotic syndrome using the 13-valent pneumococcal conjugate vaccine.
    Vaccine. 2016 Aug 26. pii: S0264-410X(16)30734.
    PubMed     Text format     Abstract available


  546. KARAFILLAKIS E, Dinca I, Apfel F, Cecconi S, et al
    Vaccine hesitancy among healthcare workers in Europe: A qualitative study.
    Vaccine. 2016 Aug 26. pii: S0264-410X(16)30701.
    PubMed     Text format     Abstract available


  547. CHENG T, Wang X, Song Y, Tang X, et al
    Chimpanzee adenovirus vector-based avian influenza vaccine completely protects mice against lethal challenge of H5N1.
    Vaccine. 2016 Aug 26. pii: S0264-410X(16)30762.
    PubMed     Text format     Abstract available


  548. IDOKO OT, Hampton LM, Mboizi RB, Agbla SC, et al
    Acceptance of multiple injectable vaccines in a single immunization visit in The Gambia pre and post introduction of inactivated polio vaccine.
    Vaccine. 2016 Aug 25. pii: S0264-410X(16)30604.
    PubMed     Text format     Abstract available


  549. ANH DD, Thiem VD, Anh NT, Huong VM, et al
    Randomized safety and immunogenicity trial of a seasonal trivalent inactivated split virion influenza vaccine (IVACFLU-S) in healthy young Vietnamese adults.
    Vaccine. 2016 Aug 24. pii: S0264-410X(16)30739.
    PubMed     Text format     Abstract available


  550. OLADEJO O, Allen K, Amin A, Frew PM, et al
    Comparative analysis of the Parent Attitudes about Childhood Vaccines (PACV) short scale and the five categories of vaccine acceptance identified by Gust et al.
    Vaccine. 2016 Aug 23. pii: S0264-410X(16)30731.
    PubMed     Text format     Abstract available


  551. ROBERTS JN, Graham BS, Karron RA, Munoz FM, et al
    Challenges and opportunities in RSV vaccine development: Meeting report from FDA/NIH workshop.
    Vaccine. 2016 Aug 23. pii: S0264-410X(16)30655.
    PubMed     Text format     Abstract available


  552. STARK GV, Sivko GS, VanRaden M, Schiffer J, et al
    Cross-species prediction of human survival probabilities for accelerated anthrax vaccine absorbed (AVA) regimens and the potential for vaccine and antibiotic dose sparing.
    Vaccine. 2016 Aug 22. pii: S0264-410X(16)30465.
    PubMed     Text format     Abstract available


  553. SHEN C, Liu Q, Zhou Y, Ku Z, et al
    Inactivated coxsackievirus A10 experimental vaccines protect mice against lethal viral challenge.
    Vaccine. 2016 Aug 22. pii: S0264-410X(16)30705.
    PubMed     Text format     Abstract available


  554. BOSE A, Munshi R, Tripathy RM, Madhusudana SN, et al
    A randomized non-inferiority clinical study to assess post-exposure prophylaxis by a new purified vero cell rabies vaccine (Rabivax-S) administered by intramuscular and intradermal routes.
    Vaccine. 2016 Aug 20. pii: S0264-410X(16)30662.
    PubMed     Text format     Abstract available


  555. FAN W, Chen XF, Shen C, Guo ZR, et al
    Hepatitis B vaccine response in obesity: A meta-analysis.
    Vaccine. 2016 Aug 18. pii: S0264-410X(16)30699.
    PubMed     Text format     Abstract available


  556. CHOE YJ, Lee HJ, Lee H, Oh CE, et al
    Emergence of antibiotic-resistant non-vaccine serotype pneumococci in nasopharyngeal carriage in children after the use of extended-valency pneumococcal conjugate vaccines in Korea.
    Vaccine. 2016 Aug 18. pii: S0264-410X(16)30702.
    PubMed     Text format     Abstract available


  557. SHIH CT, Chang YC, Wang HL, Lin CC, et al
    Comparing the rubella seronegativity in pregnant women who received one dose of rubella vaccine at different ages in Taiwan.
    Vaccine. 2016 Aug 17. pii: S0264-410X(16)30696.
    PubMed     Text format     Abstract available


  558. SUMNER RP, Ren H, Ferguson BJ, Smith GL, et al
    Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulators.
    Vaccine. 2016 Aug 17. pii: S0264-410X(16)30659.
    PubMed     Text format     Abstract available


  559. MONEY DM, Moses E, Blitz S, Vandriel SM, et al
    HIV viral suppression results in higher antibody responses in HIV-positive women vaccinated with the quadrivalent human papillomavirus vaccine.
    Vaccine. 2016 Aug 17. pii: S0264-410X(16)30673.
    PubMed     Text format     Abstract available


  560. LONG JE, Drayson MT, Taylor AE, Toellner KM, et al
    Corrigendum to 'Morning vaccination enhances antibody response over afternoon vaccination: A cluster-randomised trial' [Vaccine 34 (2016) 2679-2685].
    Vaccine. 2016 Aug 16. pii: S0264-410X(16)30703.
    PubMed     Text format    


  561. SINGH SM, Alkie TN, Nagy E, Kulkarni RR, et al
    Delivery of an inactivated avian influenza virus vaccine adjuvanted with poly(D,L-lactic-co-glycolic acid) encapsulated CpG ODN induces protective immune responses in chickens.
    Vaccine. 2016 Aug 16. pii: S0264-410X(16)30666.
    PubMed     Text format     Abstract available


  562. SILLERO-ZUBIRI C, Marino J, Gordon CH, Bedin E, et al
    Feasibility and efficacy of oral rabies vaccine SAG2 in endangered Ethiopian wolves.
    Vaccine. 2016 Aug 16. pii: S0264-410X(16)30693.
    PubMed     Text format     Abstract available


  563. MCLEAN KA, Goldin S, Nannei C, Sparrow E, et al
    The 2015 global production capacity of seasonal and pandemic influenza vaccine.
    Vaccine. 2016 Aug 13. pii: S0264-410X(16)30676.
    PubMed     Text format     Abstract available


  564. CHOOTIPONGCHAIVAT S, Chantarastapornchit V, Kulpeng W, Ceria JA, et al
    Vaccination program in a resource-limited setting: A case study in the Philippines.
    Vaccine. 2016 Aug 13. pii: S0264-410X(16)30671.
    PubMed     Text format     Abstract available


  565. ARMSTRONG G, Gallagher N, Cabrey P, Graham AM, et al
    A population based study comparing changes in rotavirus burden on the Island of Ireland between a highly vaccinated population and an unvaccinated population.
    Vaccine. 2016 Aug 12. pii: S0264-410X(16)30661.
    PubMed     Text format     Abstract available


  566. CLOSE RM, Pearson C, Cohn J
    Vaccine-preventable disease and the under-utilization of immunizations in complex humanitarian emergencies.
    Vaccine. 2016 Aug 12. pii: S0264-410X(16)30697.
    PubMed     Text format     Abstract available


  567. TADDIO A, Wong H, Welkovics B, Ilersich AL, et al
    A randomized trial of the effect of vaccine injection speed on acute pain in infants.
    Vaccine. 2016 Aug 12. pii: S0264-410X(16)30695.
    PubMed     Text format     Abstract available


  568. GUERRA FM, Rosella LC, Dunn S, Wilson SE, et al
    Early impact of Ontario's human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): A population-based assessment.
    Vaccine. 2016 Aug 12. pii: S0264-410X(16)30677.
    PubMed     Text format     Abstract available


  569. TANNER R, O'Shea MK, Fletcher HA, McShane H, et al
    In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy.
    Vaccine. 2016 Aug 12. pii: S0264-410X(16)30656.
    PubMed     Text format     Abstract available


  570. VISSER O, Kraan J, Akkermans R, Ruiter RA, et al
    Assessing determinants of the intention to accept a pertussis cocooning vaccination: A survey among Dutch parents.
    Vaccine. 2016 Aug 11. pii: S0264-410X(16)30607.
    PubMed     Text format     Abstract available


  571. GUPTA G, Giannino V, Rishi N, Glueck R, et al
    Immunogenicity of next-generation HPV vaccines in non-human primates: Measles-vectored HPV vaccine versus Pichia pastoris recombinant protein vaccine.
    Vaccine. 2016 Aug 11. pii: S0264-410X(16)30649.
    PubMed     Text format     Abstract available


  572. VALCARCEL SALAMANCA B, Hagerup-Jenssen ME, Flem E
    Uptake and timeliness of rotavirus vaccination in Norway: The first year post-introduction.
    Vaccine. 2016 Aug 10. pii: S0264-410X(16)30674.
    PubMed     Text format     Abstract available


  573. WESTMAN ME, Malik R, Hall E, Harris M, et al
    The protective rate of the feline immunodeficiency virus vaccine: An Australian field study.
    Vaccine. 2016 Aug 10. pii: S0264-410X(16)30511.
    PubMed     Text format     Abstract available


  574. CHEN W, Messonnier M, Zhou F
    Trends in childhood vaccine purchase costs in the US public sector: 1996-2014.
    Vaccine. 2016 Aug 10. pii: S0264-410X(16)30669.
    PubMed     Text format     Abstract available


  575. SUAREZ V, Michel F, Toscano CM, Bierrenbach AL, et al
    Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: Time series analyses.
    Vaccine. 2016 Aug 9. pii: S0264-410X(16)30610.
    PubMed     Text format     Abstract available


  576. ELNEKAVE E, Dekker A, Eble P, van Hemert-Kluitenberg F, et al
    The long term effect of age and maternally derived antibodies against foot and mouth disease on the serological response following vaccination in young dairy calves.
    Vaccine. 2016 Aug 9. pii: S0264-410X(16)30650.
    PubMed     Text format     Abstract available


  577. HOLBROOK BC, D'Agostino RB Jr, Parks GD, Alexander-Miller MA, et al
    Adjuvanting an inactivated influenza vaccine with flagellin improves the function and quantity of the long-term antibody response in a nonhuman primate neonate model.
    Vaccine. 2016 Aug 8. pii: S0264-410X(16)30667.
    PubMed     Text format     Abstract available


  578. GROHMANN G, Francis DP, Sokhey J, Robertson J, et al
    Challenges and successes for the grantees and the Technical Advisory Group of WHO's influenza vaccine technology transfer initiative.
    Vaccine. 2016 Aug 6. pii: S0264-410X(16)30645.
    PubMed     Text format     Abstract available


  579. HADINEGORO SR, Arredondo-Garcia JL, Guy B, Bouckenooghe A, et al
    Answer to the review from Halstead and Russell "Protective and immunological behavior of chimeric yellow fever dengue vaccine" (DOI 10.1016/j.vaccine.2016.02.004).
    Vaccine. 2016;34:4273-4.
    PubMed     Text format    


  580. VAN DAMME P, Stanley M
    Re: Letter to the Editor: P. van Damme et al., Vaccine 34 (2016) 757-761, as a reply to Ryser et al's letter in Vaccine.
    Vaccine. 2016;34:4272.
    PubMed     Text format    


  581. RYSER M, Berlaimont V, Mihalyi A
    Letter to the Editor; P. Van Damme et al. Vaccine 34 (2016) 757-761.
    Vaccine. 2016;34:4271.
    PubMed     Text format    


  582. DAGAN R, Juergens C, Trammel J, Patterson S, et al
    Modeling pneumococcal nasopharyngeal acquisition as a function of anticapsular serum antibody concentrations after pneumococcal conjugate vaccine administration.
    Vaccine. 2016;34:4313-20.
    PubMed     Text format     Abstract available


  583. KERN A, Zhou CW, Jia F, Xu Q, et al
    Live-vaccinia virus encapsulation in pH-sensitive polymer increases safety of a reservoir-targeted Lyme disease vaccine by targeting gastrointestinal release.
    Vaccine. 2016 Aug 5. pii: S0264-410X(16)30657.
    PubMed     Text format     Abstract available


  584. LI X, Huang J, Zhang M, Funakoshi R, et al
    Human CD8+ T cells mediate protective immunity induced by a human malaria vaccine in human immune system mice.
    Vaccine. 2016 Aug 5. pii: S0264-410X(16)30663.
    PubMed     Text format     Abstract available


  585. METCALFE HJ, Steinbach S, Jones GJ, Connelley T, et al
    Protection associated with a TB vaccine is linked to increased frequency of Ag85A-specific CD4+ T cells but no increase in avidity for Ag85A.
    Vaccine. 2016 Aug 4. pii: S0264-410X(16)30653.
    PubMed     Text format     Abstract available


  586. XIA Q, Geng F, Zhang FF, Liu CL, et al
    Enhancement of fibroblast activation protein alpha-based vaccines and adenovirus boost immunity by cyclophosphamide through inhibiting IL-10 expression in 4T1 tumor bearing mice.
    Vaccine. 2016 Aug 3. pii: S0264-410X(16)30652.
    PubMed     Text format     Abstract available


  587. PALKONYAY L, Fatima H
    A decade of adaptation: Regulatory contributions of the World Health Organization to the Global Action Plan for Influenza Vaccines (2006-2016).
    Vaccine. 2016 Aug 3. pii: S0264-410X(16)30608.
    PubMed     Text format     Abstract available


  588. OHANNESSIAN R, Yaghobian S, Verger P, Vanhems P, et al
    A systematic review of serious video games used for vaccination.
    Vaccine. 2016 Aug 3. pii: S0264-410X(16)30646.
    PubMed     Text format     Abstract available


  589. RASMUSSEN KJ, Mattsson AH, Pilely K, Asferg CA, et al
    Proteome-wide antigen discovery of novel protective vaccine candidates against Staphylococcus aureus infection.
    Vaccine. 2016 Aug 2. pii: S0264-410X(16)30589.
    PubMed     Text format     Abstract available


  590. TROGDON JG, Shafer PR, Shah PD, Calo WA, et al
    Are state laws granting pharmacists authority to vaccinate associated with HPV vaccination rates among adolescents?
    Vaccine. 2016 Aug 2. pii: S0264-410X(16)30654.
    PubMed     Text format     Abstract available


    July 2016
  591. ROLLIER CS, Hill AV, Reyes-Sandoval A
    Influence of adenovirus and MVA vaccines on the breadth and hierarchy of T cell responses.
    Vaccine. 2016 Jul 30. pii: S0264-410X(16)30648.
    PubMed     Text format     Abstract available


  592. WAHID R, Holt R, Hjorth R, Berlanda Scorza F, et al
    Chemistry, manufacturing and control (CMC) and clinical trial technical support for influenza vaccine manufacturers.
    Vaccine. 2016 Jul 30. pii: S0264-410X(16)30644.
    PubMed     Text format     Abstract available


  593. JONES CE, Munoz FM, Spiegel HM, Heininger U, et al
    Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women.
    Vaccine. 2016 Jul 29. pii: S0264-410X(16)30615.
    PubMed     Text format     Abstract available


  594. SIRIMA SB, Mordmuller B, Milligan P, Ngoa UA, et al
    A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children.
    Vaccine. 2016 Jul 28. pii: S0264-410X(16)30625.
    PubMed     Text format     Abstract available


  595. CHOUDHRY A, Mathena J, Albano JD, Yacovone M, et al
    Safety evaluation of adenovirus type 4 and type 7 vaccine live, oral in military recruits.
    Vaccine. 2016 Jul 27. pii: S0264-410X(16)30616.
    PubMed     Text format     Abstract available


  596. FISKER AB, Biering-Sorensen S, Lund N, Djana Q, et al
    Contrasting female-male mortality ratios after routine vaccinations with pentavalent vaccine versus measles and yellow fever vaccine. A cohort study from urban Guinea-Bissau.
    Vaccine. 2016 Jul 27. pii: S0264-410X(16)30617.
    PubMed     Text format     Abstract available


  597. KIM JH, Talbot HK, Mishina M, Zhu Y, et al
    High-dose influenza vaccine favors acute plasmablast responses rather than long-term cellular responses.
    Vaccine. 2016 Jul 26. pii: S0264-410X(16)30591.
    PubMed     Text format     Abstract available


  598. PAN Y, Deem MW
    Prediction of influenza B vaccine effectiveness from sequence data.
    Vaccine. 2016 Jul 26. pii: S0264-410X(16)30588.
    PubMed     Text format     Abstract available


  599. LINDSTRAND A, Galanis I, Darenberg J, Morfeldt E, et al
    Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8years after vaccine introduction in Stockholm, Sweden.
    Vaccine. 2016 Jul 26. pii: S0264-410X(16)30614.
    PubMed     Text format     Abstract available


  600. KRAAN H, Ten Have R, van der Maas L, Kersten G, et al
    Incompatibility of lyophilized inactivated polio vaccine with liquid pentavalent whole-cell-pertussis-containing vaccine.
    Vaccine. 2016 Jul 25. pii: S0264-410X(16)30613.
    PubMed     Text format     Abstract available


  601. CRAMER JP, Dubischar K, Eder S, Burchard GD, et al
    Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO(R) in elderly subjects: Open-label, uncontrolled, multi-center, phase 4 study.
    Vaccine. 2016 Jul 23. pii: S0264-410X(16)30612.
    PubMed     Text format     Abstract available


  602. RECKER M, Vannice K, Hombach J, Jit M, et al
    Assessing dengue vaccination impact: Model challenges and future directions.
    Vaccine. 2016 Jul 22. pii: S0264-410X(16)30562.
    PubMed     Text format     Abstract available


  603. VAN DAMME P, Bonanni P, Bosch FX, Joura E, et al
    Corrigendum to "Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines" [Vaccine 34 (2016) 757-761].
    Vaccine. 2016 Jul 22. pii: S0264-410X(16)30619.
    PubMed     Text format    


  604. HOONAKKER ME, Verhagen LM, van der Maas L, Metz B, et al
    Adaptive immune response to whole cell pertussis vaccine reflects vaccine quality: A possible complementation to the Pertussis Serological Potency test.
    Vaccine. 2016 Jul 21. pii: S0264-410X(16)30584.
    PubMed     Text format     Abstract available


  605. NG E, Sanmartin C, Elien-Massenat D, Manuel DG, et al
    Vaccine-preventable disease-related hospitalization among immigrants and refugees to Canada: Study of linked population-based databases.
    Vaccine. 2016 Jul 21. pii: S0264-410X(16)30559.
    PubMed     Text format     Abstract available


  606. LOUIK C, Kerr S, Van Bennekom CM, Chambers C, et al
    Safety of the 2011-12, 2012-13, and 2013-14 seasonal influenza vaccines in pregnancy: Preterm delivery and specific malformations, a study from the case-control arm of VAMPSS.
    Vaccine. 2016 Jul 21. pii: S0264-410X(16)30558.
    PubMed     Text format     Abstract available


  607. HERATH S, Le Heron A, Colloca S, Patterson S, et al
    Strain-dependent and distinctive T-cell responses to HIV antigens following immunisation of mice with differing chimpanzee adenovirus vaccine vectors.
    Vaccine. 2016 Jul 21. pii: S0264-410X(16)30611.
    PubMed     Text format     Abstract available


  608. CHAMBERS CD, Johnson DL, Xu R, Luo YJ, et al
    Safety of the 2010-11, 2011-12, 2012-13, and 2013-14 seasonal influenza vaccines in pregnancy: Birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants, a study from the cohort arm of VAMPSS.
    Vaccine. 2016 Jul 20. pii: S0264-410X(16)30478.
    PubMed     Text format     Abstract available


  609. ZHANG X, Sharma PK, Peter Goedegebuure S, Gillanders WE, et al
    Personalized cancer vaccines: Targeting the cancer mutanome.
    Vaccine. 2016 Jul 20. pii: S0264-410X(16)30399.
    PubMed     Text format     Abstract available


  610. YU X, Wang Y, Xia Y, Zhang L, et al
    A DNA vaccine encoding VP22 of herpes simplex virus type I (HSV-1) and OprF confers enhanced protection from Pseudomonas aeruginosa in mice.
    Vaccine. 2016 Jul 20. pii: S0264-410X(16)30590.
    PubMed     Text format     Abstract available


  611. LUO J, Shi H, Tan Y, Niu X, et al
    Two potential recombinant rabies vaccines expressing canine parvovirus virion protein 2 induce immunogenicity to canine parvovirus and rabies virus.
    Vaccine. 2016 Jul 19. pii: S0264-410X(16)30603.
    PubMed     Text format     Abstract available


  612. BARDENHEIER BH, Duderstadt SK, Engler RJ, McNeil MM, et al
    Adverse events following pandemic influenza A (H1N1) 2009 monovalent and seasonal influenza vaccinations during the 2009-2010 season in the active component U.S. military and civilians aged 17-44years reported to the Vaccine Adverse Event Reporting Sy
    Vaccine. 2016 Jul 19. pii: S0264-410X(16)30592.
    PubMed     Text format     Abstract available


  613. BENNETT A, Bar-Zeev N, Cunliffe NA
    Measuring indirect effects of rotavirus vaccine in low income countries.
    Vaccine. 2016 Jul 18. pii: S0264-410X(16)30564.
    PubMed     Text format     Abstract available


  614. PARSONS E, Epstein J, Sedegah M, Villasante E, et al
    Decrease in circulating CD25hiFoxp3+ regulatory T cells following vaccination with the candidate malaria vaccine RTS,S.
    Vaccine. 2016 Jul 18. pii: S0264-410X(16)30581.
    PubMed     Text format     Abstract available


  615. ANH DD, Jayadeva G, Kuriyakose S, Han HH, et al
    The safety and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis (dTpa) booster vaccine in healthy Vietnamese children.
    Vaccine. 2016 Jul 16. pii: S0264-410X(16)30568.
    PubMed     Text format     Abstract available


  616. HIRTH J, Kuo YF, Laz TH, Starkey JM, et al
    Concordance of adolescent human papillomavirus vaccination parental report with provider report in the National Immunization Survey-Teen (2008-2013).
    Vaccine. 2016 Jul 16. pii: S0264-410X(16)30587.
    PubMed     Text format     Abstract available


  617. DURANDO P, Esposito S, Bona G, Cuccia M, et al
    The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy.
    Vaccine. 2016 Jul 13. pii: S0264-410X(16)30582.
    PubMed     Text format     Abstract available


  618. MACINTYRE CR, Shaw P, Mackie FE, Boros C, et al
    Immunogenicity and persistence of immunity of a quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children.
    Vaccine. 2016 Jul 9. pii: S0264-410X(16)30473.
    PubMed     Text format     Abstract available


  619. SMITH AJ, Li Y, Bazin HG, St-Jean JR, et al
    Evaluation of novel synthetic TLR7/8 agonists as vaccine adjuvants.
    Vaccine. 2016 Jul 8. pii: S0264-410X(16)30560.
    PubMed     Text format     Abstract available


  620. VAN DEN DOBBELSTEEN GP, Fae KC, Serroyen J, van den Nieuwenhof IM, et al
    Immunogenicity and safety of a tetravalent E. coli O-antigen bioconjugate vaccine in animal models.
    Vaccine. 2016 Jul 6. pii: S0264-410X(16)30518.
    PubMed     Text format     Abstract available


  621. SOUZA AR, Maruyama CM, Safadi MA, Lopes MH, et al
    Antibody persistence after serogroup C meningococcal conjugate vaccine in children with sickle cell disease.
    Vaccine. 2016 Jul 6. pii: S0264-410X(16)30549.
    PubMed     Text format     Abstract available


  622. DUQUE H, Naranjo J, Carrillo C, Burbano A, et al
    Protection induced by a commercial bivalent vaccine against Foot-and-Mouth Disease 2010 field virus from Ecuador.
    Vaccine. 2016 Jul 6. pii: S0264-410X(16)30550.
    PubMed     Text format     Abstract available


  623. CLARKE DK, Hendry RM, Singh V, Rose JK, et al
    Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment.
    Vaccine. 2016 Jul 6. pii: S0264-410X(16)30548.
    PubMed     Text format     Abstract available


  624. CAROLE TEVI-BENISSAN M, Moturi E, Anya BM, Aschalew T, et al
    Contribution of polio eradication initiative to effective new vaccine introduction in Africa, 2010-2015.
    Vaccine. 2016 Jul 5. pii: S0264-410X(16)30389.
    PubMed     Text format     Abstract available


  625. MOA AM, Chughtai AA, Muscatello DJ, Turner RM, et al
    Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: A systematic review and meta-analysis of randomised controlled trials.
    Vaccine. 2016 Jul 2. pii: S0264-410X(16)30515.
    PubMed     Text format     Abstract available


    June 2016
  626. YAN Q, Wu L, Chen L, Qin Y, et al
    Vesicular stomatitis virus-based vaccines expressing EV71 virus-like particles elicit strong immune responses and protect newborn mice from lethal challenges.
    Vaccine. 2016 Jun 30. pii: S0264-410X(16)30509.
    PubMed     Text format     Abstract available


  627. HANSEN J, Timbol J, Lewis N, Pool V, et al
    Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlers.
    Vaccine. 2016 Jun 30. pii: S0264-410X(16)30513.
    PubMed     Text format     Abstract available


  628. GOUMA S, Ten Hulscher HI, Schurink-van 't Klooster TM, de Melker HE, et al
    Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection.
    Vaccine. 2016 Jun 29. pii: S0264-410X(16)30514.
    PubMed     Text format     Abstract available


  629. FAIZ NM, Cortes AL, Guy JS, Fogle JE, et al
    Efficacy of various Marek's disease vaccines protocols for prevention of Marek's disease virus-induced immunosuppression.
    Vaccine. 2016 Jun 28. pii: S0264-410X(16)30512.
    PubMed     Text format     Abstract available


  630. GRIFFITHS UK, Bozzani FM, Chansa C, Kinghorn A, et al
    Costs of introducing pneumococcal, rotavirus and a second dose of measles vaccine into the Zambian immunisation programme: Are expansions sustainable?
    Vaccine. 2016 Jun 28. pii: S0264-410X(16)30474.
    PubMed     Text format     Abstract available


  631. VOYSEY M, Kandasamy R, Yu LM, Baudin M, et al
    The predicted persistence and kinetics of antibody decline 9years after pre-school booster vaccination in UK children.
    Vaccine. 2016 Jun 27. pii: S0264-410X(16)30475.
    PubMed     Text format     Abstract available


  632. MUSA A, Abba B, Ningi AM, Gali E, et al
    Enhancing transit polio vaccination in collaboration with targeted stakeholders in Kaduna State, Nigeria: Lessons learnt: 2014-2015.
    Vaccine. 2016 Jun 27. pii: S0264-410X(16)30390.
    PubMed     Text format     Abstract available


  633. FEKADU L, Okeibunor J, Nsubuga P, Kipela JM, et al
    Reaching the unreached with polio vaccine and other child survival interventions through partnership with military in Angola.
    Vaccine. 2016 Jun 25. pii: S0264-410X(16)30395.
    PubMed     Text format     Abstract available


  634. VAN DAMME P, Meijer CJ, Kieninger D, Schuyleman A, et al
    A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in men.
    Vaccine. 2016 Jun 25. pii: S0264-410X(16)30480.
    PubMed     Text format     Abstract available


  635. CUTTS FT, Claquin P, Danovaro-Holliday C, Rhoda DA, et al
    Monitoring vaccination coverage: Defining the role of surveys.
    Vaccine. 2016 Jun 24. pii: S0264-410X(16)30477.
    PubMed     Text format     Abstract available


  636. VOYSEY M, Sadarangani M, Clutterbuck E, Bolgiano B, et al
    The impact of administration of conjugate vaccines containing cross reacting material on Haemophilus influenzae type b antibody responses in infants: A systematic review and meta-analysis of randomised controlled trials.
    Vaccine. 2016 Jun 24. pii: S0264-410X(16)30462.
    PubMed     Text format     Abstract available


  637. KEMMEREN J, Honsbeek M, Dijkstra F, de Lange M, et al
    Comparison of different collection methods for reported adverse events following pandemic and seasonal influenza vaccination.
    Vaccine. 2016 Jun 24. pii: S0264-410X(16)30479.
    PubMed     Text format     Abstract available


  638. CONDIT RC, Williamson AL, Sheets R, Seligman SJ, et al
    Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains.
    Vaccine. 2016 Jun 23. pii: S0264-410X(16)30225.
    PubMed     Text format     Abstract available


  639. LEE C, Whetten K, Omer S, Pan W, et al
    Hurdles to herd immunity: Distrust of government and vaccine refusal in the US, 2002-2003.
    Vaccine. 2016 Jun 22. pii: S0264-410X(16)30472.
    PubMed     Text format     Abstract available


  640. MIHIGO RM, Okeibunor JC, O'Malley H, Masresha B, et al
    Investing in life saving vaccines to guarantee life of future generations in Africa.
    Vaccine. 2016 Jun 21. pii: S0264-410X(16)30460.
    PubMed     Text format     Abstract available


  641. GORDON DL, Sajkov D, Honda-Okubo Y, Wilks SH, et al
    Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax delta inulin adjuvant.
    Vaccine. 2016 Jun 21. pii: S0264-410X(16)30397.
    PubMed     Text format     Abstract available


  642. SCHERR CL, Augusto B, Ali K, Malo TL, et al
    Provider-reported acceptance and use of the Centers for Disease Control and Prevention messages and materials to support HPV vaccine recommendation for adolescent males.
    Vaccine. 2016 Jun 20. pii: S0264-410X(16)30461.
    PubMed     Text format     Abstract available


  643. LEE SY, Ko MK, Lee KN, Choi JH, et al
    Application of mouse model for effective evaluation of foot-and-mouth disease vaccine.
    Vaccine. 2016 Jun 20. pii: S0264-410X(16)30407.
    PubMed     Text format     Abstract available


  644. SHEN C, Ku Z, Zhou Y, Li D, et al
    Virus-like particle-based vaccine against coxsackievirus A6 protects mice against lethal infections.
    Vaccine. 2016 Jun 20. pii: S0264-410X(16)30441.
    PubMed     Text format     Abstract available


  645. KRAICER-MELAMED H, O'Donnell S, Quach C
    Corrigendum to "The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50years of age and older: A systematic review and meta-analysis" [Vaccine 34 (2016) 1540-1550].
    Vaccine. 2016 Jun 18. pii: S0264-410X(16)30469.
    PubMed     Text format    


  646. CHABOT DJ, Ribot WJ, Joyce J, Cook J, et al
    Protection of rhesus macaques against inhalational anthrax with a Bacillus anthracis capsule conjugate vaccine.
    Vaccine. 2016 Jun 18. pii: S0264-410X(16)30455.
    PubMed     Text format     Abstract available


  647. BARBOUR EK, Abou Assi CA, Shaib H, Hamadeh S, et al
    Corrigendum to "Evaluation of a Salmonella Enteritidis vaccine and related ELISA for respective induction and assessment of acquired immunity to the vaccine and/or Echinacea purpurea in Awassi Ewes" [Vaccine 33 (2015) 2228-2231].
    Vaccine. 2016 Jun 18. pii: S0264-410X(16)30468.
    PubMed     Text format    


  648. MYERS KL
    Predictors of maternal vaccination in the United States: An integrative review of the literature.
    Vaccine. 2016 Jun 18. pii: S0264-410X(16)30466.
    PubMed     Text format     Abstract available


  649. YOSHIKAWA T, Ihara T, Watanabe M, Nishimura N, et al
    Symposium report of the 19th annual meeting of the Japanese Society for Vaccinology 2015: What is the role of clinicians in vaccinology?
    Vaccine. 2016 Jun 18. pii: S0264-410X(16)30454.
    PubMed     Text format    


  650. VALENTE C, Hinds J, Gould KA, Pinto FR, et al
    Impact of the 13-valent pneumococcal conjugate vaccine on Streptococcus pneumoniae multiple serotype carriage.
    Vaccine. 2016 Jun 17. pii: S0264-410X(16)30430.
    PubMed     Text format     Abstract available


  651. SANDBULTE MR, Gauger PC, Kitikoon P, Chen H, et al
    Neuraminidase inhibiting antibody responses in pigs differ between influenza A virus N2 lineages and by vaccine type.
    Vaccine. 2016 Jun 17. pii: S0264-410X(16)30400.
    PubMed     Text format     Abstract available


  652. LIVENGOOD JL, Lanka S, Maddox C, Tewari D, et al
    Detection and differentiation of wild-type and a vaccine strain of Streptococcus equi ssp. equi using pyrosequencing.
    Vaccine. 2016 Jun 17. pii: S0264-410X(16)30459.
    PubMed     Text format     Abstract available


  653. SUI J, Yang D, Qiao C, Xu H, et al
    Protective efficacy of an inactivated Eurasian avian-like H1N1 swine influenza vaccine against homologous H1N1 and heterologous H1N1 and H1N2 viruses in mice.
    Vaccine. 2016 Jun 16. pii: S0264-410X(16)30408.
    PubMed     Text format     Abstract available


  654. LV F, Lu Y, Hao ZL, Zhao YH, et al
    Preparation and heat resistance study of porcine reproductive and respiratory syndrome virus sugar glass vaccine.
    Vaccine. 2016 Jun 15. pii: S0264-410X(16)30402.
    PubMed     Text format     Abstract available


  655. SANFTENBERG L, Schrors HJ, Schelling J
    Influences on immunization rates: Vaccination coverage of mumps, measles, rubella and varicella before and after the STIKO intervention 2011 - A retrospective study.
    Vaccine. 2016 Jun 15. pii: S0264-410X(16)30440.
    PubMed     Text format     Abstract available


  656. MCQUAID F, Pask S, Locock L, Davis E, et al
    Attitudes towards antenatal vaccination, Group B streptococcus and participation in clinical trials: Insights from focus groups and interviews of parents and healthcare professionals.
    Vaccine. 2016 Jun 15. pii: S0264-410X(16)30436.
    PubMed     Text format     Abstract available


  657. MARTINS KA, Dye JM, Bavari S
    Considerations for the development of Zika virus vaccines.
    Vaccine. 2016 Jun 15. pii: S0264-410X(16)30425.
    PubMed     Text format    


  658. ROSE N, Andraud M, Bigault L, Jestin A, et al
    A commercial PCV2a-based vaccine significantly reduces PCV2b transmission in experimental conditions.
    Vaccine. 2016 Jun 15. pii: S0264-410X(16)30404.
    PubMed     Text format     Abstract available


  659. XU Q, Cui N, Ma X, Wang F, et al
    Evaluation of a chimeric multi-epitope-based DNA vaccine against subgroup J avian leukosis virus in chickens.
    Vaccine. 2016 Jun 15. pii: S0264-410X(16)30403.
    PubMed     Text format     Abstract available


  660. HAIDARI LA, Brown ST, Ferguson M, Bancroft E, et al
    The economic and operational value of using drones to transport vaccines.
    Vaccine. 2016 Jun 15. pii: S0264-410X(16)30435.
    PubMed     Text format     Abstract available


  661. HAWKES D, Dunlop RA, Benhamu J
    Calls by alternative medicine practitioners for vaccinated vs unvaccinated studies is not supported by evidence.
    Vaccine. 2016;34:3223-4.
    PubMed     Text format    


  662. URUENA A, Vizzotti C, San Juan JA
    Response to Orellano et al. regarding cost-utility analysis of dengue vaccination in a country with heterogeneous risk of dengue transmission.
    Vaccine. 2016;34:3222.
    PubMed     Text format    


  663. ORELLANO PW, Salomon OD
    Will dengue vaccination be cost-effective for Argentina? Reply to letter by Uruena et al. regarding "Cost-utility analysis of dengue vaccination in a country with heterogeneous risk of dengue transmission".
    Vaccine. 2016;34:3221.
    PubMed     Text format    


  664. HANKIN-WEI A, Rein DB, Hernandez-Romieu A, Kennedy MJ, et al
    Cost-effectiveness analysis of catch-up hepatitis a vaccination among unvaccinated/partially-vaccinated children.
    Vaccine. 2016 Jun 14. pii: S0264-410X(16)30464.
    PubMed     Text format     Abstract available


  665. TONTINI M, Romano MR, Proietti D, Balducci E, et al
    Preclinical studies on new proteins as carrier for glycoconjugate vaccines.
    Vaccine. 2016 Jun 14. pii: S0264-410X(16)30463.
    PubMed     Text format     Abstract available


  666. TOWNSEND-PAYNE K, Ladhani SN, Findlow H, Slack M, et al
    Children with Haemophilus influenzae type b (Hib) vaccine failure have long-term bactericidal antibodies against virulent Hib strains with multiple capsular loci.
    Vaccine. 2016 Jun 14. pii: S0264-410X(16)30457.
    PubMed     Text format     Abstract available


  667. WIYSONGE CS, Waggie Z, Hawkridge A, Schoub BD, et al
    The Cape Town Declaration on Vaccines 2012: Unlocking the full potential of vaccines in Africa.
    Vaccine. 2016 Jun 14. pii: S0264-410X(16)30398.
    PubMed     Text format     Abstract available


  668. KLUG B, Robertson JS, Condit RC, Seligman SJ, et al
    Adventitious agents and live viral vectored vaccines: Considerations for archiving samples of biological materials for retrospective analysis.
    Vaccine. 2016 Jun 14. pii: S0264-410X(16)00157.
    PubMed     Text format     Abstract available


  669. LEE GJ, Quan FS
    Protection induced by early stage vaccination with pandemic influenza virus-like particles.
    Vaccine. 2016 Jun 14. pii: S0264-410X(16)30410.
    PubMed     Text format     Abstract available


  670. SAADATIAN-ELAHI M, Aaby P, Shann F, Netea MG, et al
    Heterologous vaccine effects.
    Vaccine. 2016 Jun 13. pii: S0264-410X(16)30433.
    PubMed     Text format     Abstract available


  671. LI Z, Zhang Y, Wang Q, Li Z, et al
    Purification design and practice for pertactin, the third component of acellular pertussis vaccine, from Bordetella pertussis.
    Vaccine. 2016 Jun 11. pii: S0264-410X(16)30442.
    PubMed     Text format     Abstract available


  672. LANGLEY JM, MacDougall DM, Halperin BA, Swain A, et al
    Rapid surveillance for health events following a mass meningococcal B vaccine program in a university setting: A Canadian Immunization Research Network study.
    Vaccine. 2016 Jun 11. pii: S0264-410X(16)30438.
    PubMed     Text format     Abstract available


  673. MULLINS TL, Zimet GD, Rosenthal SL, Morrow C, et al
    Human papillomavirus vaccine-related risk perceptions and subsequent sexual behaviors and sexually transmitted infections among vaccinated adolescent women.
    Vaccine. 2016 Jun 9. pii: S0264-410X(16)30439.
    PubMed     Text format     Abstract available


  674. ABDULLAHI LH, Kagina BM, Cassidy T, Adebayo EF, et al
    Knowledge, attitudes and practices on adolescent vaccination among adolescents, parents and teachers in Africa: A systematic review.
    Vaccine. 2016 Jun 8. pii: S0264-410X(16)30437.
    PubMed     Text format     Abstract available


  675. SILFVERDAL SA, Icardi G, Vesikari T, Flores SA, et al
    A Phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at 2, 4, and 11-12 months.
    Vaccine. 2016 Jun 7. pii: S0264-410X(16)30380.
    PubMed     Text format     Abstract available


  676. STOWE J, Andrews N, Ladhani S, Miller E, et al
    The risk of intussusception following monovalent rotavirus vaccination in England: A self-controlled case-series evaluation.
    Vaccine. 2016 Jun 7. pii: S0264-410X(16)30204.
    PubMed     Text format     Abstract available


  677. FELDSTEIN LR, Matrajt L, Elizabeth Halloran M, Keitel WA, et al
    Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies.
    Vaccine. 2016 Jun 4. pii: S0264-410X(16)30393.
    PubMed     Text format     Abstract available


  678. KOWALCZYK A, Doener F, Zanzinger K, Noth J, et al
    Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity.
    Vaccine. 2016 Jun 3. pii: S0264-410X(16)30372.
    PubMed     Text format     Abstract available


  679. HELLERINGER S, Asuming PO, Abdelwahab J
    The effect of mass vaccination campaigns against polio on the utilization of routine immunization services: A regression discontinuity design.
    Vaccine. 2016 Jun 3. pii: S0264-410X(16)30363.
    PubMed     Text format     Abstract available


  680. SOYSAL A, Karabag-Yilmaz E, Kepenekli E, Karaaslan A, et al
    The impact of a pneumococcal conjugate vaccination program on the nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among healthy children in Turkey.
    Vaccine. 2016 Jun 3. pii: S0264-410X(16)30369.
    PubMed     Text format     Abstract available


  681. ORTIZ JM, Molinari MP, Gravisaco MJ, Paoletta MS, et al
    Evaluation of different heterologous prime-boost immunization strategies against Babesia bovis using viral vectored and protein-adjuvant vaccines based on a chimeric multi-antigen.
    Vaccine. 2016 Jun 3. pii: S0264-410X(16)30379.
    PubMed     Text format     Abstract available


  682. ZHANG L, Wen Z, Lin J, Xu H, et al
    Improving the immunogenicity of a trivalent Neisseria meningitidis native outer membrane vesicle vaccine by genetic modification.
    Vaccine. 2016 Jun 3. pii: S0264-410X(16)30375.
    PubMed     Text format     Abstract available


  683. STADLER J, Zoels S, Eddicks M, Kraft C, et al
    Assessment of safety and reproductive performance after vaccination with a modified live-virus PRRS genotype 1 vaccine in pregnant sows at various stages of gestation.
    Vaccine. 2016 Jun 3. pii: S0264-410X(16)30368.
    PubMed     Text format     Abstract available


  684. HABIB MA, Soofi S, Mach O, Samejo T, et al
    Effect of booster doses of poliovirus vaccine in previously vaccinated children, Clinical Trial Results 2013.
    Vaccine. 2016 Jun 3. pii: S0264-410X(16)30391.
    PubMed     Text format     Abstract available


  685. PEPRAH D, Palmer JJ, Rubin GJ, Abubakar A, et al
    Perceptions of oral cholera vaccine and reasons for full, partial and non-acceptance during a humanitarian crisis in South Sudan.
    Vaccine. 2016 Jun 2. pii: S0264-410X(16)30364.
    PubMed     Text format     Abstract available


  686. COLLADO R, Prenafeta A, Gonzalez-Gonzalez L, Perez-Pons JA, et al
    Probing vaccine antigens against bovine mastitis caused by Streptococcus uberis.
    Vaccine. 2016 Jun 2. pii: S0264-410X(16)30370.
    PubMed     Text format     Abstract available


  687. MURPHY TF, Kirkham C, Johnson A, Brauer AL, et al
    Sulfate-binding protein, CysP, is a candidate vaccine antigen of Moraxella catarrhalis.
    Vaccine. 2016 Jun 2. pii: S0264-410X(16)30371.
    PubMed     Text format     Abstract available


  688. BEST EJ, Walls T, Souter M, Neeff M, et al
    Pneumococcal vaccine impact on otitis media microbiology: A New Zealand cohort study before and after the introduction of PHiD-CV10 vaccine.
    Vaccine. 2016 Jun 2. pii: S0264-410X(16)30367.
    PubMed     Text format     Abstract available


  689. HOLT PG, Snelling T, White OJ, Sly PD, et al
    Transiently increased IgE responses in infants and pre-schoolers receiving only acellular Diphtheria-Pertussis-Tetanus (DTaP) vaccines compared to those initially receiving at least one dose of cellular vaccine (DTwP) - Immunological curiosity or cana
    Vaccine. 2016 Jun 2. pii: S0264-410X(16)30374.
    PubMed     Text format     Abstract available


  690. TOGASHI T, Sugizaki K, Mitsuya N, Kogawara O, et al
    Immunogenicity and safety of a fully liquid aluminum phosphate adjuvanted Haemophilus influenzae type b PRP-CRM-conjugate vaccine in healthy Japanese children: A phase III, randomized, observer-blind, multicenter, parallel-group study.
    Vaccine. 2016 Jun 2. pii: S0264-410X(16)30376.
    PubMed     Text format     Abstract available


  691. KAWAKAMI K, Kishino H, Kanazu S, Toshimizu N, et al
    Revaccination with 23-valent pneumococcal polysaccharide vaccine in the Japanese elderly is well tolerated and elicits immune responses.
    Vaccine. 2016 Jun 2. pii: S0264-410X(16)30378.
    PubMed     Text format     Abstract available


  692. VILAJELIU A, Ferrer L, Munros J, Gonce A, et al
    Pertussis vaccination during pregnancy: Antibody persistence in infants.
    Vaccine. 2016 Jun 2. pii: S0264-410X(16)30377.
    PubMed     Text format     Abstract available


  693. RADIN JM, Hawksworth AW, Myers CA, Ricketts MN, et al
    Influenza vaccine effectiveness: Maintained protection throughout the duration of influenza seasons 2010-2011 through 2013-2014.
    Vaccine. 2016 Jun 2. pii: S0264-410X(16)30324.
    PubMed     Text format     Abstract available


    May 2016
  694. GIESE C, Mereckiene J, Danis K, O'Donnell J, et al
    Low vaccination coverage for seasonal influenza and pneumococcal disease among adults at-risk and health care workers in Ireland, 2013: The key role of GPs in recommending vaccination.
    Vaccine. 2016 May 30. pii: S0264-410X(16)30318.
    PubMed     Text format     Abstract available


  695. MCCONEGHY KW, Wing C
    A national examination of pharmacy-based immunization statutes and their association with influenza vaccinations and preventive health.
    Vaccine. 2016 May 21. pii: S0264-410X(16)30241.
    PubMed     Text format     Abstract available


  696. HEQUET D, Pascual M, Lartey S, Pathirana RD, et al
    Humoral, T-cell and B-cell immune responses to seasonal influenza vaccine in solid organ transplant recipients receiving anti-T cell therapies.
    Vaccine. 2016 May 21. pii: S0264-410X(16)30311.
    PubMed     Text format     Abstract available


  697. GIRARD MP, Le-Grand R, Picot V, Longuet C, et al
    Report of the Cent Gardes HIV Vaccines Conference. Part 1: The antibody response; Fondation Merieux Conference Center, Veyrier-du-Lac, France, 25-27 October 2015.
    Vaccine. 2016 May 20. pii: S0264-410X(16)30314.
    PubMed     Text format     Abstract available


  698. DOS SANTOS G, Haguinet F, Cohet C, Webb D, et al
    Risk of solid organ transplant rejection following vaccination with seasonal trivalent inactivated influenza vaccines in England: A self-controlled case-series.
    Vaccine. 2016 May 20. pii: S0264-410X(16)30299.
    PubMed     Text format     Abstract available


  699. DREDZE M, Broniatowski DA, Hilyard KM
    Zika vaccine misconceptions: A social media analysis.
    Vaccine. 2016 May 20. pii: S0264-410X(16)30291.
    PubMed     Text format    


  700. REGAN AK, Klerk N, Moore HC, Omer SB, et al
    Effectiveness of seasonal trivalent influenza vaccination against hospital-attended acute respiratory infections in pregnant women: A retrospective cohort study.
    Vaccine. 2016 May 20. pii: S0264-410X(16)30322.
    PubMed     Text format     Abstract available


  701. BORGGREN M, Nielsen J, Karlsson I, Dalgaard TS, et al
    A polyvalent influenza DNA vaccine applied by needle-free intradermal delivery induces cross-reactive humoral and cellular immune responses in pigs.
    Vaccine. 2016 May 19. pii: S0264-410X(16)30320.
    PubMed     Text format     Abstract available


  702. LI J, Li J, Aipire A, Luo J, et al
    The combination of Pleurotus ferulae water extract and CpG-ODN enhances the immune responses and antitumor efficacy of HPV peptides pulsed dendritic cell-based vaccine.
    Vaccine. 2016 May 19. pii: S0264-410X(16)30312.
    PubMed     Text format     Abstract available


  703. HARAPAN H, Anwar S, Setiawan AM, Sasmono RT, et al
    Dengue vaccine acceptance and associated factors in Indonesia: A community-based cross-sectional survey in Aceh.
    Vaccine. 2016 May 18. pii: S0264-410X(16)30316.
    PubMed     Text format     Abstract available


  704. RAMEZANPOUR B, de Foucauld J, Kortekaas J
    Emergency deployment of genetically engineered veterinary vaccines in Europe.
    Vaccine. 2016 May 18. pii: S0264-410X(16)30296.
    PubMed     Text format     Abstract available


  705. YOKOKURA Y
    Special lecture "Strategies for the widespread application of vaccination".
    Vaccine. 2016 May 18. pii: S0264-410X(16)30213.
    PubMed     Text format    


  706. FOGEL I, Brosh-Nissimov T, Vager G, Aviv Y, et al
    Estimated prevalence of smallpox vaccine contraindications in Israeli adolescents.
    Vaccine. 2016 May 18. pii: S0264-410X(16)30315.
    PubMed     Text format     Abstract available


  707. HANNAMAN D, Dupuy LC, Ellefsen B, Schmaljohn CS, et al
    A Phase 1 clinical trial of a DNA vaccine for Venezuelan equine encephalitis delivered by intramuscular or intradermal electroporation.
    Vaccine. 2016 May 17. pii: S0264-410X(16)30242.
    PubMed     Text format     Abstract available


  708. PELLEGRINO M, Rodriguez N, Vivas A, Giraudo J, et al
    Staphylococcus aureus avirulent mutant vaccine induces humoral and cellular immune responses on pregnant heifers.
    Vaccine. 2016 May 16. pii: S0264-410X(16)30297.
    PubMed     Text format     Abstract available


  709. THOMPSON MG, Gaglani MJ, Naleway AL, Dowell SH, et al
    Reduced serologic sensitivity to influenza A virus illness among inactivated influenza vaccinees.
    Vaccine. 2016 May 16. pii: S0264-410X(16)30260.
    PubMed     Text format     Abstract available


  710. ZHANG Q, Liu Z, Hou J, Wang S, et al
    Improved safety of a replication-competent poxvirus-based HIV vaccine with the introduction of the HSV-TK/GCV suicide gene system.
    Vaccine. 2016 May 16. pii: S0264-410X(16)30295.
    PubMed     Text format     Abstract available


  711. MIYAHARA R, Jasseh M, Gomez P, Shimakawa Y, et al
    Barriers to timely administration of birth dose vaccines in The Gambia, West Africa.
    Vaccine. 2016 May 16. pii: S0264-410X(16)30300.
    PubMed     Text format     Abstract available


  712. ASTURIAS EJ, Wharton M, Pless R, MacDonald NE, et al
    Contributions and challenges for worldwide vaccine safety: The Global Advisory Committee on Vaccine Safety at 15 years.
    Vaccine. 2016 May 16. pii: S0264-410X(16)30301.
    PubMed     Text format     Abstract available


  713. PARRELLA A, Braunack-Mayer A, Collins J, Clarke M, et al
    Prioritizing government funding of adolescent vaccinations: recommendations from young people on a citizens' jury.
    Vaccine. 2016 May 16. pii: S0264-410X(16)30302.
    PubMed     Text format     Abstract available


  714. GRAHAM BS
    Vaccines against respiratory syncytial virus: The time has finally come.
    Vaccine. 2016 May 13. pii: S0264-410X(16)30257.
    PubMed     Text format     Abstract available


  715. SUNAGAR R, Kumar S, Franz BJ, Gosselin EJ, et al
    Vaccination evokes gender-dependent protection against tularemia infection in C57BL/6Tac mice.
    Vaccine. 2016 May 13. pii: S0264-410X(16)30208.
    PubMed     Text format     Abstract available


  716. BONA G, Castiglia P, Zoppi G, de Martino M, et al
    Safety and immunogenicity of a CRM or TT conjugated meningococcal vaccine in healthy toddlers.
    Vaccine. 2016 May 12. pii: S0264-410X(16)30292.
    PubMed     Text format     Abstract available


  717. KENNEDY RB, Poland GA, Ovsyannikova IG, Oberg AL, et al
    Impaired innate, humoral, and cellular immunity despite a take in smallpox vaccine recipients.
    Vaccine. 2016 May 11. pii: S0264-410X(16)30277.
    PubMed     Text format     Abstract available


  718. GOMES MG, Gordon SB, Lalloo DG
    Clinical trials: The mathematics of falling vaccine efficacy with rising disease incidence.
    Vaccine. 2016 May 10. pii: S0264-410X(16)30230.
    PubMed     Text format    


  719. GALA RP, D'Souza M, Zughaier SM
    Evaluation of various adjuvant nanoparticulate formulations for meningococcal capsular oolysaccharide-based vaccine.
    Vaccine. 2016 May 10. pii: S0264-410X(16)30293.
    PubMed     Text format     Abstract available


  720. BLAGBOROUGH AM, Musiychuk K, Bi H, Jones RM, et al
    Transmission blocking potency and immunogenicity of a plant-produced Pvs25-based subunit vaccine against Plasmodium vivax.
    Vaccine. 2016 May 10. pii: S0264-410X(16)30290.
    PubMed     Text format     Abstract available


  721. VAN WERKHOVEN CH, Hollingsworth RC, Huijts SM, Bolkenbaas M, et al
    Pneumococcal conjugate vaccine herd effects on non-invasive pneumococcal pneumonia in elderly.
    Vaccine. 2016 May 9. pii: S0264-410X(16)30274.
    PubMed     Text format     Abstract available


  722. HOTEZ PJ, Strych U, Lustigman S, Bottazzi ME, et al
    Human anthelminthic vaccines: Rationale and challenges.
    Vaccine. 2016 May 9. pii: S0264-410X(16)30259.
    PubMed     Text format     Abstract available


  723. BUMBAROV V, Golender N, Erster O, Khinich Y, et al
    Detection and isolation of Bluetongue virus from commercial vaccine batches.
    Vaccine. 2016 May 9. pii: S0264-410X(16)30094.
    PubMed     Text format     Abstract available


  724. MOWBRAY F, Marcu A, Godinho CA, Michie S, et al
    Communicating to increase public uptake of pandemic flu vaccination in the UK: Which messages work?
    Vaccine. 2016 May 8. pii: S0264-410X(16)30278.
    PubMed     Text format     Abstract available


  725. ZHAO Z, Smith PJ, Hill HA
    Evaluation of potentially achievable vaccination coverage with simultaneous administration of vaccines among children in the United States.
    Vaccine. 2016 May 6. pii: S0264-410X(16)30272.
    PubMed     Text format     Abstract available


  726. OZAKI T, Asano Y
    Development of varicella vaccine in Japan and future prospects.
    Vaccine. 2016 May 6. pii: S0264-410X(16)30214.
    PubMed     Text format     Abstract available


  727. KUSAKABE T, Ozasa K, Kobari S, Momota M, et al
    Intranasal hydroxypropyl-beta-cyclodextrin-adjuvanted influenza vaccine protects against sub-heterologous virus infection.
    Vaccine. 2016 May 6. pii: S0264-410X(16)30121.
    PubMed     Text format     Abstract available


  728. DINDA AK, Bhat M, Srivastava S, Kottarath SK, et al
    Novel nanocarrier for oral Hepatitis B vaccine.
    Vaccine. 2016 May 6. pii: S0264-410X(16)30258.
    PubMed     Text format     Abstract available


  729. BRONIATOWSKI DA, Hilyard KM, Dredze M
    Effective vaccine communication during the disneyland measles outbreak.
    Vaccine. 2016 May 6. pii: S0264-410X(16)30198.
    PubMed     Text format     Abstract available


  730. XU J, Zhou F, Reed C, Chaves SS, et al
    Cost-effectiveness of seasonal inactivated influenza vaccination among pregnant women.
    Vaccine. 2016 May 5. pii: S0264-410X(16)30211.
    PubMed     Text format     Abstract available


  731. DUDEK K, Bednarek D, Ayling RD, Kycko A, et al
    An experimental vaccine composed of two adjuvants gives protection against Mycoplasma bovis in calves.
    Vaccine. 2016 May 5. pii: S0264-410X(16)30262.
    PubMed     Text format     Abstract available


  732. THOMPSON EL, Vamos CA, Sappenfield WM, Straub DM, et al
    Relationship status impacts primary reasons for interest in the HPV vaccine among young adult women.
    Vaccine. 2016 May 5. pii: S0264-410X(16)30228.
    PubMed     Text format     Abstract available


  733. MEALING N, Hayen A, Newall AT
    Assessing the impact of vaccination programmes on burden of disease: Underlying complexities and statistical methods.
    Vaccine. 2016 May 5. pii: S0264-410X(16)30143.
    PubMed     Text format     Abstract available


  734. JIANG X, Zhang C, Zhao Y, Kong X, et al
    Immune effects of the vaccine of live attenuated Aeromonas hydrophila screened by rifampicin on common carp (Cyprinus carpio L).
    Vaccine. 2016 May 4. pii: S0264-410X(16)30240.
    PubMed     Text format     Abstract available


  735. VENEREO-SANCHEZ A, Gilbert R, Simoneau M, Caron A, et al
    Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.
    Vaccine. 2016 May 4. pii: S0264-410X(16)30264.
    PubMed     Text format     Abstract available


  736. FENG H, Segales J, Fraile L, Lopez-Soria S, et al
    Effect of high and low levels of maternally derived antibodies on porcine circovirus type 2 (PCV2) infection dynamics and production parameters in PCV2 vaccinated pigs under field conditions.
    Vaccine. 2016 May 4. pii: S0264-410X(16)30263.
    PubMed     Text format     Abstract available


  737. ORENSTEIN WA, Simon R
    Introduction to issue of highlighted research presented at the 2015 National Foundation for Infectious Diseases Annual Conference on Vaccine Research.
    Vaccine. 2016 May 4. pii: S0264-410X(16)30273.
    PubMed     Text format    


  738. WHITE JA, Estrada M, Flood EA, Mahmood K, et al
    Development of a stable liquid formulation of live attenuated influenza vaccine.
    Vaccine. 2016 May 4. pii: S0264-410X(16)30239.
    PubMed     Text format     Abstract available


  739. SIVKO GS, Stark GV, Tordoff KP, Taylor KL, et al
    Evaluation of early immune response-survival relationship in cynomolgus macaques after anthrax vaccine adsorbed vaccination and Bacillus anthracis spore challenge.
    Vaccine. 2016 May 4. pii: S0264-410X(16)30202.
    PubMed     Text format     Abstract available


  740. FRENCK RW JR, Fiquet A, Gurtman A, van Cleeff M, et al
    Immunogenicity and safety of a second administration of 13-valent pneumococcal conjugate vaccine 5 years after initial vaccination in adults 50 years and older.
    Vaccine. 2016 May 4. pii: S0264-410X(16)30268.
    PubMed     Text format     Abstract available


  741. GOLDENBERG D, Lublin A, Rosenbluth E, Heller ED, et al
    Optimized polypeptide for a subunit vaccine against avian reovirus.
    Vaccine. 2016 May 4. pii: S0264-410X(16)30177.
    PubMed     Text format     Abstract available


  742. CORACE KM, Srigley JA, Hargadon DP, Yu D, et al
    Using behavior change frameworks to improve healthcare worker influenza vaccination rates: A systematic review.
    Vaccine. 2016 May 4. pii: S0264-410X(16)30236.
    PubMed     Text format     Abstract available


  743. RIZZO C, Bella A, Alfonsi A, Puzelli S, et al
    Influenza vaccine effectiveness in Italy: Age, subtype-specific and vaccine type estimates 2014/15 season.
    Vaccine. 2016 May 4. pii: S0264-410X(16)30237.
    PubMed     Text format     Abstract available


  744. CONTRERAS M, de la Fuente J
    Control of Ixodes ricinus and Dermacentor reticulatus tick infestations in rabbits vaccinated with the Q38 Subolesin/Akirin chimera.
    Vaccine. 2016 May 4. pii: S0264-410X(16)30267.
    PubMed     Text format     Abstract available


  745. TANIUCHI M, Platts-Mills JA, Begum S, Uddin MJ, et al
    Impact of enterovirus and other enteric pathogens on oral polio and rotavirus vaccine performance in Bangladeshi infants.
    Vaccine. 2016 May 3. pii: S0264-410X(16)30254.
    PubMed     Text format     Abstract available


  746. BRODER CC, Weir DL, Reid PA
    Hendra virus and Nipah virus animal vaccines.
    Vaccine. 2016 May 3. pii: S0264-410X(16)30072.
    PubMed     Text format     Abstract available


  747. SHEN CF, Jacob D, Zhu T, Bernier A, et al
    Optimization and scale-up of cell culture and purification processes for production of an adenovirus-vectored tuberculosis vaccine candidate.
    Vaccine. 2016 May 3. pii: S0264-410X(16)30265.
    PubMed     Text format     Abstract available


  748. BOTTERO D, Gaillard ME, Zurita E, Moreno G, et al
    Characterization of the immune response induced by pertussis OMVs-based vaccine.
    Vaccine. 2016 May 2. pii: S0264-410X(16)30244.
    PubMed     Text format     Abstract available


  749. FERNANDEZ-BELLON H, Vergara-Alert J, Almagro V, Rivas R, et al
    Vaccination against H5 avian influenza virus induces long-term humoral immune responses in flamingoes (Phoenicopterus spp.).
    Vaccine. 2016 May 2. pii: S0264-410X(16)30243.
    PubMed     Text format     Abstract available


    April 2016
  750. IVANCIC-JELECKI J, Forcic D, Jagusic M, Kosutic-Gulija T, et al
    Influence of population diversity on neurovirulence potential of plaque purified L-Zagreb variants.
    Vaccine. 2016;34:2383-9.
    PubMed     Text format     Abstract available


  751. LI M, Li C, Song S, Kang H, et al
    Development and antigenic characterization of three recombinant proteins with potential for Glasser's disease prevention.
    Vaccine. 2016;34:2251-8.
    PubMed     Text format     Abstract available


  752. TAFURI S, Gallone MS, Gallone MF, Pappagallo MT, et al
    Monitoring the process of measles elimination by serosurveillance data: The Apulian 2012 study.
    Vaccine. 2016;34:2092-5.
    PubMed     Text format     Abstract available


  753. LEE MS, Igari Y, Tsukui T, Ishii KJ, et al
    Current status of synthetic hemozoin adjuvant: A preliminary safety evaluation.
    Vaccine. 2016;34:2055-61.
    PubMed     Text format     Abstract available


  754. LEBENS M, Terrinoni M, Karlsson SL, Larena M, et al
    Construction and preclinical evaluation of mmCT, a novel mutant cholera toxin adjuvant that can be efficiently produced in genetically manipulated Vibrio cholerae.
    Vaccine. 2016;34:2121-8.
    PubMed     Text format     Abstract available


  755. CARDIN RD, Bravo FJ, Pullum DA, Orlinger K, et al
    Replication-defective lymphocytic choriomeningitis virus vectors expressing guinea pig cytomegalovirus gB and pp65 homologs are protective against congenital guinea pig cytomegalovirus infection.
    Vaccine. 2016;34:1993-9.
    PubMed     Text format     Abstract available


  756. HU G, Wang N, Yu W, Wang Z, et al
    Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B.
    Vaccine. 2016;34:1896-903.
    PubMed     Text format     Abstract available


  757. HUTCHINGS HA, Evans A, Barnes P, Healy MA, et al
    Does frequent residential mobility in early years affect the uptake and timeliness of routine immunisations? An anonymised cohort study.
    Vaccine. 2016;34:1773-7.
    PubMed     Text format     Abstract available


    March 2016
  758. NUNES S, Felix S, Valente C, Simoes AS, et al
    The impact of private use of PCV7 in 2009 and 2010 on serotypes and antimicrobial resistance of Streptococcus pneumoniae carried by young children in Portugal: Comparison with data obtained since 1996 generating a 15-year study prior to PCV13 introduc
    Vaccine. 2016;34:1648-56.
    PubMed     Text format     Abstract available


  759. CHAMPION OL, Gourlay LJ, Scott AE, Lassaux P, et al
    Immunisation with proteins expressed during chronic murine melioidosis provides enhanced protection against disease.
    Vaccine. 2016;34:1665-71.
    PubMed     Text format     Abstract available


  760. DURRHEIM DN
    Every rabies death is a veterinary and health system failure until proven otherwise.
    Vaccine. 2016 Mar 21. pii: S0264-410X(16)30033.
    PubMed     Text format    


  761. SARMIENTO JD, Villada F, Orrego JC, Franco JL, et al
    Adverse events following immunization in patients with primary immunodeficiencies.
    Vaccine. 2016;34:1611-6.
    PubMed     Text format     Abstract available


  762. NICOLI F, Gallerani E, Skarlis C, Sicurella M, et al
    Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection.
    Vaccine. 2016 Mar 18. pii: S0264-410X(16)00333.
    PubMed     Text format     Abstract available


  763. AGUEMON CT, Tarantola A, Zoumenou E, Goyet S, et al
    Rabies transmission risks during peripartum - Two cases and a review of the literature.
    Vaccine. 2016 Mar 3. pii: S0264-410X(16)00260.
    PubMed     Text format     Abstract available


  764. FEIRING B, Laake I, Molden T, Haberg SE, et al
    Do selective immunisation against tuberculosis and hepatitis B reach the targeted populations? A nationwide register-based study evaluating the recommendations in the Norwegian Childhood Immunisation Programme.
    Vaccine. 2016 Mar 3. pii: S0264-410X(16)00255.
    PubMed     Text format     Abstract available


    February 2016
  765. SAMO M, Choudhary NR, Riebe KJ, Shterev I, et al
    Immunization with the Haemophilus ducreyi trimeric autotransporter adhesin DsrA with alum, CpG or imiquimod generates a persistent humoral immune response that recognizes the bacterial surface.
    Vaccine. 2016;34:1193-200.
    PubMed     Text format     Abstract available


  766. SALVERDA ML, Meinderts SM, Hamstra HJ, Wagemakers A, et al
    Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles.
    Vaccine. 2016;34:1025-33.
    PubMed     Text format     Abstract available


  767. DROPPA-ALMEIDA D, Vivas WL, Silva KK, Rezende AF, et al
    Recombinant CP40 from Corynebacterium pseudotuberculosis confers protection in mice after challenge with a virulent strain.
    Vaccine. 2016;34:1091-6.
    PubMed     Text format     Abstract available


  768. CHIANG CY, Liu SJ, Hsieh CH, Chen MY, et al
    Recombinant lipidated dengue-3 envelope protein domain III stimulates broad immune responses in mice.
    Vaccine. 2016;34:1054-61.
    PubMed     Text format     Abstract available


  769. FEUNOU PF, Mielcarek N, Locht C
    Reciprocal interference of maternal and infant immunization in protection against pertussis.
    Vaccine. 2016;34:1062-9.
    PubMed     Text format     Abstract available


  770. SANDER B, Wong WW, Yeung MW, Ormanidhi O, et al
    The cost-utility of integrated cervical cancer prevention strategies in the Ontario setting - Can we do better?
    Vaccine. 2016 Feb 15. pii: S0264-410X(16)00158.
    PubMed     Text format     Abstract available


  771. SAKTHI S, Palaniyandi K, Gupta UD, Gupta P, et al
    Lipoprotein LpqS deficient M. tuberculosis mutant is attenuated for virulence in vivo and shows protective efficacy better than BCG in guinea pigs.
    Vaccine. 2016;34:735-43.
    PubMed     Text format     Abstract available


  772. MENEZES AP, Azevedo J, Leite MC, Campos LC, et al
    Nasopharyngeal carriage of Streptococcus pneumoniae among children in an urban setting in Brazil prior to PCV10 introduction.
    Vaccine. 2016;34:791-7.
    PubMed     Text format     Abstract available


    January 2016
  773. TAN HX, Gilbertson BP, Jegaskanda S, Alcantara S, et al
    Recombinant influenza virus expressing HIV-1 p24 capsid protein induces mucosal HIV-specific CD8 T-cell responses.
    Vaccine. 2016 Jan 28. pii: S0264-410X(16)00074.
    PubMed     Text format     Abstract available


  774. SURADHAT S, Wongyanin P, Sirisereewan C, Nedumpun T, et al
    Transdermal delivery of plasmid encoding truncated nucleocapsid protein enhanced PRRSV-specific immune responses.
    Vaccine. 2016;34:609-15.
    PubMed     Text format     Abstract available


  775. KUMAR S, Koul M
    Newcastle disease virus: A constant threat to the poultry industry in India.
    Vaccine. 2016;34:597-8.
    PubMed     Text format    


  776. AVILA MOURA A, de Mello MJ, Correia JB
    Serological statuses of pregnant women in an urban Brazilian population before and after the 2008 rubella immunization campaign.
    Vaccine. 2016;34:445-50.
    PubMed     Text format     Abstract available


  777. DINELLI MI, Ono E, Viana PO, Spina FG, et al
    Response to immunization in children born to renal transplant recipients using immunosuppressive drugs during gestation.
    Vaccine. 2016;34:404-7.
    PubMed     Text format     Abstract available


  778. KENDALL BA, Dascomb KK, Mehta RR, Stockmann C, et al
    Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children.
    Vaccine. 2016;34:474-8.
    PubMed     Text format     Abstract available


  779. ARANYOS AM, Roff SR, Pu R, Owen JL, et al
    An initial examination of the potential role of T-cell immunity in protection against feline immunodeficiency virus (FIV) infection.
    Vaccine. 2016 Jan 20. pii: S0264-410X(16)00043.
    PubMed     Text format     Abstract available


  780. TASHER D, Rahav G, Levine H, Sofer D, et al
    How many OPV rounds are required to stop wild polio virus circulation in a developed country? Lessons from the Israeli experience.
    Vaccine. 2016;34:299-301.
    PubMed     Text format    


  781. HUO YF, Huang QH, Lu M, Wu JQ, et al
    Attenuation mechanism of virulent infectious bronchitis virus strain with QX genotype by continuous passage in chicken embryos.
    Vaccine. 2016;34:83-9.
    PubMed     Text format     Abstract available


  782. PAYAKACHAT N, Hadden KB, Ragland D
    Promoting Tdap immunization in pregnancy: Associations between maternal perceptions and vaccination rates.
    Vaccine. 2016;34:179-86.
    PubMed     Text format     Abstract available


    December 2015
  783. ABD-ELGHAFFAR AA, Ali AE, Boseila AA, Amin MA, et al
    Inactivation of rabies virus by hydrogen peroxide.
    Vaccine. 2015 Dec 27. pii: S0264-410X(15)01838.
    PubMed     Text format     Abstract available


  784. CHANG DH, Bednarczyk RA, Becker ER, Hockenberry JM, et al
    Trends in U.S. hospitalizations and inpatient deaths from pneumonia and influenza, 1996-2011.
    Vaccine. 2015 Dec 17. pii: S0264-410X(15)01774.
    PubMed     Text format     Abstract available


  785. KUMAR A, Das S, Mullick R, Lahiri P, et al
    Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: A novel VLP prime-adenovirus boost strategy.
    Vaccine. 2015 Dec 12. pii: S0264-410X(15)01727.
    PubMed     Text format     Abstract available


    October 2015
  786. KERKHOVE MD, Cooper MJ, Eick-Cost AA, Sanchez JL, et al
    Risk factors for severe outcomes among members of the United States military hospitalized with pneumonia and influenza, 2000-2012.
    Vaccine. 2015 Oct 19. pii: S0264-410X(15)01426.
    PubMed     Text format     Abstract available


    September 2015
  787. KILLICK MA, Grant ML, Cerutti NM, Capovilla A, et al
    Env-2dCD4 complexes act as super immunogens and elicit potent, broadly neutralizing antibodies against clinically relevant human immunodeficiency virus type 1 (HIV-1).
    Vaccine. 2015 Sep 30. pii: S0264-410X(15)01332.
    PubMed     Text format     Abstract available


  788. BECK Z, Matyas GR, Jalah R, Rao M, et al
    Differential immune responses to HIV-1 envelope protein induced by liposomal adjuvant formulations containing monophosphoryl lipid A with or without QS21.
    Vaccine. 2015 Sep 12. pii: S0264-410X(15)01244.
    PubMed     Text format     Abstract available


    July 2015
  789. KOUL PA, Bali NK
    Influenza vaccination in India: Challenges for universal adoption.
    Vaccine. 2015 Jul 18. pii: S0264-410X(15)00965.
    PubMed     Text format    


  790. KORIOTH-SCHMITZ B, Perley CC, Sixsmith JD, Click EM, et al
    Rhesus immune responses to SIV Gag expressed by recombinant BCG vectors are independent from pre-existing mycobacterial immunity.
    Vaccine. 2015 Jul 17. pii: S0264-410X(15)00944.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: